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After several years working as a senior resident in dermatology at the University Hospital of 
North Norway, I was introduced to a skilled and innovative multidisciplinary group of 
scientists, with interests in chronic inflammatory disease, metabolic disturbances, and host-
microbe interactions; spanning both basic biological research as well as epidemiological 
cohort studies. I thereby joined the “Tromsø Staph and Skin Study” group in 2006, and 
plunged into the world of epidemiological research. I received a grant from the Northern 
Norway Regional Health Authority to pursue the project leading to this thesis from 2009.  
Exploring a PhD has been a great adventure. I found it very stimulating to have the time to 
deep dig into the literature and take part in generating hypothesis as well as collecting, 
analyzing and presenting the data. This has been a very rewarding experience, both 
professionally and personally. I aspire to continue an academic career, as well as returning to 
tend to my patients. 
It has been an eye-opener for me to see how many research questions still lack adequate 
answers within dermatology, as well as realizing the importance of quality in every step of the 
research process. This applies not only for those who  aspire to work as a scientist, but also 
for physicians in general, in order to evaluate what is presented to you and making the right 
decisions for your patients. 
 
“It does happen exceptionally that a practicing doctor makes a contribution to science; but it 
happens much oftener that he draws disastrous conclusions from his clinical experience 
because he has no conception of scientific method, and believes, like any rustic, that the 
handling of evidence and statistics needs no expertise.”  
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Recently it has been suggested that the chronic inflammatory disease psoriasis is more than 
skin deep, as it has been associated with several diseases, including diabetes and 
cardiovascular disease. Psoriasis can be attributed to genetic liability as well as environmental 
risk factors. The overall aim of the thesis was to study time trends in psoriasis prevalence and 
investigate whether excess weight was associated with psoriasis development, including 
potential synergisms with smoking. Furthermore, the association between psoriasis and the 
metabolic syndrome, a predictor for diabetes and cardiovascular disease, was explored; all 
within the population-based North-Norwegian Tromsø study cohort from 1979 to 2008. 
We observed an increase in the self-reported prevalence of psoriasis over the past 30 years 
among adults above age 29; with more than doubled odds of psoriasis reported in 2007-08 as 
compared with 1979-80, independent of the investigated birth cohort and population ageing. 
The lifetime prevalence of psoriasis was 11% among adults in the 2007-08 survey. This 
increasing trend could partially be due to increased awareness of the disease in the population; 
however, our results are also supported by others, indicating a global trend. 
Overweight above a threshold of body mass index (BMI) 27-28 kg/m2 increased the risk of 
psoriasis by 32-41% in 7-13 years follow-up in both genders combined, with even higher risk 
among overweight and obese non-smokers 62-71%. In Tromsø 4 (1994-95), adult weight-gain 
led to up to 90% increased risk of psoriasis development from age 45, regardless of weight 
category. Smoking almost doubled the risk of psoriasis, but there was no indication of a 
multiplicative effect of overweight and smoking. The cumulative effect from smoking and 
obesity on psoriasis development may explain some of the increase in psoriasis observed in 
our study and in comparable populations.  
When investigating the association between psoriasis and the metabolic syndrome, 32% of 
psoriatics versus 24% of the reference population met the criteria for the metabolic syndrome. 
Men with psoriasis had a stable 35% increased odds of metabolic syndrome compared to 
persons without psoriasis, while young women with psoriasis displayed a four times increased 
odds of developing the metabolic syndrome. We observed a dose-response relationship 
between the severity of psoriasis and the odds of abdominal overweight in women. Further 
studies to evaluate the potential benefit from screening for the metabolic syndrome in patients 




Nyere kunnskap tyder på at psoriasis ikke bare er en kronisk inflammatorisk sykdom 
begrenset til huden, da psoriasis også kan være forbundet med økt risiko for andre sykdommer 
som diabetes og hjertekar sykdom. Utvikling av psoriasis betinger genetisk predisposisjon, 
men miljøfaktorer kan påvirke debut og senere forløp. Den overordnede målsetningen for 
avhandlingen var derfor å studere tidstrender av psoriasisforekomst, samt å evaluere hvorvidt 
overvekt, vektøkning og kombinasjon av røyking og overvekt kan øke risiko for psoriasis hos 
begge kjønn og i ulike aldersgrupper. Vi ønsket også å se nærmere på sammenhengen mellom 
psoriasis og metabolsk syndrom, en kjent risikofaktor for diabetes og hjertekarsykdom, i en 
populasjonsbasert kohort i Nord-Norge, Tromsø undersøkelsen, undersøkt ved fem tidspunkt i 
Tromsø 2-6 fra 1979 til 2008.  
Vi fant en økning i selvrapportert psoriasis, med mer enn doblet risiko for psoriasis i 2007-08 
sammenlignet med i 1979-80 uavhengig av hvilken fødselskohort eller aldersgruppe som ble 
undersøkt, fra fylte 29 år. I 1979-80 rapporterte 11% av voksne å ha eller ha hatt psoriasis. 
Økningen i psoriasisforekomst kan dels skyldes økt bevissthet rundt sykdommen i 
befolkningen. Det er imidlertidig rapportert doblet forekomst av psoriasis også i andre 
befolkninger, noe som indikerer en global trend. 
Overvekt med kroppsmasseindeks (BMI) fra 27-28 kg/m2 ga en 32-41% økt risiko for 
utvikling av psoriasis i løpet av 7-13 år oppfølgingstid hos begge kjønn kombinert og opptil 
62-71% økt risiko hos ikke-røykere med overvekt og fedme. Hos deltakere som var 45 år eller 
eldre i Tromsø 4 (1994-95), ga vektøkning fra 25-årsalder en opptil 90% økt risiko for 
psoriasis. Røykere hadde doblet risiko for psoriasis, men det var ingen synergistisk effekt av 
røyk og overvekt. Den samlede effekten av overvekt og røyking, kan muligens forklare noe av 
økningen i psoriasis både i Tromsø kohorten og i sammenlignbare populasjoner.  
I Tromsø 6, 2007-08, påviste vi betydelig høyere forekomst av metabolsk syndrom hos 
deltakere med psoriasis; 32% versus 24% hos øvrige deltakere. Menn med psoriasis hadde en 
35% økt odds for metabolsk syndrom sammenlignet med menn uten psoriasis. Den sterkeste 
sammenhengen fant vi blant unge kvinner, der psoriasis var forbundet med fire ganger økt 
odds for metabolsk syndrom. Vi fant et dose-respons forhold mellom alvorlighetsgrad av 
psoriasis og odds for abdominal overvekt hos kvinner. Studier som vurderer nytten av 
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1. Background  
Psoriasis is a chronic relapsing inflammatory immune-mediated skin disease leading to 
substantial morbidity.1 A condition similar to psoriasis was already described by Hippocrates 
(460-377 BC) and in the Holy Bible, while the final description and naming of the disease 
was made by Robert Willan (1757-1812) and Ferdinand Hebra (1816-80).2 Despite that most 
cases are mild plaque types which may come and go through life; studies indicate that the 
impact on a person’s quality of life may be substantial.3,4 Over the past decade psoriasis has 
been associated with several comorbid conditions including diabetes and cardiovascular 
disease,5-7 as well as overall mortality in more severe cases; indicating that the psoriasis 
plaques seen on the skin surface may represent mere tips of the iceberg.3,8-13  A large part of 
psoriasis can be attributed to genetic liability; however, a substantial part of the disease 
phenotype is caused by environmental risk factors, including lifestyle, giving a potential for 
primary prevention of both the disease itself and possible secondary comorbidities.14 Changes 
in environmental exposures, like the obesity epidemic which leads to increased systemic 
inflammation, may also influence time trends of psoriasis.  
 
1.1 Prevalence and incidence 
The debut of psoriasis can appear at all ages, and while some studies describe an increasing 
prevalence with age up until approximately 60-70 years, others have defined two peaks of 
onset; one between age 20-39 and another between 50-69 years.15 Some investigators debate 
that there is a type I and type II psoriasis, depending on the age of onset before or after 
middle-age (40-50 years);1,16 where type I may be more severe and influenced by specific 
genetic factors, and type II may be milder and more influenced by environmental factors.17 
Traditionally, it has been said that 70-75% of psoriasis cases represent type I.16 Although a 
younger debut is described in women, there does not seem to be a gender difference in the 
predilection for developing psoriasis in a lifelong perspective.15 In general a young debut and 
close family members with severe disease may indicate that a more severe course of disease 
can be expected.16 Cohort studies from the general population investigating the natural history 
of psoriasis in modern times are needed.18  
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The prevalence, or prevalence proportion, of psoriasis gives the proportion of the population 
with psoriasis either at one point in time, point prevalence, or during a defined time period, 
period prevalence. From population-based samples, psoriasis prevalence is reported spanning 
from < 0.5 to 8.5%.15 Among certain native groups like South American Indians, Australian 
aborigines and inhabitants of isolated Pacific Islands psoriasis rates as low as zero have been 
suggested; while the world’s highest reported prevalence rate of 11.8% comes from 
Kazaschye, in the former Soviet Union.15,19 Unfortunately, the methods used to ascertain these 
results were not available for evaluation.20 A previous prevalence study from the US found 
higher psoriasis frequencies in persons with Caucasian versus African heritage, indicating 
ethnical differences in liability.21 Low prevalence rates are also consistently reported from 
Asia.15 Population-based data are still limited from most of Asia including India, as well as 
South-America and Africa. Psoriasis in children is rare and scarcely investigated with 
prevalence reported between 0-2%.15  
True differences in psoriasis prevalence between geographical regions, countries and 
populations may be explained by genetic and environmental factors, and may generate 
hypotheses of disease aetiology.19 The use of both point prevalence and lifetime prevalence 
within different age ranges to assess disease frequency across studies is likely one of the 
reasons why there seems to be large variations in the prevalence of psoriasis throughout the 
world. Also, many prevalence estimates referred to today come from clinical studies or 
database samples and may not be truly representative of the general population. The highest 
lifetime prevalence reported from population-based data comes from two general health 
surveys in Scandinavia.22 In the Oslo Health Study (HUBRO, 2000-01), Norway, 8.5% of the 
sampled adult population reported having received a diagnosis of psoriasis by a physician 
sometime in their lifetime.22 In the related time period (2006-08), a Danish general population 
study reported a lifetime physicians’ diagnosed prevalence of 7.1%.23 However, both studies 
were criticized due to low attendance (HUBRO, 46%/ Danish study 44%).  
The incidence of psoriasis encompasses the number of new psoriasis cases over a fixed time 
period divided by the population at risk of developing psoriasis.24 This represents the short-
time burden of disease, and provides valuable cases for research in terms of risk factors for 
new onset of disease. To our knowledge, a limited number of studies have investigated the 
incidence of psoriasis in the general population, and most of them were based on various 
health databases.25-32 Incidence rates among Caucasian adults have been reported to vary 
between 79 to 230 cases per 100,000 person years.15 
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1.2 Time trends in psoriasis  
Changes in environmental and lifestyle exposures may influence the incidence and prevalence 
of psoriasis, making it necessary to repeat assessment of psoriasis on a regular basis within 
defined populations. Updated prevalence proportions are important in order to determine the 
clinical and economic burden related to psoriasis, as well as giving directions in terms of the 
burden of concomitant disease. Not the least, changes in incidence and prevalence trends 
within a relatively short timeframe points in the direction of possible influencing modifiable 
environmental factors which may be of importance in terms of prevention or treatment of 
psoriasis.  
Two US studies investigating trends in psoriasis incidence based on a health service database 
found that the incidence of psoriasis doubled in both children and adults between the 1970s 
and today.29,30 On the other hand, a nationwide study in a Norwegian twin panel sampled in 
1992 and 1998, found no indication of increasing psoriasis incidence among young adults in 
the relatively short time frame observed, also supported by a Dutch study based on general 
practice data, 26 as well as a study of Swedish conscripts across the 1952-77 birth cohorts.33 
Repeating population-based studies suggested a higher prevalence of psoriasis in both the US 
adult population as well as the Chinese population over the past 20-30 years.34,35 Furthermore, 
a large study from the United Kingdom General Practice Research Database (UK GPRD) 
found a period prevalence of psoriasis of only 1.5% in the total population from 1987 to 
2002;36 which is comparable to a survey from the UK in the late sixties.37  
Studies of psoriasis from large general population samples are scarce and longitudinal 
observations of changing lifetime prevalence within the same population over a longer time 
period, using the same methodology, are largely lacking. Thus, there is limited evidence 
regarding trends in psoriasis prevalence and possible influences from age, birth cohort and 
time period effects. An age effect is defined as a change in the frequency of a condition 
according to age, irrespective of the examined birth cohort or time period.24 A birth cohort or 
cohort effect is a change in the frequency of a condition according to the year of birth, 
independent of age and calendar time.24 A time period or period effect applies to a change in 
the frequency of a condition or trait which affects an entire population over a period of time, 
irrespective of their age or the year they are born in.24 
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Changes in psoriasis prevalence within a stable population, studied with the same study 
design over time may largely be explained by environmental factors. The population-based 
Tromsø study cohort with repeated assessments over three decades allows for the 
investigation of the trend in psoriasis prevalence according to age, birth cohort and time 
period.  The second Tromsø study in 1979-80 reported a lifetime prevalence of 4.8% of self-
reported psoriasis among adults which was the highest figure from a population based study 
worldwide at that time.38 Another Norwegian study from the same time period showed large 
regional differences in psoriasis prevalence with an almost doubled prevalence in the two 
northernmost counties,39 raising the question if figures from the Tromsø cohort could now be 
at even higher levels. 
 
1.3 The pathophysiology of psoriasis 
Psoriasis is regarded to be a multifactorial immune mediated disease, but the pathophysiology 
of the condition is not fully understood (Figure 1).40 Alterations in skin barrier and immune 
genes facilitate an abnormal response triggered by yet largely unidentified environmental risk 
factors or antigens.41 This leads to a complex interplay between the skin epithelium and 
connective tissue with the innate and adaptive immune system; including activation of antigen 
presenting cells (e.g. myeloid dendritic cells which produce Interleukine (IL)12 and IL-23) 
and thereby expansion and activation of T-helper lymphocytes Th1 and  Th17. The activated 
lymphocytes again produce several cytokines, e.g. interferon-γ, tumor necrosis factor (TNF) 
and leads to further increase of IL-17 and IL-22, as well as antimicrobial peptides and growth 
factors; which increases the natural turnover of the epidermis and eventually leads to 







Figure 1. Proposed Schema of the Evolution of a Psoriatic Lesion from Initiation to Maintenance of Disease. 







Early studies have shown a greater frequency of psoriasis among both parents and siblings, 
suggesting a heritable component in the aetiology of the disease.43-45  Twin studies have 
shown greater concordance rates for psoriasis in monozygote than in dizygote twins;46,47 
however, the concordance rates for monozygote twins do not reach 100%, something which 
suggests that environmental factors also play a role. High concordance rates have been found 
in older twin studies, where the heritability has been suggested to be as high as 80-90%.46,47 A 
more recent Norwegian twin cohort study below age 32, suggested that approximately 66% of 
the phenotypic variance in psoriasis of the early onset type can be attributed to additive 
genetic effects; while the remaining liability is a result of non-shared environmental factors.48 
A recent Danish study including twins age 20-71 years also supported these findings.49  
The mode of inheritance seems complex;50 reaching now 44 known susceptibility loci of 
major and minor effect mainly involved with the epidermal-barrier, innate immune system, 
antigen presentation and T-cell function.14,51 Despite several genome wide association studies 
(GWAS) a significant proportion of psoriasis heritability remains to be clarified.14 Additional 
genetic risk factors may remain to be discovered. Alternatively, the known genetic component 
in psoriasis may account for far more of the variance in susceptibility than currently 
recognized, as part of the missing heritability may be due to gene–gene interactions; a known 
example includes the interaction between risk alleles at HLA-C and ERAP1 in psoriasis.52 The 
main genetic determinant of psoriasis of the early onset type seems to be PSORS1, located 
within the major histocompatibility complex (MHC) on chromosome 6. Three genes within 
this region have been the major targets for investigations; most importantly HLA-Cw6 which 
encodes a class I MHC-protein.1 Studies suggest that the different clinical phenotypes of 
psoriasis are genetically heterogeneous, and that there may be a difference in the genetics of 
plaque psoriasis of the late versus early onset type.14,53-55  
Gene-environment interaction may also contribute to the missing link in understanding the 
heritability in psoriasis (Figure 3, page 20). The effect of a certain low-penetrance 
susceptibility mutation on the development of the psoriasis phenotype may depend on the 
burden of environmental risk factors. There are known examples of gene-environment 
interactions in psoriasis;56 for instance a polymorphism in IL12B was associated with 
increased risk of psoriasis in a nested case-control study, but only among overweight 
individuals.57 Recently epigenetic mechanisms have emerged as a putative link between 
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genetic and environmental factors.58-60 Differences in DNA methylation and gene expression 
in psoriatic plaques suggest that epigenetic dysregulation of biological pathways involved 
with immune response, cell cycle and apoptosis may be involved in the pathogenesis of 
psoriasis.58-61 
 
1.4    The clinical morphology of psoriasis  
There are no set diagnostic criteria for psoriasis, and a dermatologist’s diagnosis is considered 
the gold standard. Clinically the epidermis presents with a sharply defined, raised 
erythematous and silvery scaled, papules or plaques of mostly symmetrical distribution.1 
There is a marked heterogeneity in the clinical morphology of psoriasis. Approximately 90% 
of psoriasis cases are plaque types,40 also known as psoriasis vulgaris (Figure 2); and most of 
the research today applies to this subgroup. Patients with plaque psoriasis usually present with 
symmetrical distributed, often itchy and painful, plaques from 1 to more than 10 cm in 
diameter, commonly located on the scalp, elbows, knees and lower back. Other manifestations 
of psoriasis include guttate psoriasis, which refers to the abrupt onset of multiple small “drop-
like” lesions (< 1 cm) mainly on the truncus, and is most commonly seen in children and 
young adults. Inverse psoriasis is commonly present alongside plaque psoriasis, and refers to 
the distribution of psoriasis in the intertrigenous areas. In the literature, frequencies of 
psoriasis patients with nail involvement vary between 10% and 82%.62,63 Two rare and 
potentially life threatening forms of psoriasis are generalized pustular psoriasis and 
erythrodermic psoriasis. Palmoplantar pustulosis (PPP) has traditionally been considered a 
localized type of pustular psoriasis limited to the palms and plantar area of the feet, mainly 
affecting women from middle-age; however, many now consider this a distinct entity.64  




Figure 2. Plaque psoriasis. Picture courtesy of Wikicommons.com. 
 
While the appearance of classical plaque psoriasis is distinct, less common subtypes of 
psoriasis can be confused with other skin conditions. Inverse psoriasis can initially be 
misdiagnosed as intertrigo or fungal or bacterial infections, however the opposite assumption 
where intertrigo is referred to a dermatologist as suspected inverse psoriasis is uncommon. 
The subungual hyperkeratosis and oncholysis which is often found in nail psoriasis can easily 
be misdiagnosed as fungal disease, and many psoriasis patients are treated with antifungals 
initially before the right diagnosis is made. Seborrheic dermatitis of the scalp and face may 
also be confused with psoriasis.  
Approximately 70-80% of those affected by plaque psoriasis have mild disease.65 Severity can 
be measured by various tools, but the standard measures used in most randomized controlled 
trials (RCTs) as well as in clinical practice are; the Psoriasis Area Screening Index (PASI),66 
which measures the degree of erythema, induration, scaling and the percentage of affected 
body surface in various body areas, and the Dermatological Quality of Life Index (DLQI) 
which is a questionnaire with different questions regarding the impact of psoriasis on daily 
life.67 Both measures complement each other, as psoriasis in certain areas like the face, hands 
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or genitals can have a much larger impact on a person’s physical and mental wellbeing than 
the PASI indicates.  
The severity of disease, as well as potential comorbidities and patient compliance, decide 
what therapeutic interventions are suggested. Traditionally, local therapy with potent steroids, 
sometimes in combination with topical Vitamin D, is the first-line therapy. With more 
extensive disease Ultra Violet (UV) therapy, climate therapy, or oral therapy in form of 
immune suppressants like Methotrexate or more rarely Cyclosporine A; or the retinoid 
Acitretin is used. In the past decade, biologic agents have proven their efficacy in therapy 
resistant psoriasis making psoriasis research a “hot topic”.  
 
1.5 Environmental risk factors  
Several environmental factors have been associated with psoriasis. Firstly, studies have shown 
higher prevalence of psoriasis closer to the earth’s poles.15,19 Latitude is a likely marker of UV 
radiation, genetic selection or perhaps a difference in antigen exposure/ infection trends.19,68 
UV radiation has several effects on the immune system; for instance the endogenous 
production of Vitamin D is directly influenced by UV radiation. Reduced levels of Vitamin D 
have been seen in psoriasis patients compared to healthy controls in smaller clinic based 
studies.69,70 Furthermore, topical Vitamin D has been used in psoriasis treatment for decades. 
Secondly, both clinical and immunological evidence has suggested a link between an upper 
respiratory tract infection, mainly with streptococcus species, and the subsequent 
development of psoriasis, mostly of the guttate subtype and in young people.28,68,71,72 Severe 
cases of psoriasis in relation to HIV infection have also been reported.73 Moreover, clinicians 
have since long registered that psoriasis plaques can appear in sites of trauma, for instance in 
the area of an operation wound or after an extensive sunburn. This effect is known as the 
Köbner phenomenon.2 It is postulated that damaged DNA from keratinocytes which is 
released upon injury, forms aggregates with antimicrobial peptides and thereby triggers a 
cascade of inflammation.1 In addition, drugs like antibiotics, lithium, antihypertensive agents, 
and NSAIDS have been questioned to be possible risk factors for psoriasis; however, these 
assumptions are mainly based on case reports and case series.74,75 In a large-scale study from 
the UK GPRD database there was only a weak association between psoriasis and antibiotic 
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use, however this was likely confounded by the reports of previous infections.28 More 
research is needed in order to draw conclusions in this matter.  
1.5.1 Lifestyle risk factors: stress, physical activity, alcohol and smoking  
There are few longitudinal cohorts investigating risk factors influencing psoriasis 
development, however a few studies of stress/ depressive state, physical activity, alcohol and 
smoking in relation to risk of psoriasis have been performed. Further efforts have been made 
in the time period from we started our data gathering up until today. Interestingly, some 
changes in potentially important lifestyle factors seem to parallel changes in psoriasis 
prevalence and incidence, as the major lifestyle epidemics of physical inactivity, overweight 
and obesity. Importantly, data are still largely lacking in terms of critical age windows and 
doses of exposure, as well as evaluation of potential gender differences, possible interactions 
between exposures as well as gene-environment interactions.  
Psoriasis patients regularly report increased psychosocial stress as a self-observed reason for 
disease exacerbation, and it is suggested that stress and an individual’s ability to cope with 
stress can play a role in the exacerbation of the disease, however causality has not been 
established.76,77 A recent meta-analysis concluded that the higher prevalence of depression 
found among persons with psoriasis is most likely due to tertiary study populations and 
differential misclassification through questionnaires, where psoriasis symptoms are confused 
with depressive symptoms.78 However, there is evidence supporting associations between 
anxiety and depression and risk of psoriasis onset.79-81 Physical inactivity is linked to both 
inflammation and oxidative stress, which can potentially influence psoriasis development and 
severity.82 There are to date few studies investigating the effect of physical inactivity on 
psoriasis incidence and severity, and very few of these have been specifically designed to look 
at physical inactivity as a main predictor of psoriasis.82 However, an inverse association 
between vigorous physical activity and risk of psoriasis was recently found in women,83 and 
further studies are warranted. 
Alcohol may induce psoriasis by affecting the immune system through keratinocyte 
proliferation, or upregulation of proinflammatory cytokines,84 as well as being associated with 
increased infection and trauma risk.85 Some studies indicate a potential increased risk of 
psoriasis with increasing intake of alcohol, especially among men who drink large amounts of 
alcohol.85-88 However, a recent literature review indicated that although the average alcohol 
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consumption among psoriatics may be increased in many populations, there is not sufficient 
evidence to evaluate if alcohol is a risk factor for psoriasis.89 
Interestingly, smoking has been associated with psoriasis in several cross-sectional studies, 
and has also been implicated as a risk factor in the debut of disease.90,91 The biological effect 
of smoking derives from a complex interplay between several substances, importantly 
nicotine and carbon monoxide, and can be modulated by genetic vulnerability, gender, and 
degree of consumption.77,92 In a US study smoking was observed to influence psoriasis 
incidence, with a relative risk for current smokers between 1.8 to 2.7, and a positive dose-
dependent association.93 There was also indication of an increased risk among past smokers, 
which decreased with time.93 The possible psoriasis subtype, or comorbid condition, PPP has 
an even higher reported association with smoking; however, few population-based data are 
available.64,77 Due to the biological effects of smoking, it has been hypothesized that smoking 
may act synergistically and potentiate the effect of other exposures. In a study from Italy, a 
multiplicative effect of the combined exposure to obesity and cigarette smoking on the odds 
of psoriasis was suggested, with up to tripled odds of psoriasis among those who were both 
obese and current or prior smokers.77 More studies are needed to explore this synergism 
within a longitudinal population-based design. 
1.5.2 Overweight, obesity, weight gain and psoriasis 
Overweight and obesity has reached epidemic proportions worldwide during the last 
decades.94 Globally approximately 35% of adults were overweight in 2008 (body mass index, 
BMI = 25-<30 kg/m2), while 11% were obese (BMI ≥ 30 kg/m2).95 In Norway, the proportion 
of persons defined as obese has increased from 8-10% in 1985 to approximately 20-23%. In 
2007-08, both in the sixth Tromsø study, as well as in the Health Examination in North 
Trøndelag (HUNT) study, over 50% of the adult population was overweight.96 There is a 
growing interest in the contribution of excess weight to systemic low grade chronic 
inflammation, which may also influence the risk of psoriasis.14,97 Basic research indicates that 
adipocytes and activated inflammatory macrophages can play a role in both psoriasis and 
excess weight; however, the exact mechanisms behind the association remain unclear.97  
The relationship between overweight, obesity and psoriasis has long been discussed, after 
Lindegård first described this association within a Swedish hospital-based cohort.98 Since then 
numerous, mainly cross-sectional, studies have found positive associations.90,99 A recent 
meta-analysis showed that individuals with psoriasis have an over 50-60% increased odds of 
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being obese compared to the general population,97 with a clear dose-response relationship 
between the severity of psoriasis and the odds of obesity.97 Traditionally the higher BMI 
found in psoriasis patients was attributed to high energy intake combined with a sedentary 
lifestyle secondary to the skin disease. However, there is only one longitudinal study, from the 
UK GPRD, investigating the risk of obesity among patients with psoriasis. Within this study 
population, individuals with newly diagnosed psoriasis had an 18% increased risk of 
developing obesity compared to the control subjects during follow-up for up to ten years, but 
to our understanding, this analysis was not adjusted for baseline BMI.100 More recently, it has 
been suggested that excess weight is an independent risk factor for psoriasis.77,86 A 
publication from the UK GPRD found that overweight and obesity, increased the risk of 
psoriasis by 10-30%.28 Two later publications containing data from the renown US Nurses’ 
Health Study (NHS) cohort showed a dose-response relationship with up to two- to threefold 
increasing risk among severely obese women compared to normal weight women, as well as 
associations between adult weight gain and risk of psoriasis.25,101 The relationship between 
excess weight, weight gain and incident psoriasis has not yet been investigated in a 
longitudinal cohort representing both genders over time. Interestingly, others have also 
suggested that the observed increased risk of psoriasis among those who are overweight could 
lead to secular changes in the incidence and prevalence of psoriasis.102 
 
1.6 Psoriasis and comorbidities 
Over the past decade psoriasis has been increasingly associated with a whole range of 
comorbidities including among others depression, autoimmune disease (Mb Crohn), 
lymphoma and some other cancers, obesity, hypertension, dyslipidemia, metabolic syndrome 
(MetS), type II diabetes, thromboembolic disease, cardiovascular disease (myocardial 
infarction and stroke) and increased mortality.5,6,12,13,103-105   
The traditional comorbid condition associated with psoriasis is psoriasis arthritis (PsA).5 PsA 
is characterized by the presence of mostly sero-negative inflammatory arthritis in a psoriasis 
patient which fulfils the as of 2006 internationally agreed on Classification criteria for 
psoriatic arthritis (CASPAR criteria).5,106 Clinically the patients develop pain, swelling and 
tenderness of the joints and surrounding ligaments/ tendons, which in worst case can lead to 
joint destruction. A study from the UK GPRD found a total prevalence of PsA of 0.2% in the 
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general population, while the prevalence was 8.6% among psoriasis patients, with higher 
numbers among those with more severe psoriasis or longer disease duration.107 A European 
multicentre trial found that approximately 20% of psoriasis patients develop psoriasis arthritis 
within a 30 year period, and that those with more severe disease were more likely to develop 
PsA.108 Most patients who present with PsA already have established psoriasis. However, the 
severity of plaque psoriasis does not necessarily correlate with the severity of PsA.109 PsA is 
difficult to study as it is not easy to separate if the risk factors apply to the whole disease 
continuum of psoriasis and PsA or for PsA as an isolated component and more studies are 
needed.110 Importantly, persons who also have PsA may have a greater risk of cardiovascular 
disease, compared to those with psoriasis alone.105 
The increased burden of comorbidities among persons with psoriasis has led to the hypothesis 
that psoriasis is a systemic inflammatory condition.6 One may hypothesize that there could be 
common pathophysiological mechanisms operating for psoriasis as well as for several other 
chronic diseases. A recent meta-analysis of four GWAS psoriasis cohorts from Sweden and 
the US found that patients with psoriasis share common genetic single nucleotide 
polymorphisms (SNPs) which are suggested to increase the risk of dyslipidemia, hypertension 
and coronary artery disease in itself.111 Another meta-analysis found that over 677 genes were 
up-regulated and 443 were down-regulated in psoriasis plaques compared to non-lesional 
skin, enlightening the complexity of the genetic aspects of the condition.112 The multitude of 
activated genes in psoriasis plaques indicates that multiple biomarkers are produced locally 
and likely released into systemic circulation, depending on the extent of the affected body 
surface.113,114 The Th-1 and Th-17 inflammatory cytokines which are increased in psoriasis 
pathogenesis (Figure 1, page 11) may influence angiogenesis, insulin signaling, adipogenesis, 
lipid metabolism and immune cell trafficking, and thereby potentially impact other conditions 
like obesity, diabetes, thrombosis and atherosclerosis. Vice versa, inflammatory cytokines and 
hormones produced by adipose tissue may influence psoriasis debut or severity by induction 





Figure 3. The proposed interplay between psoriasis, chronic inflammation and cardiovascular disease. 
 
1.6.1  Psoriasis and the metabolic syndrome 
There is growing evidence of an association between psoriasis and the metabolic syndrome 
(MetS),116-118 The MetS is a cluster of risk factors (overweight/obesity, dyslipidemia, insulin 
resistance, and hypertension) associated with a doubling of cardiovascular disease risk and a 
five times greater risk of developing type II diabetes.119,120 Overlapping inflammatory 
pathways as well as shared genetic susceptibility may be potential biological mechanisms 
behind the association between psoriasis and the MetS;121 however, the exact mechanisms 
remain unclear. Apart from obesity, recent meta-analyses have demonstrated a relationship 
between psoriasis and dyslipidemia (odds ratio (OR) 1.5),105 diabetes (OR 1.59),13 as well as 
hypertension (OR 1.58).122 There was also indication of a positive dose-response relationship 
with all components; finding increasing odds with greater severity of psoriasis.13,122,123 
A recent meta-analysis reported an odds ratio for MetS of 2.3 among patients with psoriasis 
compared to their reference groups.118 However, a limitation of this analysis was the scarcity 
of data from truly population-based studies, lack of uniform screening procedures for 
psoriasis and MetS, as well as missing information on potential confounding lifestyle factors. 
Two fairly small population-based health surveys have provided conflicting results. The 
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North-American National Health and Nutrition Examination Survey (NHANES; 2003-06, n= 
2,456) reported a two-fold increase in the risk of MetS among persons with self-reported 
psoriasis, and an even higher risk among women.116 In contrast, in a comparable Danish study 
(n= 3,374) no association was observed.23 Interestingly, a positive dose-response association 
between the severity of psoriasis and odds of MetS was seen in a large case-control study 
from the UK GPRD.117  
Questions remain concerning the link between psoriasis and the MetS in the general 
unselected population and the extent to which age and gender influences the risk of the MetS 
in psoriasis. Furthermore, abdominal obesity measured through waistline has become the 
preferred component of the MetS, and a new and lower waistline cut-off for abdominal 
obesity has been suggested.124 There are few studies investigating psoriasis and risk of MetS 
which have had data on waistline measurements. The first-ever public health agenda for 
psoriasis recently released by the United States Centers for Disease Control and Prevention 
(CDC) points to needs for more population-based cohort studies, including analysis of age 
and gender disparities, of relationships between psoriasis and obesity, metabolic- and 
cardiovascular disease,125 also underlined by others.18,126,127 In recent meta-analyses 
discrepancies between population-based and clinic-/register-based study populations, as well 









2. Aims of Thesis  
The overall aim of the thesis was to investigate time trends in psoriasis prevalence, and 
exploring overweight and weight increase as an environmental risk factor for psoriasis 
development; as well as investigating the association between psoriasis and the metabolic 
syndrome, including age and gender variations, within a population-based cohort. 
More specifically the aims were to examine the following:   
• Whether the prevalence of self-reported psoriasis increased over the time period 
from 1979 to 2008 in a population-based cohort. Moreover, whether there were 
changes across the surveys (time period effects) and birth cohorts (birth cohort 
effects), independent of population aging.  
 
• How overweight and weight gain, as well as overweight in combination with 
smoking, influenced the odds of psoriasis, and whether these associations may be 
modified by age and gender within a population-based cohort.  
 
• How psoriasis is related to the metabolic syndrome and whether this association 















Figure 4. The city of Tromsø, Norway, 69°N, our research laboratory. Private picture. 
 
3.1 The Tromsø Study  
The Tromsø Study (www.tromsostudy.com) is a single centre multipurpose researcher 
initiated population-based study with repeated high quality health surveys inviting inhabitants 
in the municipality of Tromsø, Norway (Figure 4).130 Tromsø is the largest city in North 
Norway and a modern regional capital with the world’s northernmost university. The 
municipality of Tromsø is thought to be representative of a Northern European, white, urban 
population.131 Tromsø has grown from 42,253 in 1974 at the study start-up, to close to 70,000 
in the last Tromsø survey. The great majority of the city inhabitants, and thereby study 
participants are ethnic Norwegian/ Caucasian, but also includes an indigenous Sami and Kven 
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minority (3-4%, according to the 2007-08 Tromsø study). There was limited immigration 
from non-ethnic Norwegians or non-Europeans in the time period.  
The Tromsø study was initiated in the early seventies as a combined effort between the 
University of Tromsø, Tromsø University Hospital and the Norwegian Health Authorities in 
search of explanations for the high levels of cardiovascular disease in North Norway.132,133 It 
is now run and owned by the University of Tromsø. The design and cohort profile of the six 
surveys from the adult population have been described in detail (Paper I-III).130,131 I will 
therefore only briefly summarize the main patterns of data collection included in the present 
work.  
All measurements have been made according to standardized procedures by trained health 
professionals in each survey attempting minimal diversity in the time period. The first survey 
was carried out in 1974 (T1) on men only and is not included in the present studies. Further 
studies were performed in 1979-80 (Tromsø 2, T2), 1986-87 (Tromsø 3, T3), 1994-95 
(Tromsø 4, T4), 2001 (Tromsø 5, T5) and 2007-08 (Tromsø 6, T6) in both genders (Figure 
5).130  
The aim of the Tromsø study has been to include large representative samples of the 
population, with invitation to whole birth cohorts and random samples based on the official 
population registry. The total sample size has varied somewhat. In T2-4 and T6 new birth 
cohorts were consecutively added. Detailed information regarding the sampling strategy is 
described elsewhere.130,131 In T5, a larger portion of those invited was selected from T4 
participants, making this survey slightly different from a sampling point of view. The overall 
participation rate has been 66-85% and somewhat declining,130 but is still relatively high.131  
 
3.2 Study design and study population  
The total number of participants with valid consent for study participation from the five 
surveys were; 16,554 in T2, 21,734 in T3, 26,957 in T4, 8,039 in T5, and 12,982 in T6. 
Tromsø 1 was not included in any of our analysis because it did not include data on self-
reported psoriasis.   
The analysis of trends in psoriasis prevalence in Paper I was based on five cross-sectional 
surveys.130 All attendees from Tromsø 2-6 with the following exceptions were included: to 
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reduce the risk of recall bias in older ages, a total of 1,400 participants above 79 years old in 
T4-6 were excluded from the analysis. Further, to avoid selection bias due to non-random 
invitation of youngsters in T3, 1,134 participants under 20 years old were excluded. An 
additional 90 participants in T2-3 were excluded because they did not belong to the invited 
birth cohorts in these surveys. In T5, 538 participants below age 30 were excluded, because 
this age group was represented by only one birth cohort (1971) and may not be representative 
for all individuals age 20-30.  
 
 
Figure 5. Methodological approach and study samples for Papers I-III. Study inclusion criteria are described 





All persons with missing psoriasis data were excluded from the analysis in each cross 
sectional survey. A total of 13,565 observations in T2-6 with missing self-reported psoriasis 
data were omitted. This leaves, 14,434 observations from T2, 16,345 observations from T3, 
22,328 observations from T4, 6,130 observations from T5, and 10,302 observations from T6 
eligible to enter the analysis, and represents a total of 69,539 observations from 33,387 unique 
individuals born from 1915 to 1977 (Figure 5). 
For the analysis of how overweight/obesity, weight gain, and overweight and smoking 
combined, may influence the risk of psoriasis, a prospective study design was used (Paper II) 
(Figure 5). Tromsø 4 was used as baseline and the response to the question regarding psoriasis 
status in follow-up surveys up to 7 years (Tromsø 5, 2001) to 13 years later (Tromsø 6, 2007-
08) was the outcome variable. In Tromsø 4 all subjects age 25-97 years were invited, and a 
total of 27,158 subjects (77%) attended.130 A total of 26,957 attendees with valid consent were 
available for the analysis. In this cohort, follow-up data on psoriasis status was available for 
11,328 individuals. The following exclusion criteria were applied using baseline data in T4: 
age ≥ 70 years (n=547); missing data on self-reported psoriasis (n=1,106); self-reported 
psoriasis diagnosis (prevalent disease) (n=739); being pregnant (n=100); missing measured 
BMI (n=7); and missing smoking status T4 (n=8) or smoking only cigars and pipe (n=69); 
giving a total of 8,752 included in the analysis with baseline BMI as main predictor. In 
analysis of adult gain in BMI based on self-reported weight at age 25 years and measured 
height at baseline, 26 individuals with age < 26 years at baseline were excluded to insure that 
they did not have psoriasis within one year of study enrollment, and 384 individuals were 
excluded due to missing report of weight at 25 years, giving a study sample of 8,342 
individuals.  
A validation of self-reported weight at age 25 was performed among 900 repeat attendees 
who had their weight measured at age 24-26 years in T2, T3, or T4, and recalled their weight 
at age 25 years in T5 or T6.  
In Paper III, the association between psoriasis and odds of MetS was investigated within a 
cross-sectional study design (Figure 5). The sampling strategy in the sixth Tromsø study is 
described in detail (Paper III).131 In total 9,625 men and 10,137 women aged 30-87 years were 
invited, and 12,984 participants attended (66%).131 Two participants have since withdrawn 
their consent. Moreover, all subjects over the age of 79 (n=531), were excluded due to risk of 
recall bias as well as healthy survivor bias. In addition pregnant women (n=28), and 
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participants with missing data on both self-reported lifetime psoriasis and doctor’s diagnosis 
of psoriasis (n=1,176) or measured MetS components (n=726) were excluded; leaving a total 
of 10,521 individuals, 5,499 women and 5,022 men, for the analysis.  
 
3.3 Data Collection 
3.3.1. Questionnaire and register data 
In all surveys, the subjects have been invited through an invitation letter, and a first 
questionnaire (Q1) has been enclosed with the invitation. A second questionnaire (Q2) was 
handed out at the screening centre; which was to be returned either on site or through the 
mail; approximately 90-96% of attendees did so.130,131 Q2 in T4 and Q1 in T5 differed slightly 
for attendees from age 70 years. Over the years both questionnaires have expanded and 
include information on a wide range of exposures, symptoms, diseases and medications 
(Appendix I-V). The original Norwegian-language versions are available at the study website 
(www.tromsostudy.com). Also, a short interview was made, in order to check the 
questionnaires for inconsistency, as well as focusing on medications and women’s 
reproductive health. 
Assessment of psoriasis 
Life-time self-reported psoriasis was assessed in Q2 using the following question; in T2 and 
T3: “Do you have or have you had the skin disease psoriasis?” In T4 and T5 the question was: 
“Do you have or have you had psoriasis?” and in T6: “Do you have or have you ever had 
psoriasis?” Answers were; yes or no. In T6, the question “Have you ever been diagnosed with 
psoriasis by a physician?” was added for validation and comparability purposes.  
In Paper I and II the self-reported psoriasis was used for consistency within the surveys. In 
Paper III self-reported psoriasis and/ or self-reported doctors`s diagnosed psoriasis was 
combined. Persons who answered yes to any or both of these questions were classified as 
having lifetime psoriasis.  
Also in T6 (Q2), a question to self-evaluation of present disease severity was added. “Answer 
on a scale from 0 to 10, where 0 corresponds to no symptoms and 10 correspond to worst 
imaginable complaints; “If you answered YES to that you have or have had psoriasis: How 
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much are you affected by your psoriasis today: Scale 0-10 with 0=No complaint, 10=worst 
possible complaint” (Paper III). Furthermore, information on medication from the Norwegian 
Prescription Database (NorPD) was used as a proxy for disease severity (Paper III). 
Information on all prescriptions for outpatient treatment of psoriasis from 1 October 2006 to 1 
June 2009 was linked with data on a selected set of variables from T6. This analysis included 
all individuals age 30-79 with self-reported psoriasis and measured waist circumference 
(WC), n=1,192. Persons who received systemic drugs were considered to have moderate to 
severe psoriasis.  
Assessment of lifestyle variables 
Socioeconomic status 
Questions on marital status, total household income, and educational level were available, and 
educational level reflecting variations in socioeconomic status was mainly used in our 
analyses.134  
Alcohol consumption 
In all surveys, participants who were not teetotalers indicated their usual frequency of 
drinking sessions (in T2 and T3 also separated by type of beverage). In Paper I and III we 
dichotomized those reporting a weekly number of drinking sessions of 2-3 or more as higher 
alcohol consumers versus all others. In T4 (Paper II), the average daily gram intake of alcohol 
was computed from number of units of intake of wine (16.6 g/unit), beer (11.7 g/unit) and 
spirits (7.4 g/unit) within a two week period. The validity of self-reported data on alcohol 
consumption was examined in the fourth Tromsø study, where a strong positive association 
was found between self-reported alcohol use and measured gamma-glutamyltransferase.135  
Smoking 
In all surveys, participants indicated whether they were present daily smokers (T4 split by 
type of tobacco; the vast majority were cigarette smokers) and smoking history including 
previous daily smoking, years since stopped smoking, total number of smoke-years, and 
average daily number of cigarettes or weekly number of tobacco packs. Smoking status was 
described through a dichotomous variable in form of present versus never or past smokers 
(Paper I and II). In Paper II and III, smoking status was also reported with three categories; 
current daily smoking, former daily smoking and never smoking. In Paper II, smoking at 
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baseline (T4) was further elaborated in pack years defined as number of cigarettes per day x 
number of years smoked divided by twenty; this was further categorized into four pack-year 
categories: 0, 1-9, 10-19, 20+.  The validity of self-reported smoking has been evaluated in 
other Norwegian cohorts (see discussion of Methodology).136,137  
Physical activity  
In all surveys apart from Tromsø 4, the participants indicated their usual level of leisure 
activity in the past year using one of four response categories: level 1: reading, watching 
television, or engaging in sedentary, activities; level 2: at least 4 hours a week of walking, 
bicycling, or engaging in other types of physical activity; level 3: at least 4 hours a week 
exercising to keep fit and participating in recreational athletics; and level 4: regular, vigorous 
training or participating in competitive sports several times a week. This self-reported 
physical activity variable has been  validated,138  and was further validated within a subsample 
of Tromsø 6 attendees, with acceptable concurrence with heart rate, metabolic profile and the 
level of measured physical fitness.139 There was also an acceptable degree of tracking 
between the previously reported physical activity level over time among repeat attendees.140 
In Paper I and III we dichotomized those reporting sedate lifestyles (level 1) versus all others. 
In T4, participants indicated their usual level of recreational physical activity as the average 
weekly number of hours (0, <1, 1-2, 3+ hours) spent doing light activities (not sweating or out 
of breath) and hard activities (sweating/ out of breath) separately. This question on physical 
activity has been used in prior Scandinavian studies.141 In Paper II the physical activity score 
was calculated as a combined variable of the sum of hours of light and heavy physical activity 
in spare time per week, with heavy physical activity given double weight.142 Work place 
physical activity in terms of four categories of work from sitting still to hard manual labor 
was reported in all surveys. Due to the relatively large degree of missing related to those who 
were seniors, unemployed or on disability pension, this question was not used in multivariable 
analysis and only used to describe the population (Paper I). 
 
3.3.2. Clinical measurements and body composition 
When measuring blood pressure the used cuff was selected after measurement of the 
circumference of the right upper arm. Blood pressure was recorded three times with one 
minute intervals in a sitting position after two minutes rest, by the use of an automatic blood 
pressure measurement device and the mean of the two last readings was generated. In T4 a 
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Dinamap Vital Signs Monitor 1846, Critikon, GE Healthcare, Norway, was used while in T6 
a Dinamap Pro care 300 Monitor from the same company was used.  
BMI and waist circumference  
In all surveys, height and weight were measured to the first decimal amongst participants, 
who wore light clothing and no shoes. In T6 an electrical scale; Jenix DS 102 stadiometer; 
Dong Sahn Jenix, Seoul, Korea, was used. Body mass index (BMI) was computed as weight 
divided by height squared (kg/m2). In T6 and in the second visit of T4 and T5, waist 
circumference (WC) was measured at the umbilical line to the nearest centimetre, without 
outerwear, by using a measuring tape. Hip circumference was measured around the widest 
part of the thigh to the nearest centimetre, and the waist to hip ratio was computed.  
In T5 and T6, self-reported weight at age 25 years was reported. “Estimate your body weight 
when you were 25 years old?” (kg). In the analysis in Paper II, the first survey with available 
data was chosen in order to estimate weight change from age 25 up till the date of 
participation in T4 (for individuals age 26 years or more in T4). Among 900 attendees who 
had their weight measured at age 24-26 years in T2 (1979-80), T3 (1986-87), or T4 (1994-
95), and recalled their weight at age 25 years in T5 (2001) or T6 (2007-08), Pearson 
correlation coefficient was 0.89 (women, n=532, R=0.80; mean self-reported weight at 25 
years = 57.7 kg and measured at 24-26 years = 59.7 kg; men, n=368, R=0.79, mean self-
reported weight at 25 years = 74.9 kg and measured at 24-26 years = 75.2 kg). The validity of 
recalled weight has been investigated in prior publications, and found to be acceptable, (See 
discussion of methodology).143,144  
Laboratory analysis 
All blood samples were taken non-fasting; however, during the visit at the survey centre they 
were only allowed to drink water or black coffee/tea. The time since last meal was recorded. 
The specimens were taken from the antecubital vein with the subjects sitting in an upright 
position.  
In T4, serum was prepared by centrifugation after 1 h rest at room temperature, and further 
analyzed at the Department of Clinical Chemistry, University Hospital of North Norway:  
Serum total cholesterol and triglyceride analyses were performed by enzymatic colorimetric 
methods with commercial kits (CHOD-PAP for cholesterol and GPO-PAP for triglycerides; 
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Boehringer–Mannheim, Mannheim, Germany). Serum high-density (HDL) cholesterol was 
measured after the precipitation of lower density lipoprotein with heparin and manganese 
chloride.  
 
In T6, within 30 minutes in room temperature the blood samples were centrifuged and 
transferred within one hour to plastic tubes kept between 1-10 degrees Celsius. Twice a day, 
the samples were sent to the accredited Department of Laboratory Medicine at the University 
Hospital of North-Norway for analysis (ISO-standard 17025).131 Total cholesterol 
(Coefficient of Variation, CVa: 1.5%) and triglycerides (CVa: 3.7%) were analyzed within 10 
hours using an enzymatic colorimetric method. HDL (CVa: 3.3%) was analyzed using a 
homogenous enzymatic colorimetric method. High sensitivity CRP (CVa: 1.2%) was 
analyzed by a particle-enhanced immunoturbidimetric assay. These analysis were performed 
on a Modal PPE auto-analyzer using regents from Roche Diagnostics AS, Norway. HbA1c 
(CVa: 2.0%) was analyzed the next day on blood samples collected in EDTA anticoagulation 
vessels. The analysis was performed by high-performance liquid chromatography (HPLC) 
with an automated analyzer (Variant II, Bio-Rad Laboratories, Hercules, CA, USA).  
 
Assessment of metabolic syndrome 
The metabolic syndrome was assessed using the new unified definition of the International 
Diabetes Federation (IDF) as well as the National Heart, Lung and Blood Institute, and 
others.120 In order to be defined as having the MetS participants were required to have 
minimum three of the five criteria related to MetS; central obesity defined by waistline using 
two different waist criteria, raised triglyceride, reduced HDL-C, raised blood pressure, and 
raised fasting plasma glucose. The specific cut-off values for each component are described in 
Paper III, Supplementary material. Due to non-fasting of participants raised fasting glucose 
was replaced with HbA1c ≥ 6.1% according to established cut-off value for pre-diabetes 6.1–
6.4% (Paper III).145 HbA1c ≥ 6.0% was the best cut-off for impaired glucose tolerance among 






In 2006-2007 (Tromsø 6), present use of antidiabetic medication (insulin and pills), 
antihypertensive and cholesterol lowering (statin use) medication were reported, and data on 
present use was included in the analysis (Paper III).  
 
3.4 Statistical analysis  
To investigate time trends in psoriasis prevalence, exploring overweight and obesity as an 
environmental risk factor for psoriasis development; as well as investigating the association 
between psoriasis and the metabolic syndrome, within The Tromsø study cohort the Statistical 
packages, SAS 9.2 (SAS Institute, Inc., Cary, NC) and SPSS 20-21 (SPSS Inc., Chicago, IL) 
were used. Two-sided p-values below 0.05 were considered statistically significant. Most 
analyses were stratified by gender, due to the known gender differences in lifestyle, body 
composition and metabolic risk factors in the adult and elderly population. Descriptive 
characteristics of the study population were presented as means (SD) or proportions (%). 
When comparing the means of continuous variables between groups, Student’s t-test was 
used, and when comparing the distribution of categorical variables between groups, Pearson’s 
chi-squared test was used. Correlations between covariates were assessed using Pearson’s 
correlation coefficient.  
When evaluating associations of demographic, lifestyle and metabolic risk factors with 
psoriasis, univariable and multivariable logistic regression models were used. In general, 
variables of statistical significance, variables with a biologically plausible explanation, and 
variables that were known risk factors for psoriasis from former studies, were kept in the 
multivariable models. Statistical interaction was evaluated by the inclusion of multiplicative 
interaction terms in the logistic regression models. Subjects with missing values for 
exposures, outcome, or covariates were excluded from the analyses.   
In Paper I, the statistical methods were chosen in order to try to disentangle age, birth cohort 
and time period effects in the trends of psoriasis prevalence.147 Data were first presented 
graphically in six different panels in order to visualize and explore age, birth cohort and time 
period trends according to the epidemiological method described by Palmore.148,149 We then 
examined three different designs: cross-sectional differences in psoriasis prevalence between 
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10-year age groups in each of the surveys; indicating birth cohort or age effects, time-lag 
differences in psoriasis prevalence between the surveys for 10-year age groups; indicating 
birth cohort or time period effects, and longitudinal changes in psoriasis prevalence within 
10-year birth cohorts followed over time; indicating time period or age effects. The irregular 
intervals between the surveys T2-6 made it necessary to approximate some of the data points 
in the graphs following birth cohorts. When there are corresponding patterns in two of the 
designs and no changes in the third, there is only one kind of effect. When changes are seen in 
all three designs, two or three effects are present. When there are no measurable changes in 
any design, there is no effect.  
Odds ratios for self-reported psoriasis per 10 year increase in age, per 10 year increase in birth 
cohort and between time periods were estimated by generalized linear models (PROC 
GENMOD in SAS). Response probability distribution ‘binomial’ and link function ‘logit’ 
were chosen. In order to control for possible dependencies between repeated observations 
within subjects an unstructured covariance matrix was used in all models. As there was no 
clear pattern of interactions in the graphical presentation of data (almost no crossing lines), 
interaction terms were not included in the models. In order to increase the validity of the 
results sensitivity analysis were performed. When adjusting for age as a continuous variable 
in the multivariable model, the OR estimates were minimally changed. When subjects with 
missing psoriasis data were recoded to negative responders in the same multivariable model, 
almost identical OR estimates were observed.  
In the prospective analysis of BMI and adult weight gain (from age 25 to baseline) in relation 
to odds of psoriasis, T4 was used as baseline and response to question about psoriasis in 
follow-up surveys up to 7 years (T5) to 13 years later (T6) as outcome variable (Paper II). 
Incidence proportions (number of incident psoriasis in T5 and T6/ total number in the baseline 
population without psoriasis) in the total population, and by gender, BMI and weight change 
category were estimated. Logistic regression models were used to estimate the odds of 
psoriasis and adjust for potential confounders. BMI at baseline was investigated both as a 
continuous, dichotomous (cut-off 27-28 kg/m2, close to upper BMI quartile), as well as a 
categorical variable (modified WHO classification, category one and two combined) in both 
age-adjusted and multivariable analysis including also gender, present smoking (yes/no), 
average daily alcohol intake (g/day), and a score of recreational physical activity. For the 
analysis of adult BMI/ weight change as predictor of psoriasis, gender and age specific Z-
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scores and quartiles of BMI/ weight change were calculated within 5 year age groups (age at 
baseline; 26-<30, 30-<35, …65-<70) and the same multivariable logistic regression models 
were used without age and gender as covariates, including also mean of BMI at age 25 and at 
baseline. Potential interactions with gender, age and smoking status were tested in the 
regression analyses as described above. We also investigated ‘biological interactions’ between 
overweight and smoking as defined by Rothman;150 interactions were analysed using the 
Synergy index (S) scores (Paper II).150  
In a sensitivity analysis, observations with missing psoriasis data at baseline were recoded as 
not having psoriasis, which lead to slightly higher effect estimates. We also performed 
separate age-adjusted analysis for persons with incomplete data on covariates, which did not 
influence the results. In a further sensitivity analysis persons who only attended T5 were 
excluded, without this leading to any major influences on the results. Furthermore, those who 
reported to quit smoking within the last year prior to baseline were redefined as present 
smokers, without this leading to any changes in the results. 
Comparisons of the prevalence of MetS and its components by psoriasis status were done in 
age-stratified analysis; i.e. 30-44, 45-59, and 60-79 years, according to approximate cut-off 
for premenopause in women (<45 years) and premature cardiovascular disease (<60 years) 
(Paper III). The odds ratio (OR) for MetS according to the presence of psoriasis, was 
assessed in an age-adjusted logistic regression model (n=10,521 and n=9,662), and in a 
multivariable model adjusted for age, gender, smoking, educational level and physical activity 
in leisure time (n=9,662; observations with missing covariates excluded). Physical activity 
was included both using a binary variable (sedate versus others) and using an indicator 
variable for each category, without this influencing the model. Alcohol and statin use did not 
influence the analysis and were not included in the final model. The association between 
psoriasis and MetS may vary by age and the variation in effect size (odds ratio) may be non-
linear. Therefore we included second-degree fractional polynomial terms of age in the logistic 
regression model,151 both as main effects and as two-way interactions terms with psoriasis 
(Paper III).  
Sample size and statistical power 
The Tromsø Study is a large cohort which has been the basis for numerous high-quality 
publications on a broad spectrum of lifestyle factors, clinical measurements and biomarkers 
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and associations with different disease outcomes.130 In the present thesis the study population 
sample was dependent of the invited birth-cohorts selected by the Tromsø study. The power to 
detect associations between continuous variables is generally high. The present thesis and 
papers demonstrate that there was sufficient statistical power to detect odds ratios of 1.3-1.4 
for psoriasis and MetS. However, lack of power may be an issue in subgroup analysis and 
when studying interactions.  
 
3.5 Ethics 
The Tromsø Study has undergone evaluation by the Regional Ethical Committee (REC) as 
well as Norwegian Data Protection Authority (NDPA) and now fulfills the requirements of a 
Health Registry. The study complies with the Declaration of Helsinki, the International 
Ethical Guidelines for Biomedical Research Involving Human Subjects, as well as the 
International Guidelines for Ethical Review of Epidemiological Studies.152 The Northern 
Norway Regional Health Authorities have provided the grant for my research project 
(Medical Research Program #SFP-870-09), as well as a grant from Arne Klem’s fund for 
Norwegian dermatologists, 2008. The project is approved by the REC as well as the NDPA as 






4. Main results  
Paper I 
Is the prevalence of psoriasis increasing? Results from a 30 year follow-up of a population- 
based cohort. 
We observed a clear trend of increasing self-reported psoriasis prevalence among 33,387 men 
and women, participating up to five times in health surveys from the North Norwegian 
population between 1979 and 2008, from 4.8%  in 1979-80 to 11.4% in 2007-08, within all 
investigated birth cohorts (1915-77) and age groups above age 29. There was an independent 
effect of time period with a 2.5 times higher overall odds for psoriasis in 2007-08 than in 
1979-80, when adjusting for age and birth cohort (odds ratio, OR = 2.49; 95% confidence 
interval, CI: 2.08-2.99). There was no indication of increasing prevalence among those aged 




Overweight and weight gain influence psoriasis development in a population-based cohort.  
The incidence proportion of psoriasis in the time period from 1994 to 2008, among 8,752 men 
and women with an age range of 25-69 at baseline, was 4.7% in both genders. Above a 
threshold of BMI 27-28 kg/m2, the study participants displayed increasing odds of psoriasis 
onset in multivariable regression analysis; above versus below BMI 27 kg/m2 both genders 
combined had an OR of 1.32; 95% CI: 1.06-1.64, further increasing to OR = 1.41; 95% CI: 
1.12-1.79 at BMI 28 kg/m2, with no age or gender interaction. In analysis stratified by 
smoking status, these results were further strengthened among non-smokers with OR = 1.62; 
95% CI: 1.19-2.20, among those with BMI ≥ 28 kg/m2  versus below, and even higher odds 
among the obese ≥ 30 kg/m2; OR = 1.71, 95 % CI: 1.13-2.56. BMI and weight increase from 
the age of 25 was associated with higher odds of psoriasis from age 45 by up to 70-90% 




Present smoking was a strong risk factor for psoriasis development in both genders combined, 
OR = 1.92; 95% CI: 1.56-2.37, and there was indication of an even higher association in 
women, OR = 2.16; 95% CI: 1.62-2.88.  Although there were no significant synergistic 
effects between smoking and BMI, those who smoked and were overweight (BMI≥ 28 kg/m2) 




Psoriasis and the metabolic syndrome – a population-based study of age and gender 
differences. 
  
We observed that 10.8 % of the 10,521 individuals age 30-79 years who participated in the 
sixth Tromsø Study (T6, 2007-08) reported lifetime psoriasis of mainly mild character.  
Overall 32% of those with psoriasis versus, 24% of those without the condition fulfilled the 
criteria of the metabolic syndrome. Psoriasis was associated with a 3.82 times higher odds of 
metabolic syndrome in women at age 30 (95% CI: 1.51-9.66). While the odds decreased with 
age, the difference in prevalence of metabolic syndrome between women with and without 
psoriasis remained quite stable; age 30-44 years, 21%/ 11%; 45-59 years, 27/20; 60-79 years, 
37%/ 30%.  In men, psoriasis was associated with an almost uniform 1.35 times higher odds 
of metabolic syndrome (95% CI: 1.11-1.64) in all ages. In general, the same patterns were 
found using both the higher and the recently proposed lower waist criteria.  
Abdominal obesity was the most frequent metabolic syndrome component in women in this 
study. We observed a dose-response relation between psoriasis severity, indicated by 
treatment, in women with psoriasis, and odds of abdominal obesity measured by waistline in 







5. Discussion  
The overall aim of the thesis was to investigate time trends in psoriasis prevalence and 
exploring overweight and weight gain as potential environmental risk factors for psoriasis 
development. Furthermore, the association between psoriasis and the metabolic syndrome was 
explored, all within a population-based cohort. There are few long term population based 
studies exploring psoriasis, and the need for prospective cohort studies has been 
emphasized.18,127 The Tromsø Study is to our knowledge the oldest running cohort for 
psoriasis research among men and women worldwide with high overall participation rates in 
repeated surveys since the 1970ies; it includes self-reported psoriasis status, information on 
potential confounding lifestyle factors and measured metabolic status including laboratory 
tests.130 Improved knowledge about lifestyle risk factors for psoriasis is needed in order to 
understand the distribution of the disease and opportunities for prevention, and while many 
think we already have the answers to the question if psoriasis is a systemic disease 
independently associated with an increased burden of metabolic and cardiovascular disease, 
data up until today is not sufficient to draw conclusions about causality and potential targets 
for prevention.18,105,126,127,153   
As a general rule caution is called for when interpreting results from individual observational 
studies. In order for results to be correctly interpreted it is important that the studies are 
repeated in different populations and performed with the correct methodology.24 Each study is 
merely a small piece of a big puzzle. Basic questions to consider before drawing conclusions 
in research are  the accuracy of outcome  (in example psoriasis), predictors and other 
covariables used; if  the associations observed are true or reflect bias, confounding  or chance; 
and lastly if causality can be assumed. It is important to remember that an association between 
a predictor and an outcome may very well be statistically significant; however this does not 
automatically mean that the association is causal. Nor does it mean that because an 
association does not reach statistical significance, it cannot be causal. In many cases 
significance is not reached because of a too small sample size, while in other cases there is a 
significant association, but it has little or no biological and clinical importance.24  
Determining causality is the key to be able to use study results for primary prevention, which 
is determined to modify the occurrence of the outcome of interest.24 In order for psoriasis to 
debut several causal components act together, to form what Rothman calls a “sufficient 
cause,” defined as “a set of minimal conditions and events that inevitably produce disease.”24  
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The elimination of just one of these causal components may be sufficient to avoid disease. In 
many cases the identification of an epidemiological chain of importance to prevention 
precedes the discovery of the actual causal factor.24 Guidelines for evaluation of the causality 
of a statistical association, the so-called “Hill’s criteria” were originally developed as a part 
of the first US Surgeon General report on the health effects of smoking. Hill lists nine criteria 
which may strengthen the evidence that an association is causal;154 however, apart from 
“temporality” the inability to satisfy many of these criteria does not justify the conclusion that 
the association cannot be causal.24 The Hill’s criteria set to determine whether alternative 
explanations like bias or confounding can be reasons for the found association, and if not, 
whether a cause-effect relationship can be concluded. These criteria are: “Experimental 
evidence”: Randomized controlled trials are generally thought to give the best protection 
against bias and confounding, and are therefore at the top of the evidence pyramid. However, 
randomizing is often not feasible or socially acceptable. “Temporality”: The fact that an 
exposure happens before an outcome does not automatically imply that the association is 
causal; however, if this chain of events is not present, causality can be ruled out. “Strength of 
the association”: It is more difficult to explain away a strong association as bias or 
confounding. Associations with a relative risk above 2.0 are as a rule of thumb considered 
being strong. “Dose-response/ Biological gradient”: Confounding and bias are generally 
thought to have less explanatory value if the outcome of interest increases or decreases 
steadily in tact with increased exposure to the predictor; for instance if lung cancer increases 
with increasing number of inhaled cigarettes or psoriasis development increases with 
increasing BMI. However, it is important to recognize that other biological patterns can also 
be present; there may be a threshold pattern with increase only after a certain threshold, or a J-
shape, where small doses of the exposure have a positive health effect, while larger doses do 
not.24 “Biological plausibility”: Are there plausible biological mechanisms that can explain 
the association? This criterion is limited by the status of current knowledge. “Consistency”: 
Consistency of results supports causality, but there are many reasons why population-based 
studies may end up with different results, without this implying that the found data are 
incorrect. Consistency could also mean that there is consistent bias or confounding in all 
surveys, and must thereby be used with caution. “Coherence”: Coherence between laboratory 
and experimental data as well as epidemiological and clinical data increases the likelihood of 
causality. The cause and effect relation should not conflict with the known facts, also this 
limited by present knowledge. “Specificity”: The more specific the association between a 
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predictor and an outcome is, the bigger the probability of a causal relationship. Lastly, 
“Analogy”: The effect of similar factors must be considered.154 
5.1 Methodological considerations  
5.1.1 Validity 
Validity can be separated into two components; internal validity, dealing with the degree of 
systematic errors in the study results or internal truthfulness; and external validity or 
generalizability (see also discussion of main results), dealing with the extent to which the 
results can be generalized to be valid in other populations.  
High internal validity is a prerequisite in order to be able to draw the right conclusions in any 
study. An observed association between an exposure and an outcome may be real (causal or 
non-causal) or have three other possible explanations, which are threats to internal validity: 1) 
Chance (random error); 2) Bias (systematic error); and 3) Confounding.155 All 
epidemiological studies wish to estimate the exposures and outcomes of interest with a 
minimum of error, but there will always be some level of error in any study.  
Precision refers to the reproducibility or repeatability of a measurement, and is a measure of 
random error or sampling error, something which can never be completely avoided in 
epidemiological studies. Precision is statistically expressed by confidence intervals, and is 
dependent of a study’s size/ power and design.147 Generally, sample errors are reduced when 
using a larger study sample, as in the present population-based study. Bias is defined as the 
deviation of an estimate/ measurement from the true quantity to be estimated; in a study 
setting, this would lead to a systematic error.24 Mainly, bias related to study design and 
procedures is categorized into two groups; selection bias and information bias. Sometimes 
these types of bias are intertwined, and not easily separated.24 Some consider confounding to 
represent a third type of bias, but this will be handled separately here.  
Performing our study within the Tromsø Study meant that all overall procedures regarding 
design, recruitment, data collection and data management were handled by the quality 
assurance and quality control procedures of the Tromsø Study; which in general holds high 
quality.131 However, taking part in a large general health study limits the possibility to make 
extensive questionnaires and procedures, for instance in terms of skin disease, in order to 
minimize the total toll on attendees.  
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5.1.1.1 Selection bias: psoriasis, overweight and smoking 
The attendance rates of the Tromsø study are still well above the often used threshold of 
acceptability at 60% in high-quality surveys.131 Rates below this are thought to give a greater 
risk of selection bias, which is “a systematic error in a study that stems from the procedures 
used to select subjects and from factors that influence study participation.”155 The common 
element of such biases is “that the relation between exposure and disease is different for those 
who participate and those who do not participate in the study.”155  
Declining participation rates in health surveys are well documented.156-158 Reasons for this are 
thought to be related to several aspects; invitations to several health related research projects; 
confusing the invitation with marketing/ advertisement; unwillingness to participate when 
there is no immediate benefit associated with this; general decrease in willingness to volunteer 
in the society; lack of trust in research due to prior experience; the informed consent leaflets 
are too difficult to understand, and the time burden of participation is becoming too 
large.131,158 The subjects who have declined participation tend to be younger or very old.131 
The proportion of men has always been higher among non-attendees, e.g. overall attendance 
rates in men/women in the different surveys; Tromsø 2: 74%/ 82%; Tromsø 4: 70%/ 75%; 
Tromsø 6: 63%/ 68%.130 In the last two surveys, the participation rate was higher among those 
who had taken part in previous surveys, than among first time invited subjects.131 In T6 
(2007-08), the participation rate was similar in all age groups among first-time attendees, 
except for the oldest age group.  In the age groups 25-29 in T4, 30-34 in T5, and 30-44 in T6, 
the attendance rates were below 60%. In T6, there were relatively few persons invited and 
even fewer attending in the youngest age groups with attendance of 44% in men and 58% in 
women below age 45.131 This gives a larger risk of selection bias and potentially reduced 
validity of the estimates from these age groups, in particular among men. 
Non-attendees tended to be single, consistently throughout the surveys. In the last survey, 
59% of attendees were married versus, 41% of non-attendees.131 When comparing with central 
statistics, the educational level of attendees in T6 was somewhat higher than the general 
population in Tromsø and Norway.131 A study comparing those who only returned the first 
questionnaire in T4, with those who returned both questionnaires, found that there was a 
slight increased proportion of men (12.6% versus 10.9% of women) and smokers. Differences 
in age, BMI, blood lipids and blood pressure were minor. This suggests that those who do not 
return the second questionnaire, something which is the largest source of missing on the 
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psoriasis questions (placed in Q2) may be slightly overrepresented in terms of smoking, but 
otherwise coherent with other attendees.159 Unfortunately legal restrictions from the 
Norwegian Data Protection Authority have not allowed for analysis of morbidity and 
mortality in accordance to attendance. A study within the cohort showed that the age- and 
sex-adjusted total mortality for those who were invited to T4 differed between those who had 
attended T2-T4 (6.9/ 1,000 person-years) and those who were invited to all three surveys, but 
only attended T4 (11.1/ 1,000 person-years).130 Overall, this may indicate that constant 
attendees may be healthier and have lower overall mortality than the general population, or 
that they have a health effect from attendance. The possible healthy survivor bias among the 
elderly who attend the survey may influence the effect estimates, and will most often lead to 
underestimation of the true association, when investigating associations between exposures 
and disease.130  
A different selection bias problem would arise if the study population was recruited in terms 
of psoriasis, which often exists in studies from dermatology clinic in- or outpatient settings, 
because the degree of psoriasis seen here is not representative of the normal population with 
psoriasis. The same type of problem can develop, when persons are specifically invited to be 
screened for skin conditions, something which has been done to investigate psoriasis 
prevalence.160,161 Another frequent approach used to assess psoriasis incidence, prevalence 
and related comorbidities is the utilization of health or insurance registers. Several frequently 
cited publications have come from the UK General Practice Research Database (UK GPRD) 
where approximately 7% of the UK population’s diagnoses are registered from the 
participating general practitioners. This allows for a more truthful investigation of the burden 
of psoriasis in a general practice population; however study participants may represent a 
slightly selected group who visit their doctor with current health problems.126  
Importantly, as psoriasis was only one of a broad panel of diseases in the Tromsø Study 
questionnaires, it is less likely that participation was differential by psoriasis status. Moreover, 
there was no publicity to recruit individuals with psoriasis prior to the surveys. A hallmark 
study from Sweden in the sixties showed that individuals who do not attend general health 
examinations are no more prone to have psoriasis.44 However, psoriasis is more recently seen 
associated with both obesity and depression among others, which could potentially lead to 
less recruitment of individuals with psoriasis into the study. In our analyses we found that 
those who reported psoriasis had a lower educational level and a higher frequency of smoking 
in both genders in the investigated time period, and that they were also increasingly 
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overweight, especially in women. Both obesity as well as other unhealthy lifestyle exposures, 
like smoking, are linked to lower socioeconomic status and educational level.134,162,163 
Longitudinal studies have demonstrated a tendency to recruitment of healthier individuals in 
cohort studies.130,131,156 It is therefore a concern that persons with psoriasis, as well as those 
who are obese or smokers may be slightly underrepresented in the Tromsø study cohort, 
which may lead to attenuation of the effect estimates in our analyses.  
We reduced our sample somewhat in our analyses in order to minimize selection bias in the 
birth cohorts or age groups which may not be sufficiently represented. Furthermore, we 
performed sensitivity analyses to see if those who had missing data on psoriasis status as well 
as exposure data influenced the results, and no such indication was found, indicating limited 
bias due to missing. In conclusion, it is less likely that a large selection bias exists in the 
present studies (Paper I-III). 
5.1.1.2 Information bias - misclassification 
The design of questionnaires that correctly identify exposure and disease status may be 
challenging. Preferably an international well validated screening tool for psoriasis would have 
been used, but upon study start this did not exist. To date, there are not even international 
diagnostic criteria for psoriasis, which makes it more difficult to assess the disease. 
Information bias refers to; “a distortion of an estimate which occurs when measurement of 
either the exposure or the response is systematically inaccurate.”164 Measurement errors when 
measuring categorical variables may lead to misclassification, while measurement errors in 
continuous explanatory variables or covariates may lead to errors in the effect estimate. 
Misclassification bias upon assessment of psoriasis 
A dermatologist’s skin evaluation and diagnosis is the gold standard in assessing psoriasis. 
The lifetime prevalence of psoriasis, which was the main measure of psoriasis in this study, is 
a specific subtype of period prevalence, which sets to define the proportion of the population 
who experienced psoriasis sometimes during their lifetime up until the time of assessment.24 
When assessing point prevalence it is easier to correctly determine who has the disease in 
question at that time point; however, with a chronic relapsing disease like psoriasis, this 
approach will most likely underestimate the true burden of the condition.  
“Misclassification bias is a form of information bias where persons in the study are 
erroneously placed in different exposure or outcome categories. This misplacement can be 
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non-differential, meaning that the degree of misclassification is independent of case or control 
status, or it can be differential, meaning that the degree of misclassification differs between 
the two groups examined. In general it is said that non-differential misclassification leads to a 
weakening of the true association between a dichotomous exposure and an outcome, while 
differential misclassification can bias the association either towards or away from the null 
hypothesis.”24 The extent of this phenomenon can in most cases be measured through 
validation studies.165 A validation study sets out to assess if a test, in this instance a 
questionnaire, has the ability to distinguish between those who have psoriasis and those who 
do not.24 The key concepts here are; sensitivity; which is the ability of the test to correctly 
identify those who have the disease of interest, in this case psoriasis, and specificity; which is 
the ability of a test to correctly identify those who do not have the disease.24 Ideally one could 
measure the degree of misclassification in each case and reclassify them, something which is 
very time consuming and often impossible, or use the information from a sample of the data 
to adjust the effect estimates on a general level.  
Due to the fluctuating course of psoriasis, the validation of lifetime psoriasis through point 
prevalent examination or relying on medical record from a short timeframe, may lead to an 
underestimation of the lifetime prevalence of the disease.36,166 Inspecting and interviewing all 
persons who have reported a psoriasis diagnosis over the years from 1979 to 2008 was not 
possible due to time and resource constraints, as well as the fact that some of the participants 
were no longer available for questioning. Medical records from the practices of the multitude 
of general practitioners in Tromsø, who attend to the majority of patients with psoriasis, were 
not available. Point prevalent skin inspection after the end of survey in T6 would have given 
an indication of the burden of psoriasis in the population of Tromsø at that time, but it would 
not have given a complete answer as how to determine if the persons who did not have active 
lesions had experienced having psoriasis at some point in their life or not; nor would it give a 
complete answer to what percentage of the participants were false negatives.  
Self-report of psoriasis has been used in several studies,3,21,32,34,49,167 but has rarely been 
validated with physical examination (discussed in Paper I-III). Generally self-reported data 
give a larger risk of misclassification and represent a potential weakness in study design and 
interpretation. Validation studies have used different approaches to assure a correct diagnosis 
with conflicting results. Those who have done a physical examination within short time of 
self-report of current symptoms or validated through patient records have found relatively 
acceptable sensitivity of self-report.37,101,160 Data from the Nurses’ Health Study showed that 
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92% of self-reported psoriasis cases were definite cases of psoriasis;101 however a higher 
sensitivity of self-reported diagnosis may be expected among health care workers. Several 
studies have pointed out that up to 50% of psoriasis cases (generally mild) may be 
undiagnosed by a doctor,34,160,168 something which could potentially attenuate the effect 
estimates. Due to the healthcare system being free and easily accessible for everybody in 
Norway the degree of undiagnosed and underreported psoriasis might be smaller in our study 
than in many other countries.  
In order to perform a trend study, and assess the prevalence of psoriasis at different time 
points, we needed to use the same question to assess psoriasis for comparability. The small 
difference in phrasing of the question used to assess psoriasis from T2-T6 is not thought to 
contribute to a change in the classification of the status, but ideally all questions would be 
exactly the same and asked in the same order and graphical display in the questionnaire. The 
reproducibility of self-reported psoriasis between the first four surveys and T6 was between 
84% and 91%, meaning that when persons were asked regarding their psoriasis status they 
consistently reported the same status in the questionnaire if they previously reported a positive 
psoriasis diagnosis.24 The ability to recall prior status by repeated attendees was time 
dependent, and may indicate that individuals, whose disease has not been active for a while, 
may forget to disclose a prior positive status due to recall bias. Recall bias may lead to 
misclassification bias and in this case a smaller prevalence estimate in high age. Thus, the 
oldest birth cohorts were excluded from the study samples in order to minimize information 
bias in all studies.   
Due to the fact that most other studies have used questions regarding doctors’ or nurses’/ 
health personnel’s diagnosis of psoriasis; in T6, the question “Have you ever been diagnosed 
with psoriasis by a physician?” was added for validation and comparability purposes. In 2007-
08 (T6), 89.9% of female and 83.6% of male self-reported psoriasis cases reported diagnosis 
by a physician. A large Norwegian as well as Danish twin gene study using self-reported 
psoriasis data, where the Danish questionnaire asked whether the psoriasis diagnosis was 
given by a doctor, both found identical figures in the heritability of psoriasis, indicating a 
good overlap between the questions.48,49  
According to validation studies from comparable populations, most cases of psoriasis are 
adequately diagnosed by trained general practitioners.36,169,170 The rate of doctor’s diagnosis 
of the condition in our cohort is reported to be similar to other studies from developed 
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societies.161,171 Importantly, psoriasis has a strong hereditary component and its characteristic 
appearance is often known among family members. Prior studies have found that persons with 
skin disease tend to not seek medical attention,34,37,161,171 and that there may be a gender 
difference in the degree that they seek consultation.37 Men are in general known to have a 
higher threshold for seeking medical consultation, and reported a lower rate of physician’s 
confirmation of psoriasis diagnosis in T6. Also in T6, a question to self-evaluation of present 
disease severity on a scale from one to ten was added. This question was placed in a separate 
section for follow-up questions in the last part of the second questionnaire (Q2), and generally 
had lower response rates. Among those who answered, 15.1% stated no symptoms (0), 56.8% 
mild (1-4), 22.5% moderate (5-7), and 5.6% stated severe symptoms (8-10). The level of self-
assessed present disease severity was slightly lower than in the studies based on health 
databases, as could be expected,37,117,161 and in line with the validated results from the 
Rotterdam cohort study (Tromsø/ Rotterdam: Mild= 72%/76%, Moderate to Severe= 
28%/24%).169 In Paper I, those with a reported doctor’s diagnosis who indicated current 
psoriasis severity 0-1 in T6 were combined and defined as having no symptoms. Among those 
not reporting a doctor`s diagnosis and answering the severity questions most of the persons 
reported no or mild current symptoms, suggesting that they might not see their chronic 
relapsing skin disease as an issue in need of present treatment.  
We also linked data from the 2007-08 survey (T6) with the Norwegian Prescription Database 
(NorPD) and found that approximately 50% of the cases reporting psoriasis had received one 
or more psoriasis prescriptions (median = 2) in the time interval around T6. Information on 
medication from NorPD was attempted used as a proxy for disease severity (see Paper III). 
Disregarding missing entries, misclassification psoriasis diagnosis, or that the drugs were 
given for other diagnoses; these data indicate that half of the psoriatic population was in 
remission, did not seek medical treatment, or received climate therapy, UV-treatment or other 
hospital based treatment in the time period. This is in line with other studies who have 
validated self-report of psoriasis and find that approximately 25-70% have point prevalent 
disease at the time of survey.34,161,168,172  
The approximate six year time laps between the surveys in the Tromsø Study give some 
uncertainty as to when in the time period their psoriasis status may have changed; thereby 
relationships with incidence rates and duration of psoriasis disease could not be investigated 
(Paper II and III).  
47 
 
Our findings confirmed the relationships reported by others between daily smoking, higher 
BMI, and an increased risk of psoriasis.1,22,25,93 This supports the validity of the self-reported 
psoriasis data collected in the Tromsø Study. It is unlikely that a misclassification of psoriasis 
explains the positive associations of psoriasis with overweight, weight gain and the metabolic 
syndrome in this cohort. One could expect even stronger associations with a more specific 
definition of psoriasis.116,147 However, limiting the analysis to include only participants 
reporting a physician’s diagnosis led to a slight reduction in the effect estimates for the 
metabolic syndrome (Paper III). This may be due to chance or reflect a detection bias in 
physician’s diagnosis where persons with a less favorable metabolic profile consult their 
physician less frequently. Due to the small number of psoriasis cases without confirmed 
diagnosis, this could not be further evaluated. 
Misclassification bias upon assessment of BMI, weight change, MetS and smoking status 
All clinical measurements were performed with standardized procedures by health 
professionals in the Tromsø surveys, ensuring high validity, unlike many studies that have 
relied on self-report of weight and height. Using BMI as a tool to assess overweight and 
obesity has some limitations, especially in men, who have a higher muscle mass and larger 
bone mass. Thus, there is a risk that BMI overestimates adiposity. This may be indicated by 
our data, as different thresholds for men and women in regards to BMI as a risk factor for 
psoriasis development were suggested (Paper II). Waist circumference has proven to be a 
better measure of abdominal obesity, and was available for the full population sample in the 
2007-08 survey (Paper III).  
The degree of tracking between baseline BMI and later BMI is high in the Tromsø cohort,173 
as those who are in the higher BMI categories continue to be in the same category or increase 
over time. As 90% of the population increased in weight in the time period, the measured 
weight at the different time points was most likely representative or a slight underestimate of 
the past five year time period. When studying adult weight change in T4 participants, we 
found that in general, the largest weight gain in the population happened until middle age, 
after this the weight stabilized in both men and women (Paper II). Upon baseline in T4 a 
majority of men were already overweight; while women had the largest change in mean body 
weight in the time period from 1994-95 to 2007-08 (Characteristics, Paper I). Thus, the 
weakness in terms of interpreting the effect of BMI on incident psoriasis might be most 
important for women, as a prior study supported that short-time weight gain does not seem to 
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be the most important factor for triggering psoriasis development.86 Furthermore, our results 
indicate that the biological effect of BMI in psoriasis is dependent of the reach of a biological 
threshold; thereby the time lapse between the surveys may not be a large concern.  
Our validation study from a subsample of repeat attendees who had measured weight around 
age 25 and reported weight at age 25 found a strong correlation of R= 0.89, supporting the 
validity of this approach. The validity of recalled weight gain in adults has also been 
investigated in other studies, and found to be an acceptable method.143,144 Although 
participants tend to slightly misreports; in two US studies females underestimated their weight 
by -0.8143 to -1.4 kg,144 while men overestimated their weight by +2.3 kg.143 With increasing 
age and increasing BMI respondents tend to underestimate their own weight at age 25.143 
However, although this measure is not 100% accurate, it gives a good indication of the 
approximate weight at age 25.  
Underreporting of smoking in epidemiologic studies is common and may constitute a validity 
problem, leading to biased association measures. There is a risk that persons may not be 
completely truthful when answering questions on known unhealthy exposures to health 
professionals or insurance companies/ claims. It is more likely that the listing of exposures 
through an unidentifiable questionnaire, will lead to more truthful results. An older 
Norwegian study found a strong association between self-reported smoking habits and the 
measure of serum thiocyanate, if the questions used for assessment were asked in a neutral 
setting.136 In a recent validation of self-reported tobacco use against nicotine exposure 
assessed by plasma cotinine in a Norwegian cohort, the sensitivity and specificity for self-
reported daily smoking, using 30 nmol/l as the cut-off concentration, were 82% and 99%, 
respectively.137 Similar concordance rates in both genders have been supported by others.174 
All data in the Tromsø study were gathered in a self-administered questionnaire in a neutral 
setting, which supports the validity of the smoking questions. However, the degree of 
smoking will probably be underreported.  
The level of daily smoking has been gradually reduced in Tromsø and Norway in general over 
the past four decades. It comprised over 50% of men and 30-35% of women in the early 
seventies, and was steeply reduced among men up until today, with a delayed reduction rate in 
women mainly from the millennium (Paper I). In the last Tromsø survey (2007-08), 19% of 
men and 22% of women were smokers. A stable 10% of the Norwegian population smoke 
occasionally over the past four decades.175 Repeated cross-sectional analysis (Paper I) from 
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the Tromsø cohort shows that men have increasingly quit smoking compared to women in the 
time period. Persons may have given up smoking in the time-period between baseline and 
debut of psoriasis, something which may attenuate the effect of smoking in terms of odds of 
psoriasis. 
An accredited laboratory was chosen to perform the laboratory tests, which were also 
performed within uniform procedures of collection and analysis. However, when evaluating 
the psoriasis−MetS association in Paper III all blood samples were taken non-fasting, which 
could lead to non-differential misclassification of serum lipid levels and bias the association 
towards the null value.  
5.1.1.3  Confounding and interaction 
Confounding 
Confounding exists “when an association between a given exposure and an outcome is 
observed as a result of influence of a third variable. This factor must be causally associated 
with the outcome and causally or non-causally associated with the exposure.”24 In other 
words, there may seem to be an association between an exposure and an outcome, for instance 
psoriasis and the metabolic syndrome, when the reality is that this is related to the influence of 
a third (or more) variable(s). Confounding describes a true, but potentially misleading 
association between an exposure and an outcome, which can influence the interpretation of 
results incorrectly. In order for the confounder to have an impact on the results, it must be 
unequally distributed in the groups which are under comparison. Confounding can never be 
totally removed; however, it can be minimized through study planning and analysis methods. 
If possible, randomization of subjects leads to a larger chance of actually “comparing like 
with like.” Stratification and statistical adjustment through multivariable analysis is another 
way of searching for other explanations for the found estimate.  
Many of the traditional risk factors for psoriasis can be considered confounding factors when 
evaluating the relationship between psoriasis and potential comorbid conditions like the 
metabolic syndrome. Psoriasis has a major impact on a person’s quality of life.10,167,176 This 
may lead to unhealthy lifestyle choices, which in turn, increases the risk of several diseases.  
In the Tromsø Study detailed information on lifestyle confounders was assessed, and thereby 
we could adjust our effect estimates in multivariable regression models (e.g. physical activity, 
alcohol, smoking), and further stratify analysis to control for the effect of confounding factors 
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(e.g. smoking). There is also the possibility of residual confounding in any association, 
meaning that the confounders in question are unknown or not a part of the analysis (see also 
discussion of main results).  
Heterogeneity of effects- Interaction 
Interaction is present when “the association between a risk factor and an outcome differs in 
subgroups of the population,”165 most commonly by age or gender, but also by several other 
potential risk factors. Statistically defined interaction exists if the product term between two 
exposures is significant at a p-level of 5%. This relationship between exposures was examined 
in all the three papers. Interaction is often dealt with by stratified presentation of the data or 
the introduction of multiplicative interaction terms in multivariable regression models and 
was explored in our data.  
According to Rothman you can have a biological interaction or synergism indicating that the 
combined effect of two factors leads to a more or less than additive effect of each factor in 
itself.147 This was something we explored further in Paper II in relations to the combined risk 
of overweight and smoking on psoriasis development. 
5.1.2 Ethical considerations 
The fact that so much information is gathered from so many individuals without too large 
intervention in the Tromsø Study, based on the principle of “benefice and non-maleficence,” 
leading to multiple high-quality research publications from several research groups supports 
ethical research. The autonomy of the participants is respected and they are treated with 
dignity in all chains of the study. The information given to the study cohort has become more 
extensive through the years. As of T4 written consent is obtained and stored according to new 
regulations; while prior to this consent was given through participation. This consent can be 
withdrawn at all times. There are plans for follow-up of acutely deviant results which are 
serious or potentially life threatening from the different research groups before each survey, 
as well as measures to insure that persons do not receive unwanted information. The gathering 
and storage of biological samples and data is done according to laws and regulations, and all 




5.2 Discussion of main results  
5.2.1 Trends in psoriasis prevalence 
Our finding of a doubling in psoriasis prevalence in a general population sample is consistent 
with the increased or high prevalence and incidence found by other population-based studies, 
22,23,27,28,30,34,35,160 but not all.36,177 Importantly, studies reporting trends in psoriasis occurrence 
are sparse and not uniform.15,33,36 In a recent Danish health survey based study the self-
reported prevalence of doctors diagnosed psoriasis was reported to be 7.1%,23 and in line with 
a Norwegian study from the general population of Oslo.22 This stands in contrast to the UK 
GPRD study which found a period prevalence of only 1.5% related to the total population,36  
and a similar figure from another general practice database study was recently reported from 
Sweden.177 However, these database studies capture disease in all age groups from child to 
old age within a fairly short time frame, and may not give a total picture of the lifetime burden 
of psoriasis in adults. With a fluctuating disease like psoriasis there is a large chance that 
many chronic cases will be missed when assessing psoriasis prevalence, as individuals may 
not have visited their doctor in the investigated time frame. An American validation study 
supports that the relapsing and remitting course of psoriasis challenges the identification of 
prevalent cases in database studies.166   
In the last Tromsø survey (2007-08), 11% of the population aged 30-79 years reported a 
present or prior history of psoriasis, which is higher than in other population-based studies in 
western societies;15 but in line with recent results from Scandinavia.22,23 In T5 (2001), the 
overall prevalence of psoriasis was 8.9% and the estimated doctor`s diagnosed prevalence was 
7.7% which is fairly consistent with the results from Oslo Health Study (HUBRO; 2000-01), 
another population-based study (n= 18,770), reporting a doctor`s diagnosed prevalence rate of 
8.5% in adults.22 Interestingly, a study from 1981 using data from a telephone interview 
commissioned by Statistics Norway, where persons were asked to report any diseases, showed 
large regional differences of psoriasis within Norway with a prevalence of 1.4 % in the south 
and 2.7-3% in the north. This difference in disease could be related to climatic differences, as 
psoriasis may be more frequent closer to the earth’s poles.20,47 There are biological 
explanations as to why this may be so, as will be discussed further in regards to the results of 
Paper II. The lower prevalence reported here compared to the prevalence in the second 
Tromsø Study (1979-80) of 4.8% could be due to the study method, where many might not 
come to think of a skin condition as a “disease”, fluctuations in current symptoms, as well as 
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variation in sampling strategies.39 Thus, our findings of a clear gradual trend of increasing 
self-reported psoriasis prevalence among both genders are supported by other studies among 
comparable populations,22,23,29,30,34 but also extend existing knowledge representing a unique 
high prevalence and increase in trends in a general population located in Northern Norway.  
An interesting finding was that we observed no change in self-reported psoriasis prevalence 
among 20-29 year old men and women in the time period from 1979 to 1994. Similar 
observations were found both in Sweden in a study of 17-20-year old military recruits,33 and 
in a Norwegian study of twins below age 31 years (birth cohorts 1967-79) performed over a 
shorter time frame.32 These results are contrary to the results observed in North American 
children.29 The fact that the prevalence in the youngest study participants, with early onset 
cases, has not increased may partly be explained by different immunological patterns and 
genetic susceptibility between individuals with early and late onset psoriasis, or be due to 
differences in the cumulative exposures to lifestyle risk factors.17,178 Unfortunately the 
youngest cohorts were not invited to the two last surveys in 2001 and 2007-08. The increase 
in psoriasis prevalence among adults may be mainly related to late onset cases, which are 
suggested to be more influenced by environmental factors like lifestyle. However, a higher 
prevalence of psoriasis was also found among persons in their thirties in the last surveys, 
questioning if the trend may be developing also among those with earlier disease onset (Paper 
I). 
Repeated cross-sectional studies within the same population as presented in Paper I always 
bear the risk that other influences in the time frame can affect both exposure and outcome 
estimates. Changes in diagnostic criteria over time may lead to different definitions of disease 
and make it difficult to evaluate time trends. However, there have been no changes in 
diagnostics of psoriasis over the past decades. Specific health programs determined to change 
behaviour, could also affect exposure or outcomes, and must be taken into account when 
evaluating prevalence trends. However, psoriasis has not been a disease of high interest in the 
Norwegian media or public, nor has it been a prioritized disease by the Norwegian health 
authorities. We cannot rule out that increased awareness of psoriasis among physicians and 
the public, as well as a general higher use of health services over the past decades have 
contributed to the observed time period effect. Meanwhile, the self-reported prevalence of the 
chronic skin disease atopic dermatitis, which has been in substantially higher focus in the 
study population, did not increase among adults in the Tromsø cohort in the time period from 
1994; where we saw the main increase in psoriasis and supports that changes in awareness 
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may be less like likely to explain our results. However, one could argue that this is mainly a 
condition affecting children and young adults, and thereby a rise in prevalence due to 
increased awareness may first be detected later.  
Prevalence estimates are inherently vulnerable to selection and information bias (see 
discussion on methodology),179 but a stable pattern of selection or misclassification bias in 
repeated assessments of a prospective cohort should not influence estimates of time period 
effects. Our homogenous study population with high attendance rate, repeated assessments of 
psoriasis using almost identical methods, and strict overall study procedures strengthen the 
results related to changes in psoriasis. Due to the fact that the prevalence has more than 
doubled, increasing steadily over time in all age groups above age 29, and among all birth 
cohorts, supports that there has been a true increase in prevalence in the time period. 
In a genetically stable population, changes in the frequency of chronic non-communicable 
diseases, like psoriasis, over a fairly short time frame will most likely be explained by 
environmental factors. When evaluating population characteristics over the surveys used to 
assess the time trend of psoriasis prevalence it is evident that smoking and overweight are 
frequent modifiable risk factors associated with psoriasis.22,25 The difference in frequencies of 
lifestyle exposures between the group with self-reported psoriasis and those without the 
disease in each survey, is consistent with the hypothesis that changes in these exposures may 
influence psoriasis prevalence (see discussion main results Paper II).  
These prevalence trend data represent the general population of North Norway, but may not 
be reproducible in countries with different genetic backgrounds, socioeconomic development 
and climatic conditions. The low level of non-Caucasian attendees did not allow for any sub-
analysis based on ethnicity, and would limit the generalizability, should the increasing trend 
in psoriasis be limited to specific ethnic groups. However, recent data report doubled 
prevalence of psoriasis in the Chinese population above 40 years during the last decades,35 
and even though they are substantially lower than among individuals with Europid 
decent,15,22,23 the increasing prevalence and incidence found on multiple continents suggests a 





5.2.2 Overweight, weight gain, smoking and risk of psoriasis 
Our results, showing that men and women with excess weight had 32-71% higher odds of 
psoriasis onset, are supported by others.25,101 Setty et al. found increasing risk of psoriasis 
within increasing BMI categories at baseline, from a RR of 1.40-1.48 in the overweight and 
obese to a RR of 2.69 in the severely obese category.25 They also found a 20% reduced risk of 
psoriasis among those in the lowest WHO category.25 This was further supported by a later 
study from the same cohort.101 Upon analysis it became clear that the relationship between 
overweight and psoriasis was limited to a cut-off placed around BMI 27 kg/m2 for women and 
28 kg/m2 for men, and to our knowledge this has not been explored in prior studies. This 
difference is likely due to the higher musculoskeletal mass in men, whereby they need higher 
BMI measures to indicate adipose tissue (see discussion of methodology). Overweight above 
BMI 28 kg/m2 gave an indication of 40% and 45% increased odds of psoriasis in women and 
men respectively and no gender interaction. Upon stratification for smoking in order to further 
disentangle the independent effect of overweight, the results were strengthened in non-
smokers overall. We did not have a sufficient number of underweight or severely obese cases 
to investigate this association.  
Further, mainly cross-sectional and case-control, studies have also supported the relationship 
between overweight and psoriasis. A recent meta-analysis concluded that individuals with 
psoriasis have an over 50-60% increased odds of being obese compared to the general 
population,97 with dose-response dependency between the severity of psoriasis and the odds 
of obesity.97 A large UK study also supported that overweight and obesity both represent risk 
factors for psoriasis within a case-control design, reporting a 11-33% increase respectively,28 
even though, this analysis was limited due to unstandardized procedures and lacking 
information on major adjustment variables. A smaller Italian case-control study containing 
new onset psoriasis cases (within the last two years) found a graded positive association with 
both overweight (OR 1.6; 95% CI: 1.1-2.1) and obesity (OR 1.9; 95% CI: 1.2-2.8),77 while a 
Swedish study of  new onset cases (within the last year) matched with healthy controls found 
a 9% increased risk of psoriasis with each unit increase of BMI, and concluded that persons 
who were obese had a two-fold increased risk of psoriasis.86 Psoriasis cases that are recruited 
to dermatological specialty clinics may be more severe than those found in the general 
population, and this together with further differences in study design and populations, may 
explain the slightly lower effect estimates found in our data.77,86  
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To our knowledge this is the first study investigating weight gain as a risk factor for psoriasis 
onset in men. In the female NHS cohort the multivariate RR of psoriasis in the highest weight 
gain category was 1.88, and there was a significant trend in the risk of psoriasis development 
according to adult weight gain. Our observation that weight gain from the age of 25 was 
associated with 70-90% higher odds of psoriasis from middle-age independent of weight 
category extends previous studies. In our data, belonging to the upper quartile of adult BMI/ 
weight gain led to a 70-90% increased risk of psoriasis compared to the first quartile among 
persons aged 45 years and above (P for trend over quartiles of BMI/ weight gain = 0.009/ 
0.002. P for interaction between BMI/ weight gain and age = 0.03/ 0.02). Studies suggest that 
the different clinical phenotypes of psoriasis are genetically heterogeneous, and that there may 
be a difference in the genetics of plaque psoriasis of the late versus early onset type.14,53-55 Our 
results suggest that overweight and weight gain may be a more important risk factor for 
psoriasis among late onset cases as also supported by a  recent study in which patients with 
late onset  psoriasis had a higher proportion of obesity and elevated waist circumference than 
the early onset group.180 Contrary, data from the US Nurses’ Health Study (NHS) found no 
indication of an interaction between age and overweight as a risk factor for psoriasis.25 
However, the investigated women were mainly middle-age or above and more representative 
of the late-onset psoriasis group. Furthermore, as the US has come further than Norway in 
terms of the obesity epidemic, their mean BMI may have been increased already at a younger 
age. Thereby, the greater effect of BMI on late onset cases could be due to the prolonged 
negatively influencing inflammatory environment of living with overweight/obesity, which 
leads to a cumulative exposure which can no longer be compensated by the individual; also it 
can be due to the fact that overweight over a certain threshold mainly presents later in life in 
our population; or it can be related to interactions with weakly predisposing genetic or 
epigenetic factors.  
Our result related to excess weight and weight gain is supported by plausible biological 
mechanisms. Basic research indicates that adipocytes and activated inflammatory 
macrophages can play a role in both psoriasis and obesity.97 Adipose tissue, especially in the 
abdominal region, is an active endocrine organ which plays a key-role in lipid and glucose 
metabolism, insulin mediated processes as well as inflammation and coagulation.181 The 
tissue produces several hormones, adipokines, and a whole variety of pro-inflammatory 
cytokines important in both psoriasis as well as cardiovascular disease, among these IL-6 and 
TNF-α.42 Also, obesity-related hyperinsulinemia promotes an angiogenesis state which may 
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also increase susceptibility to psoriasis, e.g. through VEGF (Figure 3, page 20).42,97,182 
Interestingly, insulin resistance has been reported increased also in normal weight 
psoriatics.183 Psoriasis remission following bariatric surgery has been reported,184,185 and 
recently a small Danish RCT found improvement of psoriasis severity after a low-energy 
diet.186  Case reports of improved psoriasis immediately after gastric bypass, before any 
weight loss has happened, have led to the hypothesis that the effect of gastric bypass could in 
part be related to an increase in the release of the hormone glucagon-like peptide-1  which 
lowers  serum glucose and is suggested to have anti-inflammatory effects.185 Thus, it is 
biologically plausible that persons who are genetically disposed to develop the psoriasis 
phenotype may be pushed in that direction from the metabolic and inflammatory changes that 
comes from weight gain and weight over a certain level.  
Although the proportion of smokers in most westernized populations are declining, it is still 
the world`s leading cause of preventable death.187 Smoking has been identified as a predictor 
of increased psoriasis risk,86,90 and in our data present smoking was associated with a 92% 
increased odds of psoriasis in both genders combined. A recent longitudinal North American 
cohort study, combining two cohorts, also found smoking to be a strong predictor of incident 
psoriasis, with a relative risk for current smokers between 1.8 – 2.7, and displaying a dose 
dependency.93 The US study indicated a 40% higher risk in prior smokers, but with 
decreasing risk with time.93 In the Tromsø study cohort median smoke stop time in prior 
smokers in T4 was 10-14 years. This probably explains why past smoking was not an isolated 
risk factor for psoriasis in this cohort. The extensive chemical cocktail of tobacco smoke 
contains a wide range of substances with possible effects on both the central nervous system 
as well as skin and immune system.110 Chronic smoking is known to induce oxidative stress 
and affect both the innate and adaptive immune system as well as being correlated with the 
production of several proinflammatory cytokines of importance to psoriasis.93,188-190 Nicotine 
can alter the immune response by interacting with dendritic cells, T-cells and keratinocytes as 
well as by brain-immune interaction mechanisms, which may all be of importance in 
psoriasis.77,188,191,192 The genetic component of smoking behaviour in terms of potential 
overlaps with risk loci for psoriasis, is not yet established.110   
Previous studies have indicated greater health risks from smoking in women than in 
men,77,86,193 something which was also suggested in our data. One theory has been that 
smoking leads to a reduction in estrogen levels which may influence immunological diseases 
like psoriasis.87,194,195 Women had higher effect estimates when investigating the effect of 
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tobacco on psoriasis development; OR for female and male smokers versus non-smokers = 
2.16/ 1.70. Although the risk estimates for men and women showed no statistical interaction 
or differences in trend overall, smoking represented a risk factor for psoriasis from the lowest 
pack-year category in women, while this was only apparent among those within the highest 
pack-year category in men.  
An Italian case-control study investigating the combined effects of smoking and excess 
weight in both genders found increased risks of psoriasis among both past and present 
smokers, with odds of 1.9 and 1.7 respectively, and also here a higher risk in women.77 There 
was indication of a multiplicative relationship between smoking and BMI in terms of psoriasis 
risk, with a OR for psoriasis of 3.0 (95% CI: 1.8-5.2) among those who were ever smokers 
and had a BMI ≥ 30 kg/m2.77 Interestingly, the US NHS cohort showed no material change in 
the multivariable risk estimates upon adjustment for smoking when evaluating BMI as a 
predictor for psoriasis in women.25 It is biologically plausible that the effects of adiposity and 
smoking may act in concert to promote systemic chronic inflammation. In order to 
disentangle the effects of smoking and obesity, as well as evaluate potential  synergism 
between the risk factors, we performed several analysis stratified for smoking status and also 
performed Synergy-score analysis as described by Rothman, to investigate potential 
multiplicative effects.150 As smokers generally have a lower BMI there was a limited number 
of cases who were present smokers and overweight in our cohort. There was no indication of 
a multiplicative risk of psoriasis among persons exposed to ever smoking and overweight. 
However, the combined effect of smoking and overweight gave 2.3 times increased odds of 
psoriasis development in men and 2.7 times higher odds in women.  
It is not biologically unlikely that the relationship between psoriasis and overweight could go 
both ways. Especially individuals with more moderate to severe psoriasis may have a 
systemic inflammatory milieu which could have influence on adipose tissue. Not the least, the 
psychological and physiological impairment of having psoriasis can lead to unhealthier 
lifestyle habits like overeating and reduced physical activity, something which in term can 
lead to overweight and obesity. A prior cohort study indicated an increased incidence of 
obesity in psoriatics,100 but the validity of this result may be questioned as long as it is not 
clearly stated whether the analysis was adjusted for baseline BMI. 
It is possible that the effect of BMI on incident psoriasis could be confounded or modified by 
other lifestyle factors, something which we tried to assess and adjust for through our 
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multivariable regression models. A recent prospective study of female nurses found that those 
who consumed more than 2.3 units of alcohol per week had a 70% increased risk of 
developing psoriasis. When sub-analyzing for beverage type, drinking non-light beer was the 
only significant predictor.85 Another  study from the same cohort found that vigorous physical 
activity was inversely associated with the risk of  incident psoriasis in women, RR 0.73.83  We 
observed only minor differences between the univariable and multivariable models when 
adjusting for alcohol intake, recreational physical activity, and educational level which 
corresponds to limited confounding by these exposures.  
There is always the possibility of residual confounding from factors which are either unknown 
or not included in the analysis. There is ongoing work to identify further genetic loci as well 
as environmental factors and gene-environment interactions which can explain psoriasis.179 
There may be shared genetic variants that increase the susceptibility to both obesity and 
psoriasis, as shown in a recent publication on a SNP in the IL12B gene.57 However, in a meta-
analysis of four psoriasis GWAS cohorts there was no differences between psoriasis cases and 
controls in a weighted gene risk score investigating SNPs associated with increased BMI.111 
The suggested association between psychological stress, depression and psoriasis was not 
explored here.81 A large percentage of psoriasis patients feel that stressful life events can 
influence their disease;77,176 however, there are few longitudinal data on this topic, and 
conflicting results.196 Interestingly, a recent study from the US Nurses’ health study found 
persons who scored highly on depressive symptoms to have a greater risk of psoriasis 
development.81 More research is needed on this important topic.78 Another possible 
confounder is dietary composition. Novelly high salt intake has been associated with 
autoimmune disease.197,198 There is a possibility that the association between overweight and 
psoriasis is due to dietary intake of for instance a large amount of highly processed foods 
containing high concentrations of salt, which theoretically may influence both the frequency 
of overweight and the prevalence of psoriasis.   
Moreover, recent studies have suggested that the microbiome, or collective genome of 
microorganism that are residing in a given niche, may play an important role in immune 
homeostasis; where disruptions of the natural microflora, may cause immune dysfunction or 
autoimmunity.199 If increasing BMI is correlated with changes in the microbiome or infection 
susceptibility;200,201 then the association between BMI and psoriasis risk may be in part due to 
these aspects. However, studies are limited as of today.202 Importantly, some studies have 
found an association between upper respiratory infections and subsequent development of 
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psoriasis, as well as psoriasis exacerbation.28,68,71,72 A study from the UK GPRD found an 
over doubled risk of psoriasis onset within one month of a respiratory tract infection with an  
unknown pathogen among individuals age 21-40, and  increased risk was also seen after 
infectious episodes within the last year.28 However, it is unclear if these results were adjusted 
for seasonality, as psoriasis and airway infections are both generally more common in winter 
time.  Small scale studies have shown improvement of psoriasis after tonsillectomy; suggested 
to be related to a reduction of circulating T-cells that recognize streptococcal determinants as 
well as homologous skin determinants.203 A recent publication showed that the culturing of 
streptococcal extract with skin cells from subjects with psoriasis led to an activation of CLA+ 
memory T-cells and production of Th1, Th17 and Th22 cytokines, as well as other epidermal 
cell mediators.204 Intra dermal injection of the activated culture led to epidermal hyperplasia 
in mice, supporting that streptococcal infection may be an agent for psoriasis initiation.204 
McFadden et al have postulated that some of the genotypic as well as phenotypic changes in 
different immunological pathways involved in psoriasis, give protection against mortality 
during epidemics on invasive streptococcal infections and allow for persons to become 
carriers of streptococci as well as predisposing them to develop psoriasis.68  Also, patients 
with psoriasis have been seen to show larger colonization rates of Staph aureus on both 
lesional and non-lesional skin,205 and have been suggested to be carrying more toxigenic S. 
aureus strains;206 however, data are limited. Staphylococcus aureus nasal colonization is a 
major risk factors for later infections with the bacterium.207 A Danish twin study investigating 
S. aureus colonization determinants, found that the odds for nares colonization were increased 
by 73% for those reporting psoriasis.208 However, this analysis was not adjusted for BMI or 
blood sugar levels; which both represent potential confounders. In our research group, we 
found that obesity was a clear risk factor for nasal colonization with S. aureus, with up to 2.6 
times higher odds of colonization among the obese compared to those with normal weight.209 
Perhaps the crosstalk between microbial determinants as well as host and environmental 
determinant play a role in the complex puzzle that is psoriasis.  
Tromsø, and large parts of Northern Norway, have subarctic climate conditions with more 
than five months of negligible ultraviolet radiation exposure, making inhabitants vulnerable to 
Vitamin D deficiency, of possible importance for skin health.69 Climate and UV therapy are 
widely used to treat psoriasis, and the therapeutic effect of topical vitamin D on psoriasis is 
well demonstrated. Increasing BMI is inversely related to the of serum level of Vitamin D; 
where obese persons need higher doses of Vitamin D to obtain the same serum levels.210 It is 
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possible that the obesity epidemic may be especially important in the Tromsø study cohort as 
Vitamin D has been inversely linked to the severity of psoriasis,69 as well as increased risk of 
bacterial colonization and infections.211-213 We found that being in the highest serum tertile of 
Vitamin D compared to the lowest tertile (OR 0.44, 95% CI: 0.28-0.69) led to reduced 
colonization of S. aureus in the nares of men, who also had the highest colonization rates in 
the Tromsø study cohort.214  Interestingly, rotating night-shift work in US nurses also seems 
to lead to an increased risk of psoriasis by approximately 20%, which has been suggested to 
be related to reduced levels of Vitamin D through less sunlight exposure during the daytime 
or a disruption of the natural production of melatonin.215 Should the interruption of the 
circadian rhythm due to melatonin influence psoriasis, this may be of importance in the 
Tromsø study cohort, which spends three months of the year in consecutively sunlight or pitch 
darkness.  
In order to discuss causality in an association it must first be established that the risk factor 
precedes the debut of disease, in this case psoriasis. The longitudinal study design allows us to 
determine that overweight and weight gain precedes psoriasis; that it leads to an up to 70-90% 
increased odds of psoriasis in our cohort, and that the combined effect of smoking and being 
overweight leads to a high risk of psoriasis development, with 2.5 times higher odds overall 
for both genders combined. The relatively strong effect estimates, the dose-response 
relationship between gain in weight or BMI and subsequent psoriasis risk, the threshold effect 
observed in the BMI-psoriasis association, the biological plausibility, as well as consistency 
with other studies, all support that this may be a causal relationship. Overweight and obesity, 
as well as smoking, represent modifiable risk factors which may be targets for both primary 
prevention as well as supportive treatment of psoriasis in both our and comparable 
populations. As this relationship was present only after middle-age this could indicate that the 
natural history of psoriasis is changing, as there is a substantial amount of new cases 
developing in the middle-age and above population due to lifestyle influence.  
5.2.3 Association between psoriasis and the metabolic syndrome 
In the cross-sectional study in Paper III we found that young women with psoriasis had an 
almost four-fold increased odds of MetS compared to women without a history of psoriasis. 
While, these odds decreased with age, the absolute difference in prevalence of the MetS 
between women with and without psoriasis remained quite stable. Men with psoriasis had a 
uniform 35% increase in the odds of MetS compared to men without psoriasis across all ages. 
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These results confirm the findings from the smaller NHANES survey,116 as well as large-scale 
study from the UK GPRD;117 as they suggest that the association between psoriasis and the 
MetS may be strongest among women. Despite having a general practice database design, an 
age range from 45 to 65 years, different assessment criteria for MetS and incomplete 
information on potential confounders, the UK study reported almost identical overall odds as 
our study, and the MetS was found in 34% of individuals with psoriasis versus 26% of 
controls.117 Comparably, in our population; 33-39% of participants with psoriasis versus 25-
31% of those without the condition were affected depending on the used waist circumference 
criteria, supporting the external validity of our findings. In the NHANES study, with subjects 
aged 20-59 years, 40% of psoriatics versus 23% of controls fulfilled the definition of the 
MetS; while in our study the doubled prevalence of MetS among individuals with psoriasis 
was present in young women only. However, the US study population had higher waistlines 
compared to our study population;116 while a Danish study, which found no difference in 
distribution of the MetS in persons with and without psoriasis, had a lower mean waist 
circumference among attendees.216  
Several studies from multiple continents and populations have indicated that psoriasis is 
associated with several of the components of the MetS, as well as the full syndrome itself, 
giving grounds for concern that persons with psoriasis may be at higher risk of subsequent 
diabetes and cardiovascular disease.5,118,121 In the UK GPRD study, several components of the 
syndrome; namely obesity, hypertriglyceridemia and hyperglycemia, all showed dose-
response relationships with the severity of psoriasis independent of other components.117 
Although a dose-response relationship between psoriasis and the full MetS could not be 
investigated due to restrictions in the data; there was a dose-response relationship between 
psoriasis severity, indicated through oral medication use, and abdominal obesity in women in 
age-adjusted analysis.  
To our knowledge, all but two studies116,216 estimating the psoriasis−MetS association have 
been conducted in clinical settings or within samples from insurance or health care 
databases,117,118,217-221 something which potentially introduces a range of biases.126,127,169,216,222 
Truly population-based data with the ability to adjust for confounding factors as well as look 
at age and gender interactions have been limited, and lead to challenges when attempting to 
generalize the findings to  clinical practice.105 To our knowledge, no prior study has evaluated 
the risk of MetS in psoriasis by age and gender using non-linear risk models which generally 
give better fit to data than traditional linear models.151 The MetS was assessed using the new 
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harmonized criteria including two cut-offs for measured WC. Further strengths include the 
largest sample from a general population survey; including a wide age-range, high attendance, 
comprehensive assessment of lifestyle factors and clinical examinations using standardized 
and validated methods by trained health professionals, performed within a short time frame.131  
The mechanisms contributing to the U-shaped pattern by age in the psoriasis-associated odds 
of MetS in women in our study are not clearly understood. Abdominal obesity, which was the 
most frequent MetS-component in women, is also a key initiator of insulin resistance.223 Prior 
studies indicate that for increasing levels of waist circumference women exhibit more adverse 
metabolic disturbances than men.224 In women 30-44 years, approximately 75% of those with 
psoriasis versus 45% of those without psoriasis had a WC ≥ 88 cm. There have been large 
secular changes in lifestyle in the Tromsø Study population, and younger female birth cohorts 
have increasingly higher BMI and waistlines compared to prior generations (Paper I).225 This 
may explain some of the U-shaped association of psoriasis with the metabolic syndrome. 
Among the elderly the prevalence of the MetS and hypertension in particular was high; in this 
age group about 80% had hypertension independent of their psoriasis status. This age-related 
increase in metabolic components is primarily driven by other factors than psoriasis, possibly 
attenuating the OR estimates.147 Furthermore, the suggested higher cardiovascular mortality 
among individuals with psoriasis,7,8,12 could produce lower effect estimates in the older age 
groups, due to a healthy survivor bias. In men the odds of MetS in psoriatics were almost 
uniform; however, here blood pressure was already increased from middle-age, and 
triglycerides decreased with age, possibly contributing to more stable odds ratios (Paper III). 
Several potential pathophysiological mechanisms may link psoriasis with the metabolic 
syndrome.42 The chronic skin inflammation with a Th-1 and Th-17 shift, leads to an increased 
production of cytokines like TNF-alfa and IL-6; which not only promote epidermal 
hyperplasia, but also antagonize insulin signaling, effect adipokine expression and mediate 
insulin resistance and obesity.42,226 Conversely, the hyperinsulinemic state in the MetS could 
potentially promote psoriasis susceptibility or severity through increased chronic 
inflammation as well as increased angiogenesis.33,215 Insulin-resistance has been seen to block 
keratinocyte differentiation, and may contribute in the pathogenesis of both psoriasis as well 
as metabolic and cardiovascular disease.14,227,228 Furthermore, pleiotropic genetic loci (e.g. 
PSORS2-4, CDKAL1, ApoE4) suggest that there may be a common genetic susceptibility 
between psoriasis and the MetS.226 Although women with psoriasis displayed a particularly 
unfavorable metabolic profile in our study; both genders had substantially elevated hs-CRP 
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indicating low-grade systemic inflammation, despite reporting mild or no present symptoms. 
It is plausible that psoriasis serves as a marker of a common genetic susceptibility bridging 
the association between psoriasis and systemic manifestations such as the MetS given the 
right environmental conditions, as supported by recent genetic and epigenetic 
studies.19,111,112,229 
Our study extends present knowledge of the psoriasis−MetS relationship in comparisons with 
others by its thorough adjustment of important lifestyle factors.125,126 However, factors which 
have not been evaluated in this study, including genetic predisposition, infections, diet and 
mental health, may lead to residual confounding of the association (see discussion of main 
results Paper II). The impact of Psoriasis arthritis on risk of MetS is also something which we 
could not assess, as data were lacking on this important comorbid condition. Recent data from 
psoriasis and PsA patients in a clinical setting support that those who have PsA may have 
even higher risks of MetS and cardiovascular disease than persons who are only affected from 
psoriasis.105,230 Furthermore, several drugs given for psoriasis are known to induce weight-
gain or affect the blood-lipid profile. Due to the low number of persons on systemic drugs in 
this study this was not further investigated. However, including statins to our multivariable 
model did not influence the results.  
In order to evaluate causality, a longitudinal relationship between psoriasis and the MetS 
needs to be established; something which is not possible within a cross-sectional study design.  
Presently, it is not known if psoriasis is a driving factor behind the MetS or if the MetS leads 
to a debut and/or worsening of psoriasis.121 Overweight  influenced psoriasis development in 
our cohort (Paper II), and this could indicate that metabolic disturbances precede psoriasis; 
however, studies show that persons with psoriasis are more prone to develop diabetes and 
hypertension, independent of traditional risk factors like obesity.231 The strong association in 
younger women, the indication of a dose-response relationship between psoriasis severity and 
having a high waistline in women, and the consistent results also after adjustment for lifestyle 
confounders; all support a true relationship between psoriasis and the MetS. Interestingly, 
some suggest that psoriasis should be treated aggressively in order to prevent escalation of 
severity as well as secondary comorbid disease; however the data supporting this view are 
very sparse.232-236 If the reason for the comorbid conditions associated with psoriasis, lies in 
shared genetics or shared risk factors, than the aggressive treatment of psoriasis per se will not 
necessarily lead to a large influence on comorbidity. Should the comorbid conditions be 
related to elevated systemic inflammation, from substrates produced in the psoriasis plaques; 
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it seems a bit odd that persons with very mild or inactive disease, like the majority of persons 
in our study cohort, should show such an increase in the MetS, which we know to be a 
predictor of both diabetes and cardiovascular disease. More research is needed to disentangle 
this complex relationship (Figure 3, page 20).105  
Targeted screening for metabolic and cardiovascular disease risk factors for psoriasis patients, 
especially in more severe cases, has already been suggested by several expert groups.227,237-239 
In order to recommend a secondary prevention measure, and identify persons with psoriasis, 
also of mild subtypes, as high risk subjects; there must be an either causal or unbiased 
statistical association between psoriasis and the MetS.24 This means that even if the causal 
component behind the increased MetS in psoriasis is not clearly identified; the quality of our 
data, which is also supported by data from comparable populations,116,117 suggest that the 
psoriasis seen on the skin surface may be a warning sign that a person has a higher risk of 







6. Main conclusions  
The present population based cohort study among men and women, focusing on psoriasis time 
trends as well as risk factors for disease development throughout 30 years, supports a high 
and increased prevalence of this chronic skin disease. Moreover, the observed overweight 
epidemic represents a possible environmental risk factor in relation to the observed increase, 
and leads to further concern as a high burden of MetS is seen especially among young women 
with psoriasis. Specifically: 
• There was a more than a doubled risk of reporting psoriasis in the sixth Tromsø Study 
(2007-08) compared to the second study in 1979-80, with a lifetime prevalence of up 
to 11%. This increase in prevalence could not be explained by specific birth cohort 
effects or population ageing, and this suggests that environmental factors play a role in 
psoriasis development in adults above age 29. Although changes in disease awareness 
may explain some of the reported increase, it seems likely that this time trend may 
partly be explained by lifestyle changes.  
• Our findings support the results of others that overweight, weight gain and smoking 
represent modifiable risk factors that may be targets for primary prevention of 
psoriasis. Above a threshold BMI of 27-28 kg/m2 both genders combined displayed 
increasing odds of psoriasis development, and adult weight-gain was associated with 
up till 70-90% increased risk of developing psoriasis from middle-age independent of 
weight category. No synergistic effects were found between psoriasis and smoking, 
however overweight smokers displayed the highest risk of psoriasis development with 
up to 2.3 and 2.7 increased odds in men and women respectively.  
• The odds of having the MetS were substantially increased among individuals with 
psoriasis in the Tromsø study cohort, where 32% of those with psoriasis versus 24% 
of those without the condition fulfilled the criteria of the MetS. Young women 
displayed four times increased odds of having the MetS in multivariable analysis; 
while in psoriatic men there was a uniform 35% increased odds of MetS compared to 
men without the condition. Abdominal obesity was the most frequent MetS 
component in women in this study, and we observed a dose-response relation between 





7. Implications of study findings and further research  
Psoriasis is a highly prevalent disease in a lifetime perspective; affecting approximately 1 out 
of 10 adults in the Tromsø population. Despite that participants reported lifetime diagnosis in 
our recent study, approximately 5% of attendees in the last Tromsø study had received a 
prescription for psoriasis within close proximity to the survey (2006-09), indicating high 
period prevalence of psoriasis, and the demand of considerable resources from the health care 
system in region North. While the total self-reported lifetime prevalence of psoriasis is 
highest in Scandinavia, doubled figures are also reported on multiple continents, suggesting a 
global trend, and generalizability of our results to other populations. Due to the impact of 
psoriasis on quality of life, as well as all the comorbidities associated with the condition, this 
could have an effect on public health worldwide.  
Identification of environmental agents or mechanisms which may trigger psoriasis 
development, not the least giving the possibility to give targeted recommendations for 
prevention will be of importance for this large patient group, as well as benefit in the 
reduction of costs for society. The observed association between excess weight, weight gain 
and smoking on psoriasis onset may be explained by plausible biological mechanisms and is 
in line with results from others, making overweight and smoking possible preventive target in 
terms of psoriasis development. Considering the global obesity trend and high number of 
smokers, this finding is important also for other populations.  
The substantially increased prevalence of the MetS among persons with psoriasis in a general 
population setting, with mainly mild disease, supports the priorly suggested screening of 
individuals with psoriasis for the metabolic syndrome from a relatively early age, in order to 
reduce the risk of diabetes and cardiovascular outcomes in this patient group. However, more 
studies investigating the causal mechanisms behind this association and potential benefit from 
screening are needed.  
In further studies it will be interesting to explore the associations between overweight/ obesity 
and incident psoriasis within validated, more strict case definitions of psoriasis and within 
different phenotypes of psoriasis, as well as gaining detailed information on debut and 
severity, including data on potential PsA diagnosis. The prolonged follow-up period will 
allow for other analysis methods, better assessment of possible interactions due to increasing 
power, as well as repeated data from the cohort. As the degree of smoking is declining and 
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obesity is on the rise in the Troms Study cohort, it will be valuable to repeat these analyses in 
further studies to see if this influences the prevalence of psoriasis. Comparing data with other 
national and international cohorts will also be of essence, in order to validate findings and 
gain further information on the epidemiology of psoriasis. 
To date, epidemiological analyses have been limited by established cut-offs for obesity and 
related biomarkers, which does not give a sufficient picture of the complex interplay between 
psoriasis and the total pool of metabolites, known as the metabolome.240 We wish to further 
investigate the relationship between psoriasis, metabolic risk factors and cardiovascular 
disease using a novel high throughput method quantifying the total pool of metabolites, “the 
metabolome.” Novel methods like metabolomics which take into account both genetic and 
environmental influence, may also give insight into the biological mechanisms responsible for 
the interplay between the metabolic state and psoriasis.241 Characteristic combinations of 
assessed biomarkers could lead to pathway specific identification and risk assessments in 
patient groups, like psoriatics, even on an individual level.240  
Over the years several cross-sectional and case-control studies have found an increased risk of 
cardiovascular risk factors as well as myocardial infarction and stroke among individuals with 
mainly moderate to severe psoriasis.105,242,243 Nearly all studies to date were performed in 
patient or register populations without the possibility to adequately control for possible 
confounding factors, as well as being subject to several possible biases. Thus, the causality of 
the association between psoriasis and cardiovascular disease is still a matter of 
debate.7,126,127,153,169,244 There seems to be a consensus that psoriasis patients with moderate to 
severe disease have more lifestyle-related cardiovascular risk factors, but there is still 
disagreement as to if psoriasis in itself represents an independent risk factor for cardiovascular 
disease.6,7,127,244,245 Studies investigating whether the traditional Framingham risk criteria 
apply equally to psoriasis patients compared to the general population, indicate that these do 
not adequately assess the cardiovascular disease risk in persons with psoriasis.245,246 
Interestingly, the newly presented psoriasis cohort study from Rotterdam showed no increase 
in atherosclerosis or cardiovascular events among individuals with mostly mild psoriasis;169 
however, this cohort was limited due to a small sample size and selected age span of 
attendees. Recent meta-analyses have also pointed out discrepancies between truly 
population-based and register or clinic based results.105,129 
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Our research on the association between psoriasis and the MetS shows that there may be age 
and gender dependencies in the distribution of risk factors related to metabolic and 
cardiovascular disease risk among persons with psoriasis, as also supported by others.116,117 
The increased prevalence of MetS, as well as high fraction of smokers, among individuals 
with psoriasis suggests that more cardiovascular events can be expected in this patient group. 
The Tromsø Study includes in addition to self-reported psoriasis status and information on 
potential confounding lifestyle factors; measured metabolic and cardiovascular status through 
carotid ultrasound, end-point registry for cardiovascular outcomes, as well as biological 
samples for molecular analysis including DNA analysis. All of these data represent a unique 
resource for population-based research into the association between psoriasis and 
cardiovascular disease. 
Furthermore, the suggested interplay between the host and the microbiome is an interesting 
new pathway for exploration. The microbiome of healthy human skin shows great diversity, 
and microbiota compositions of psoriasis plaques indicate differences from unaffected skin.202 
Changes in the gut or skin microbiota are hypothesized to predispose or influence psoriasis in 
genetically susceptible individuals.247 A small RCT investigating the role of oral probiotics in 
systemic inflammatory disease found systemic effects of intervention, which supports that the 
immune modulatory effects of the microbiota in humans are not limited to the mucosa 
surface, but may also lead to systemic effects.248 The Tromsø Staph and Skin Study research 
group performs interdisciplinary research and plans to explore this association, including the 
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    Appendix I 
Questionnaire 1 & 2, Tromsø Study 2                   

Do you have, or have you had:    
Are you being treated for:         
Do you use:    
Do you have get or discomfort in the chest when:
If you get pain or discomfort in the chest when
walking, do you usually:
If you stop or slow down, does the pain 
disappear:
If you get pain in the calf, then:        
Do you usually have:  
Exercise and physical exertion in leisure time.
If your activity varies much, for example 
between summer and winter, then give an average.
The question refers only to the last twelve months:
Tick “Yes” beside the description that fits best:
(include walking or cycling to place of work,       
Sunday walk/stroll, etc.)
(note: duration of activity at least 4 hours a week)
During the last year, have you had:   
Tick “Yes” beside description that fits best      
(e.g. fishing season, harvest)                         
Can you usually come home from work:          
If you smoke a pipe, how many packs of tobacco
(50 grams) do you smoke per week?
Do you smoke tobacco products other than       
cigarettes daily?
If “Yes”, how long is it since you stopped: 
If you do not smoke cigarettes at present, then:
(hand-rolled or factory made)                  
If the answer was “Yes” in the previous question,
then:
(hand-rolled or factory made)                  
(e.g. office work, watchmaker, light manual work)
(e.g. shop assistant, light industrial work, teaching)
(e.g. postman, heavy industrial work, construction)
(e.g. forestry, heavy farm-work, heavy construction)
A heart attack? ................................
Angina pectoris (heart cramp)? ...............
Any other heart disease? .....................
Hardened arteries in the legs? ...............
A cerebral stroke? .............................
Diabetes? .......................................
High blood pressure? ..........................
Nitroglycerine? .................................
Walking up hills or stairs, or walking fast on level ground?
Walking at normal pace at level ground?
Stop? .......................................
Slow down? .................................
Carry on at the same pace? ..............
Within 10 minutes? ........................
After more than 10 minutes? .............
Walking? .......................................
Resting? ........................................
Does the pain increase when you walk
Does the pain disappear when you stop? .....
Cough in the morning? .........................
Phlegm chest in the morning? .................
Walking, cycling, or other forms of         
exercise at least 4 hours a week? .........
Participation in recreational sports,       
heavy gardening, etc.? ......................
Participation in hard training or sports 
competitions, regularly several times a week? Have one or more of your parents or sistersor brothers had a heart attack (heart wound)
or angina pectoris (heart cramp)?
Are two or more of your grandparents of 
Finnish origin? ................................
Do you receive a complete or partial disability pension?
Are you at present on sick leave, or receiving
rehabilitation allowance? ......................
Have you within the last 12 months received
unemployment benefit? ........................
Is housekeeping your main occupation? ......
During the last 12 months, have you had
to move for work reasons? ...................
Heavy manual labour? ......................
Work that requires a lot of walking ..........
Mostly sedentary work? ....................
Are there periods during which your working
days are longer than usual? ..................
Every weekend? ................................
Every day? .....................................
Do you usually work shifts or at nights?       
Give the average number of packs per week.
A pipe? ........................................
Cigars or cigarillos? ..........................
How many cigarettes do you smoke, or did you, 
smoke daily? Give number of cigarettes per day
smoked daily? ..............................
How many years altogether have you
More than 5  years? ......................
1 to 5 years? ..............................
3 months to 1 year? ......................
Less than 3 months? ......................
Have you previously smoked cigarettes daily?
Do you smoke cigarettes daily? ...............







No. of tobacco  packs
No. of cigarettes
No. of years   
faster or uphill? ...............................
Activity? ....................................
Reading, watching TV, or other sedentary
Work that requires a lot of walking and lifting?
Are two or more of your grandparents of   
Sami origin? ...................................
Yes
Do you get pain in the calf while:           
For those who smoke or have smoked previously:

Together with the invitation to attend you received a questionnaire from the National Mass 
Radiography Service. You delivered this questionnaire at the examination.
Cardiovascular diseases are, however, a complex group of diseases. The causes are still partly 
unknown. In Tromsø we are therefore trying to obtain a more complete description of factors which 
may be of importance for the course of these diseases, such as diet, psychological pressure (“stress”), 
social conditions, and occurrence of disease in relatives. We hope you will take the trouble to 
complete this questionnaire as well, an return it to the Tromsø Board of Health in the enclosed 
envelope.
All information in connection with the mass x-ray examination will be treated as strictly 
confidential.
ADDITIONAL QUESTIONS FOR PERSONS ATTENDING 
THE MASS X-RAY EXAMINATION IN TROMSØ
What type of bread do you usually eat?
Tick the most appropriate box.
What type of butter of margarine do 
you usually eat?
Tick the most appropriate box.
What type of milk do you usually drink?  
Tick the most appropriate box.
How many slices of bread do you  
usually eat daily?
Tick the most appropriate box.
The drawings below show cubes of butter of margarine (actual size). 
Tick the box above the cube which best resembles the amount you spread on a slice of bread.
White bread (e.g. French bread) .......................
Ordinary bread (light texture) ...............
Less than two slices ....................................
2-6 slices .....................................................
7-12 slices ...................................................
13 or more slices ........................................
Full cream milk: ordinary type or curdled ......
Do not drink milk .......................................





Do not use butter or margarine .............
YES YES 
YES YES 
Whole meal (brown) bread ...................
Home-made (brown) bread ..................
Soft margarine spread ..............................
Skimmed milk: ordinary type or curdled.........
If in doubt, try buttering a slice.                 
YOUR OWN DIET
LABEL
Are you a teetotaller?
If “No”,
How often do you eat fruit or 
vegetables?
Tick the most appropriate box.      
How many cups of coffee do you 
usually drink daily?
Tick the most appropriate box.      
How many glasses/cups of milk do 
you usually drink daily?
Tick the most appropriate box.      
Approximately how often during the 
last 12 months have you drunk so 
much wine, beer or spirits that you 
got drunk?
Tick the most appropriate box.      
How often does your main meal 
consist of fish or fish dishes?







 How often do you usually drink beer?
Tick the most appropriate box.          
 How often do you usually drink wine?
 How often do you usually drink spirits?
Tick the most appropriate box.          
Tick the most appropriate box.            
How many times a month do you eat 
boiled or fried sausages, meat balls, 
other processed meat, etc.?
Tick the most appropriate box.      
Do not drink milk, or drink less 
than 1 glass/cup ................................. 
1-2 glasses/cups..................................
3-4 glasses/cups.................................
5 or more glasses/cups...... ...............




9 or more cups...................................
Never or just a few times a year.......
Once or twice a month.....................
About once a week...........................
2-3 times a week................................
More or less daily...............................
Have never been drunk, or have not been 
drunk during the last year .............................
A few times during the last year .............
Once or twice a month ..................................
Once or twice a week  ....................................
3 or more times a week ...........................
Less than once a week..............................
Once or twice a week...............................
3-4 times a week......................................
5-6 times a week......................................
7 times a week...........................................
Never eat fruit or vegetables.....................
A few time a year........................................
Once or twice a month..............................
About once a week....................................
2-3 times a week.........................................
More or less daily........................................
Never or less than once  
a month......................................................
Once or twice a month.............................
3-4 times a month (up to once a 
week)...........................................................
5-8 times a month (up to twice a 
week)...........................................................
More than 8 times a month (more 
than twice a week).....................................
Never or just a few times a year.......
Once or twice a month.....................
About once a week...........................
2-3 times a week................................
More or less daily...............................
Never or just a few times a year.......
Once or twice a month.....................
About once a week...........................
2-3 times a week................................
More or less daily...............................
Have you had a peptic ulcer?....................
Do you often have a gnawing pain in 
the upper part of your stomach? ............
Do you suffer much from heartburn or 
regurgitation of gastric juices? ................
Do you suffer much from wind and 
rumbling in your stomach? .....................
Do you often get cramps in your stomach?
Have you ever had your large intestine 
x-rayed? ......................................................
Have you ever had gallstones? .................
Have you had kidney stones or stones 
in the urinary tract? .................................
If yes, how many times? .........................
and, when did you have the last attack? ...
Have you ever had cancer? .....................
If yes, in what year was the disease 
discovered? ..............................................
Have you taken iron tablets during 
the past 14 days? ....................................
Have you had any infectious disease 
during the past 14 days? (influenza, 
common cold, vomiting, diarrhoea, etc.)
If yes, did you suffer from stiff joints 
in the mornings lasting more than 
30 minutes? ...........................................
Have you suffered from pains lasting 
more than 3 months, in the joints 
listed below during the last 3 years?
Have you suffered from morning 
stiffness in your back lasting more 
than 30 minutes? ..................................
Have you suffered from back pain 
during the past 12 months lasting for 
more than 4 weeks? ..............................
If yes, did the back pain improve if 
you exercised? .......................................
Have you ever had arthritis? (chronic 
rheumatoid arthritis) ...........................
Have you been on sick leave, or been unable 
to work due to allergic eczema on your 
hands at any time during the past 3 years? ....
Have you had allergy-induced eczema on 
your hands during the last 12 months? .....
Do you have, or have had you the skin 
disease psoriasis? .......................................
Have you made any changes in your diet 
during the last 5 years as regards the following 
food items?
Tick each item in the appropriate 
box.
OWN ILLNESSES PAST AND PRESENT
additional questions for persons Have you ever had?
Ordinary margarine or butter
Skimmed milk ........................
Lean meat ...............................
Full cream milk ......................
Soya margarine (soft) ............
Fatty meat ..............................
Sudden paralysis or numbness on one 
side of your face or body, in your 
hand or foot ...........................................
Sudden loss of ability to speak .............
Sudden loss of eye sight, complete or 
partial, or sudden onset of double vision
Knees .................................................
Elbows ...............................................


















How often do you take painkillers such 
as Globoid, Novid, Dispril, Albyl, etc.?
Tick the most appropriate box.
Have you changed the amount of physical 
exercise you take in leisure time during 
the last five years?
Tick the most appropriate box.
Have you used such painkillers during 
the last 14 days?.........................................
ILLNESS IN PARENTS AND SIBLINGS 
Have any of these relatives had:     
SOCIAL CONDITIONS AND 
PSYCHOLOGICAL PRESSURE (“STRESS”) Have you had difficulty sleeping in the 
past couple of weeks?
Tick the most appropriate box.
Have you felt unhappy and depressed 
during the last couple of weeks?
Tick the most appropriate box.
Have you felt unable to cope with your 
difficulties during the last couple of weeks?
Tick the most appropriate box.
Do you suffer from sleeplessness?
If yes, at what time of the year do you 
suffer from sleeplessness?
Tick the most appropriate box.
How was your family's financial 
situation when you were growing up?
Tick the most appropriate box.
How many years of education have you 
had? (including primary and secondary 
schools)
Cerebral stroke or brain haemorrhage .........
Diabetes ...........................................................
Arthritis (chronic rheumatoid arthritis)..........
Cancer ..............................................................
Kidney stones or stone in urinary tract........
Psoriasis ............................................................
Peptic ulcer ......................................................
None of the above mentioned illnesses ......
Not at all ....................................................
No more than usual .................................
Rather more than usual ............................





No particular time .................................
Especially during the polar night .........
Especially during the midnight  sun season
Especially in spring and autumn ..........
Difficult to fall asleep at night? .............
Wake up a lot during the night? ..........
Wake up very early in the morning? ...
Not at all ...................................................
No more than usual .................................
Rather more than usual ...........................
Much more than usual ............................
Not at all ...................................................
No more than usual ................................
Rather more than usual ...........................
Much more than usual ............................
As before ....................................................
More than before ......................................
Less than before .........................................
1-3 times a week ................................
1-3 times a month ............................
Seldom or never ................................







 no. of  
years 
father sister brother




                                                        
 
    Appendix II 
Questionnaire 1 & 2, Tromsø Study 3                    

THE TROMSØ HEALTH SURVEY        
(Applies only to the person to whom the letter is addressed.) 
The health survey is coming now to your district. 
You find the time and place for attendance below.
You will find an orientation on the survey in the 
enclosed brochure.
We would like you to fill in the form on the back 
and take it with you to the survey.
We ask those possibly not attending to report their 
absence in the attached absence report. 
Yours sincerely
MUNICIPAL HEALTH AUTHORITY OF TROMSØ
COUNTY DOCTOR OF TROMS       UNIVERSITY OF TROMSØ
NATIONAL HEALTH SCREENING SERVICE
Birth date          Personal number                     Municipality                                                    Circuit number
Meeting place             Gender      Day and date                Time                  
First 
letter of 
last name   
MEASUREMENT 2 MEASUREMENT 3 MEASUREMENT 1 
  HEIGHT                WEIGHT  
  
Have one or more of your parents or siblings 
had a heart attack (heart wound) or angina 
pectoris (heart cramp)? …............................
Do you have, or have you had:    
Are you being treated for:             
Do you use:    
Do you get pain or discomfort in the chest when:
If you get pain or discomfort in the chest when
walking, do you usually:
If you stop or slow down, does the pain             
disappear:
Do you usually have:  
Exercise and physical exertion in leisure time.
If your activity varies much, for example between 
summer and winter, then give an average.     
The question refers only to the last year:
How often do you use salted meat 
or salted fish for dinner?
How often do you add extra salt to                  
your dinner?
What type of margarine or butter do you           
usually use on your bread?
What type of cooking fat do you 
normally use in your household?                            
If this survey suggests that you need a further   
medical examination, which general 
practitioner do you wish to be referred to?
During the last year, have you had:
What type of coffee do you usually drink daily?   
How many cups of coffee do you usually    
drink daily?
If you smoke a pipe, how many packs of             
tobacco (50 grams) do you smoke 
per week?
Do you smoke anything else other than cigarettes daily?
To be answered by those who smoke or
who have smoked previously:
If you answered “Yes”, how long is it since         
you stopped:
If you do not smoke cigarettes at present, 
then:
If the answer is “YES”, then:                                     
A heart attack? ................................................
Angina pectoris (heart cramp)?........................
A cerebral stroke? ...........................................
Diabetes? ........................................................
Less than 3 months? …....................................
3 months to 1 year? .........................................
1 -5 years? .......................................................
More than 5 years? ..........................................
How many years altogether have you
smoked daily? …...............................................
How many cigarettes do you smoke or 
did you smoke daily? …....................................
Give number of cigarettes per day ....................
(hand-rolled + factory made)
Coarsely ground coffee for brewing (boiled) ......
Finely ground filter coffee .................................
Instant coffee ....................................................
Caffeine free coffee ..........................................
Do not drink coffee ...........................................
Have you within the last 12 months received 
unemployment benefit? ….....................................
Are you at present on sick leave, or 
receiving rehabilitation benefit? .............................
Do you receive a complete or partial disability pension?
Do you usually work shifts or at
night?.....................................................................
Reading, watching TV, or other sedentary 
activity? .............................................................
Walking, cycling or other forms of 
exercise at least 4 hours a week? .....................
(include walking or cycling to
work, Sunday walk/stroll, etc.)
Participation in recreational sports, heavy
gardening, etc.? ................................................
(note: duration of activity at least 
4 hours a week)
Participation in hard training or sports 
competitions, regularly several times a week?...
Walking up hills or stairs, or walking 
fast on level ground? .......................................
Walking at normal pace at level ground?..........
Never or less than once a month ….................
Once a week or less ........................................
Twice a week or less .......................................
More than twice a week....................................
Do not use margarine or butter on bread …......
Butter ...............................................................
Hard Margarine ….............................................
Soft (soya) margarine spread............................
Butter/ margarine mixtures ...............................
Tick the most appropriate box.         
Tick the most appropriate box.         
Tick the most appropriate box.                   
Tick the most appropriate box.
                                                              
Tick the most appropriate box.         
Tick the most appropriate box.                   
Tick the most appropriate box.         




Carry on at the same pace? …........................
After less than 10 minutes? ….........................
After more than 10 minutes? ….......................
Cough in the morning? ....................................
Phlegm chest in the morning? ….....................
Rarely or never ................................................
Sometimes or often .........................................
Always or nearly always …...............................
Butter or hard margarine ..................................
Soft (soya) margarine or oil …..........................
Butter/ margarine mixtures …...........................
Do you smoke daily at present? …....................
Do you smoke cigarettes daily? …....................
(hand-rolled or factory made)
Have you previously smoked cigarettes daily?...
Cigars or cigarillos/cheroots? ….........................
A pipe? …...........................................................
Give the average number of packs per
week .................................................................
Do not drink coffee, or less than
one cup ............................................................
1 -4 cups ..........................................................
5 -8 cups ..........................................................
9 or more cups .................................................
Mostly sedentary work? ....................................
(e.g. office work, watchmaker, light manual work)
Work that requires a lot of walking? ..................
(e.g. shop assistant, light industrial work, teaching)
Work that requires a lot of walking and lifting?...
(e.g. postman, heavy industrial work, construction)
Heavy manual labour? ......................................
(e.g. forestry, heavy farm-work, heavy construction)
Is house-keeping your main occupation? ...
     
Has any one in your household (other than
yourself) been called in to a doctor for 
further medical examination after the 
previous cardiovascular disease survey? ….....
Write the doctor's name here?
No particular doctor
Yes No 











Cigarettes   
  Tobacco
   packets
Don't write here 
   FAMILY
         SYMPTOMS      
         EXERCISE       
         OWN ILLNESSES      
         SMOKING      
     COFFEE    
     EMPLOYMENT    
       FOLLOW-UP EXAMINATION       
       SALT/ FAT      
Cardiovascular heart  and circulatory diseases, on 
which the surveys of the 1974 and 1979-80 focused, 
are a very varied category of diseases whose causes 
are still partly unknown. In Tromsø we are therefore 
trying to obtain a more complete description of factors 
which may be important for the course of these 
diseases, such as diet, psychological pressure, 
“stress”, social conditions and the occurrence of 
disease in relatives. Such a description is also 
important in the search of factors that contribute to 
cancer, a group of diseases which also we try to 
combat in the coming years.
When you were called in, you received a 
questionnaire which you handed in at the survey. The 
present questionnaire asks for further information 
about your health and includes questions on various 
diseases and physical and psychological complaints. 
We have included questions on pregnancy, birth and 
menstruation.
How is your health?
Tick the box where “Yes” is appropriate.  
In addition, we are interested in obtaining information 
on the public use of medical health services in order to 
find out how to improve the health service.
We hope that you will take the trouble to fill in yet 
another questionnaire and return it to “Tromsø Board of 
Health” in the enclosed envelope. All information will be 
treated with strict confidentiality If you have any 
comments regarding the survey, you may write them 
down in the space provided on the last page of the 
questionnaire.
Yours sincerely
   Tromsø Board of Health       Department of medicine
          University of Tromsø
ADDITIONAL QUESTIONS TO 
THE TROMSØ HEALTH 
SURVEY 1986-87.
Do you have, or have you had:
Tick “Yes” or “No” for each question.          
How many times in the last 6 months have  
you had infections like a cold, influenza (flu)
diarrhoea/vomiting, or similar illnesses? .....
Have you had one of these infections in 
the past 14 days? ........................................
Have you during the last year used tablets/sprays 
or had injections for asthma or allergies?.................
Have you used any of the following 
medicines in the past 14 days?
Tick if none of the relatives have or have 
had any of those illnesses .......................
Tick for the relatives who have or have ever 
had any of the following illnesses:
Very bad ...................................................
Bad ...........................................................
Neither good nor bad, “middling” .............
Good ........................................................
Excellent ..................................................







Your appendix removed .........................
An operation for a stomach ulcer ...........









Gastric or duodenal ulcer .......................
Asthma ...................................................
Painkillers ................................................
Antipyretic drugs (to reduce fever) ..........
Eczema ointment ....................................







  GENERAL STATE OF HEALTH   ILLNESSES IN PARENTS OR SIBLINGS
   ILLNESSES 
    INFECTIONS 
   MEDICINES 
Yes
Yes  No 
 No Yes
Number 
Yes  No 
Yes  No 
Yes  No 
mother father brother Sister
   FISH  
   BREAKFAST 
   ALCOHOL  
   FRUIT 
    DIET 
CONTACT DUE TO OWN HEALTH OR ILLNESS    DINNER 
Yes  No   
Yes  No   
















How many visits have you made during the 
past year due to your own health or illness?
How often do you eat meat for dinner?
Tick the box where “Yes” is appropriate.
Number of hospital admissions in the past year
To a GP (general practitioner) ................
To a specialist (not hospital) ..................
Emergency GP .......................................
Medical officer at work ...........................
Physiotherapist .......................................
Chiropractor ............................................
Alternative practitioner  
(homoeopath, foot zone therapist, etc.) ..
Hospital outpatient department ..............
How many slices of bread do you usually eat 
daily?
Tick the box where “Yes” is appropriate.
What type of milk do you usually drink?
Tick the box where “Yes” is appropriate.
How many glasses/cups of milk do you usually 
drink daily?
Less than 2 slices ..................................
2 - 4 slices ..............................................
5 – 6 slices .............................................
7 – 12 slices ...........................................
13 or more slices ....................................
Do not drink milk .....................................
Full cream milk (ordinary or curdled) ......
Semi-skimmed milk .................................
Skimmed milk (ordinary or curdled) ........
Less than 1 glass/cup .............................
1 – 2 glasses/cups ..................................
3 – 4 glasses/cups ..................................
5 or more glasses/cups ..........................
How often do you eat cod/pollock or other 
lean fish for dinner or in a sandwich?
Tick the box where “Yes” is appropriate.
How often do you eat fatty fish such as herring, 
halibut, red fish, mackerel, salmon or trout for 
dinner or in a sandwich?
Tick the box where “Yes” is appropriate.
Do you take cod liver oil regularly?
Tick the box where “Yes” is appropriate.
Do you usually eat breakfast daily? ............
Less than once a week ............................
Once a week ............................................
Twice a week ...........................................
3 or more times a week ...........................
Less than once a week ............................
Once a week ............................................
Twice a week ...........................................
3 or more times a week ...........................
No ............................................................
During polar night ....................................
All year .....................................................
Not at all the past year ...........................
A few times .............................................
Once or twice a month ...........................
3 or more times a week ..........................
How often do you use fat like butter, 
margarine, mayonnaise, etc. with your 
dinner?
Tick the box where “Yes” is appropriate.
Do you usually eat vegetables with your 
dinner? .......................................................
How often do you usually eat fruit?
Tick the box where “Yes” is appropriate.
Are you a teetotaller?
If not,
 - How often do you usually drink beer?
Tick the box where “Yes” is appropriate.
Approximately how often have you during the 
last year  consumed alcohol corresponding to 
at least 5 small bottles of beer, a bottle of wine, 
or 1/4 bottle of spirits?
Tick the box where “Yes” is appropriate.
Less than once a week ...........................
Once or twice a week .............................
3 – 4 times a week ..................................
5 or more times a week ..........................
Less than once a week ..........................
Once or twice a week .............................
3 – 4 times a week ..................................
5 or more times a week ..........................
How often do you usually drink wine?
Tick the box where “Yes” is appropriate.
 - How often do you usually drink spirits?
Tick the box where “Yes” is appropriate.
Less than once a week ...........................
About once a week .................................
2 – 3 times a week ..................................
4 – 5 times a week ..................................
More or less ............................................
Never or just a few times a year ............
1 – 2 times a month ................................
About once a week .................................
2 – 3 times a week ..................................
More or less daily ....................................
Never or just a few times a year ............
1 – 2 times a month ................................
About once a week .................................
2 – 3 times a week ..................................
More or less daily ....................................
Never or just a few times a year ............
1 – 2 times a month ................................
About once a week .................................
2 – 3 times a week ..................................
More or less daily ....................................
  PHYSICAL ACTIVITY 
How often do you take part in physical activity 
lasting at least 20 minutes, which makes you 
perspire or become breathless?
Tick the box where “Yes” is appropriate.
Yes  No   
Yes  No   
Yes  No   
Yes  No   
Yes  No   
Yes  No   
Yes  No   
Yes  No   
Yes  No   
Yes  No   
  BACK AND JOINTS CONDITIONS
 NECK, HEAD AND SHOULDER COMPLAINTS
CHANGE IN DIETARY HABITS AND OTHER HABITS
  MARRIAGE / PARTNER 
   HOUSEHOLD
   SCHOOLING 
SLEEPLESSNESS/ LOSS OF CONSCIOUSNESS
   EMPLOYMENT 
If you usually take part in this type of activity at 
least weekly, how much time do you spend 
exercising?
Tick the box where “Yes” is appropriate.
Have you changed any of the following habits 
during the last 5 years: (Tick once for each 
question)
Rarely or never .......................................
Weekly ....................................................
Several times a week ..............................
Daily ........................................................
Less than 30 minutes a week .................
Between 30 minutes and 1 hour  a week
Between 1 and 2 hours a week ..............
More than 2 hours a week ......................
Dietary fat ..............................................
Soya margarine or oil .............................




Are you married or partner ........... .............
How old were you when you first married or 
Moved in with a partner? ............................
How many people live in your 
household?..................................................
Is anyone in your household 10 years 
or younger? ................................................
Does anyone in your household need special
care/assistance – other than the children? ....
How many years education have you had? 
(including primary and secondary schools) 
Have you had paid work the entire past year?




All or almost all ......................................
At least half ............................................
More than quarter ..................................
Less than quarter ...................................
How much house work do you normally do     
yourself?
Tick the box where “Yes” is appropriate.
During this last year have you suffered from  
back pain that has lasted longer than 4 weeks?
If yes, does the pain improve when you 
move around? .........................................
Have you suffered from morning stiffness 
in your back lasting more than 30 
minutes? ....................................................
During the past 3 years have you suffered   
from pain in any of the following joints 
lasting more than 30 minutes?
Knees ......................................................
Elbows ....................................................
Innermost finger joints ..........................
Other joints .............................................
If yes, have you suffered from stiff joints 
in the morning lasting more than 30 
minutes? ....................................................
How often do you suffer from headache?
Tick the box where “Yes” is appropriate.
Rarely of never .......................................
Once or more a month ...........................
Once or more a week .............................
Daily .......................................................
Rarely of never .......................................
Once or more a month ...........................
Once or more a week .............................
Daily .......................................................
How often do you suffer pain in the neck or   
shoulder?
Tick the box where “Yes” is appropriate.
Do the pains in your head, neck or shoulder 
reduce your ability to work?
Tick the box where “Yes” is appropriate.
Have your back, shoulder, and/or neck 
ever been x-rayed? ....................................
Little or no effect .....................................
To some degree ......................................
To a large degree ....................................
Cannot do ordinary work .........................
No particular time ...................................
Especially during the polar night .............
Especially during the midnight sun season
Especially in spring and autumn .............
Have you ever suffered from sleeplessness?
If yes, what time of the year does it affect you 
most? Tick the box where “Yes” is appropriate.
Have you at any time during the last 12 
months suffered from tiredness that has 
affected your work performance? ..............
Have you suffered from sudden loss of 
consciousness in the past year? ................
Have you noticed sudden changes in your 














 before  Less 
If you have major personal problems, do 
you expect to get help and support from 
your spouse or family? ...............................
In the last year, have you for a long time 
felt a need to seek help with personal 
problems, without doing so? ......................
During the past 2 weeks have you felt 
unable to cope with your problems?
Tick the box where “Yes” is appropriate.
Do you ever feel lonely?
Tick the box where “Yes” is appropriate.
During the past 2 weeks have you felt unhappy
or depressed?
Tick the box where “Yes” is appropriate.
Very often ...............................................
Sometimes ..............................................
Rarely or never .......................................








How old were you when you started 
menstruating? ............................................
When did your last period start? ................
How many days usually pass from the first 
day of one period to the first day of your 
next period (the time lapsed between the 
start of two periods) ..................................
Do/ did you menstruate regularly? ............
Do you usually take painkillers during 
menstruation? ............................................
Do you have any of the following complaints 
before your period:
- Are you depressed or irritable?
Tick the box where “Yes” is appropriate.
Hardly at all ..........................................
Noticeably ............................................
Very much so .......................................
Hardly at all ..........................................
Noticeably ............................................
Very much so .......................................
- Are your breasts painful?
Tick the box where “Yes” is appropriate.
- Do you have swollen hands/feet, put on 
weight, or feel bloated?
Tick the box where “Yes” is appropriate.
Hardly at all ..........................................
Noticeably ............................................
Very much so .......................................
Do the complaints disappear when you get 
your period? ...............................................
For these complaints, do you use?
     - diuretics? ............................................
     - other medications? .............................
How many children have given birth to? ....
How old were you when you got pregnant 
for the first time? ........................................
Do you use or have you ever used oral 
contraceptive pills or an intrauterine device? ........
If yes, for how many years altogether have 
you used:
    The pill? ..................................................
    An intrauterine device? ...........................
How old were you when you started using:
    The pill? ..................................................
    An intrauterine device? ...........................
If you have stopped taking the pill, did 6 
months or more pass without 
menstruating without you being pregnant?
Did you have to stop taking the pill due 
to high blood pressure? ..............................
How many times have you had a cervical 
smear test in the last 3 years? ....................
How many years is it since you had your 
last cervical smear test? ............................
MENSTRUATION
THE REMAINING SECTION OF THE 




   CERVICAL SMEAR TEST
   REACTION TO PROBLEMS
Yes  No   
Yes  No   
Yes  No  
Yes  No 
Yes  No 
Yes  No  
Yes  No 
 years    
 day  month  year




 number  




 years  
 Number of tests  
 years  
Yes  No   




Thank you for the help! Remember to post the questionnaire today!
The Tromsø survey 1986-1987
Your comments: ......................................... 
   




                                                        
 
    Appendix III 
Questionnaire 1 & 2, Tromsø Study 4                   

      The Health Survey is coming to Tromsø. 
This leaflet will tell you when and where. You will 
also find information about the survey in the enclosed 
brochure. 
     We would like you to fill in the form overleaf and 
take it with you to the examination. 
    The more people take part in the survey, the more 
valuable its results will be. We hope, therefore, that 
you will be able to come. Attend even if you feel 
healthy, if you are currently receiving medical 
treatment, or if you have had your cholesterol and 
blood pressure measured recently. 
Yours sincerely, 
Municipal Health Authorities 
Faculty of Medicine - University of Tromsø 
National Health Screening Service 
 Electoral ward No. Municipality  Social security No.Date of birth     
HEALTH SURVEY 
Invitation                                                                  
   
Welcome to the Tromsø Health Survey!                 
“THIS IS YOUR
       CHANCE”
“THIS IS A REAL 
OPPORTUNITY- TAKE IT!”
 What is your current state of health? 
 Do you have, or have you had: 
 Do you use blood pressure lowering drugs? 
Have you during the last year suffered from pains 
and/or stiffness in muscles and joints that have 
lasted continuously for at least 3 months? 
 Have you in the last two weeks felt: 
How has your physical activity in leisure time been during this 
last year? 
How many cups of coffee do you drink daily?      
Are you a teetotaller?                        
How many times a month do you normally drink      
alcohol?        
 Did any of the adults at home smoke while 
you were growing up? 
 Do you currently, or did you previously, live together
 with daily  smokers after your 20th birthday? 
 If "YES", for how many years in all? .............
 How many hours a day do you normally spend 
in smoke-filled rooms? .....
Do you yourself smoke: 
If you previously smoked daily, how long 
is it since you quit?.........................................
If you currently smoke, or have smoked     
previously:       
How many glasses of beer, wine or spirits do you        
normally drink in a fortnight?
What type of margarine or butter do you usually use on     
bread?     
What is the highest level of education you have completed?
What is your current work situation?           
How many hours of paid work do you have per 
week? 
Do you receive any of the following benefits? 
Have one or more of your parents or      
siblings  had a heart attack or had
angina (heart cramp)? ..............................
          
    
Tick one box only. 
Poor  




Angina pectoris (heart cramp)   













 Put 0 if you do not spend time in smoke-filled rooms. 
Cigarettes daily?    
Cigars/ cigarillos daily?    
A pipe daily?
How many cigarettes do you or did you  
usually smoke per day?    
How old were you when you began  
daily smoking?
How many years in all have you smoked  
daily?   
Think of your weekly average for the year. 
Time spent going to work counts as leisure time. 
Light activity (not       
sweating/out of breath)  
Hard activity (sweating/
out of breath) ..........
Coarsely ground coffee for brewing
Other coffee
Hours per week
None    Less than 1 1-2   3 or more
Put 0 if you do not drink coffee daily.     
Put 0 if less than once a month.  .....
Do not count low-alcohol beer. 
Tick one box only. 
Do not count low-alcohol beer. 
Put 0 if less than once a month. 
Don't use butter/margarine 
Butter .............
Hard margarine 
Soft margarine ....... 
Butter/margarine mixtures
Light margarine  
7-10 years primary/secondary school,          
modern secondary school
Technical school, middle school, vocational   
school, 1-2 years senior high school 
High school diploma                                       
(3-4 years)........................




Unemployed, on leave without payment
Sickness benefit (sick leave) 






   Cups      
   Cups      
    Times  
Glasses Glasses Glasses 
Beer Wine 
 
  Spirits    
 No. of     
hours  
   Years   
cigarettes
Age
        years
   Years   
   Years   
   Hours   
 Age first       






Yes No Don't know
No  A little
  
   A lot 
  Very 
  much




EDUCATION/WORK            SMOKING






    The main aim of the Tromsø Study is to improve our 
knowledge about cardiovascular diseases in order to aid 
prevention. The survey is also intended to improve our 
knowledge of cancer and other general conditions, such as 
allergies, muscle pains and mental conditions.  We would 
therefore like you to answer some questions about factors 
that may be relevant for your risk of getting these and other 
illnesses. 
   This form is a part of the Health Survey, which has been 
approved by the Norwegian Data Inspectorate and the 
Regional Board of Research Ethics. The answers will only 
be used for research purposes and will be treated in strict 
confidence. The information you give us may later be stored 
along with information from other public health registers in 
accordance with the rules laid down by the Data Inspectorate 
and the Regional Board of Research Ethics. 
  If you are in doubt about what to answer, tick the box that 
you feel fits best. 
  The completed form should be sent to us in the enclosed 
pre-paid envelope. 
Thank you in advance for helping us. 
Yours sincerely, 
Faculty of Medicine  National Health 
University of Tromsø Screening Service
 
If you do not wish to answer the questionnaire, tick the 
box below and return the form. Then you will not receive 
reminders. 
I do not wish to answer the questionnaire ..................................
 Date for filling in this form:................................
 Day  Month  Year
In which Norwegian municipality did you live  at the age of 1 year? 
If you did not live in Norway, give country of residence instead of municipality.
How was your family's financial situation during your 
childhood? 
Very good ..............................................................
How many of the first three years of your life   
How many of the first 15 years of your life                  
 Who do you live with?                
Good ........................................................................
Difficult .....................................................................
Very difficult  .............................................................
 - did you live in a town/city? .......................................
 - did your family have a cat or dog in the home? .......
 - did you live in a town/city? .......................................





Yes No  
Yes No  
Yes No  
Yes No  
Yes  No   Tick once for each item and give the number .       
 Spouse/partner ............................................
 Other people over 18 years .........................
 People under 18 years ................................
How many of the children attend day care/kindergarten? ....




Terraced /semi-detached house ........................
Other ..................................................................
 How big is your house? ..................................................
 Approximately what year was your house built? ............
 Has your house been insulated after 1970?...............
 Do you live on the lower ground floor/basement? .....
 If "Yes", is the floor laid on concrete? ...................
What is the main source of heat in your home?   
Number   
Electric heating ......................................................
Wood-burning stove .................................................
Central heating system using:                  
Paraffin ...................................................................
Electricity ................................................................
Do you have fitted carpets in the living room? ............
Is there a cat in your home? .......................................
Is there a dog in your home? ......................................
If you have paid or unpaid work, how would you describe   
 your work? 
Mostly sedentary work? .........................................
(e.g. office work, mounting) 
Work that requires a lot of walking? ..........................
(e.g. shop assistant, light industrial work, teaching)  
Work that requires a lot of walking and lifting? ..........
(e.g. postman, nursing, construction) 
Heavy manual work? .................................................
(e.g. forestry, heavy  farm-work, heavy construction) 
Can you decide yourself how your work should be         
organised? 
No, not at all ..........................................................
To a small extent ......................................................
 Who do you live with?   Yes, to a large extent ................................................
Are you on call, do you work shifts or nights?.............
Do you do any of the following jobs (full- or part-time)?




Yes, I decide myself ..................................................
       HOME   
      WORK
CHILDHOOD/YOUTH
The Tromsø Health Survey                            
   ILLNESS IN THE FAMILY  
   USE OF HEALTH SERVICES   
YOUR OWN ILLNESSES        SYMPTOMS      
Do you cough about daily for some periods of the year?
Have you ever had: 
Tick one box only for each item. Give your age at the time. 








Have you you ever had, or do you still have: 







Fibromyalgia/fibrositis/chronic pain syndrome .........





Allergy and hypersensitivity: 




Other hypersensitivity (not allergy) ....................
How many times have you had a cold, influenza (flu),
vomiting/diarrhoea, or similar in the last six months? 
Have you had this in the last 14 days?.......................
Tick for the relatives who have or have ever
had any of the following diseases: 
Tick "None" if none of your relatives have had the disease.               
Cerebral stroke or brain haemorrhage








age when they got
diabetes ..................................
If "Yes":     
Is your cough productive ? ..............................
Have you had this kind of cough for as long as
3 months in each of the last two years? ............
Have you had episodes of wheezing in your chest?
If "Yes", has this occurred:      
Tick one box only for each item.     
At night ................................................................
In connection with respiratory infections ..................
In connection with physical exertion ........................
In connection with very cold weather .......................
Have you noticed sudden changes in your pulse 
or heart rhythm in the last year?.................................
How often do you suffer from sleeplessness? 
Never, or just a few times a year .........................
1-2 times a month .....................................................
Approximately once a week ......................................
More than once a week .............................................
If you suffer from sleeplessness, what time       
of the year does it affect you most? 
No particular time of year ...................................
Especially during the polar night .............................
Especially during the midnight sun season .............
Especially in spring and autumn ..............................
Have you in the last year suffered from sleeplessness
to the extent that it has affected your ability to work?...
How often do you suffer from headaches? 
Rarely or never .....................................................
Once or more a month ...............................................
Once or more  a week ...............................................
Daily ...........................................................................
Does the thought of getting a serious illness ever 
worry you? 
Not at all ...............................................................
Only a little ................................................................
Some .........................................................................
Very much .................................................................
How many visits have you made during the past year 
due to your own health or illness:
Tick 0 if you have not had such contact 
To a general practitioner (GP)/Emergency GP ............
To a psychologist or psychiatrist .....................................
To an other medical specialist (not at a hospital) ............
To a hospital out-patient clinic .....................................
Admitted to a hospital ......................................................
To a medical officer at work .............................................
To a physiotherapist ....................................................
To a chiropractor .............................................................
To an acupuncturist .........................................................
To a dentist ..................................................................
To an alternative practitioner (homoeopath, foot zone therapist, etc.) 
To a healer, faith healer, clairvoyant  ..............................
Number of times 
the past year
Yes  No  
Yes  No  
Yes  No  
Yes  No  
Yes  No  
Age    
times     
Mother Father Brother Sister Child None  
Gastric/duodenal ulcer surgery ....................
MEDICATION AND DIETARY SUPPLEMENTS            FOOD HABITS           
       FRIENDS      
Have you for any length of time in the past year used any of the 
following medicines or dietary supplements daily or almost daily? 
Indicate how many months you have used them. 
Put 0 for items you have not used. 
Medicines
Painkillers ............................................................







Dietary supplements            
Iron tablets ...........................................................
Calcium tablets or bonemeal ...................................
Vitamin D supplements ............................................
Other vitamin supplements ..................................
Cod liver oil or fish oil capsules ...............................
Have you in the last 14 days used the following             
medicines  or dietary supplements? 
Tick one box only for each item. 
Medicines            
months
good
friends    
Painkillers           .............................................................
Antipyretic drugs (to reduce fever) ...........................
Migraine drugs .........................................................
Eczema cream/ointment ..........................................
Heart medicines (not blood pressure) ......................




Other drugs for nervous conditions ..........................
Antacids ...............................................................
Gastric ulcer drugs ...................................................
Insulin .......................................................................
Diabetes tablets ........................................................





Calcium tablets or bonemeal ...................................
Vitamin D supplements ............................................
Other vitamin supplements ..................................
Cod liver oil or fish oil capsules ................................
- jam and other sweet spreads .......
confidentially with and who give you help when you need it? 259
Do not count people you live with, 
but do include other relatives!  
How many of these good friends do you have 
contact with at least once a month? .........................
Do you feel you have enough good friends? ...........
How often do you normally take part in organised   
gatherings, e.g. sewing circles, sports clubs, 
political meetings, religious or other associations?     
Never, or just a few times a year .........................
1-2 times a month ....................................................
Approximately once a week .....................................
More than once a week ............................................ Waffles, cakes, etc. ..................
Chocolate .......................................
Sugar-free ("Light") soft drinks .....








- lean fish (e.g. cod)  ....................
- fatty fish (e.g. salmon/redfish)
- sausage/meatloaf/ meatballs .....
Dinner with
- unprocessed meat......................
Breakfast cereal/ oat meal, etc. ...
Boiled or fried egg ........................
Yoghurt ....................................
How many times per week do you normally eat the following foodstuffs? 
How many good friends do you have whom you can talk
What kind of fat is normally used in cooking         
(not on the bread) in your home? 
A catering portion is enough for about
If you use butter or margarine on your bread, how many slices does   
a small catering portion normally cover? By this, we mean the 






Tick one or two boxes! 
The bread I eat is most similar to:
Sleeping pills 
How much (in number of glasses, cups, potatoes or slices) do you   
usually eat or drink daily of the following foodstuffs? 
Tick one box for each foodstuff. 
Full milk (ordinary or curdled) (glasses)
Semi-skimmed milk .........................
(ordinary or curdled) (glasses)
Tea (cups) .......................................
Orange juice (glasses) ....................
Potatoes .....................................
Slices of bread in total 
(incl. crisp-bread) ............................
Slices of bread with 
- fish 
(e.g. mackerel in tomato sauce) .....
- lean meat                    
(e.g. ham) .......................................
- fat meat                       
(e.g. salami) ....................................
- cheese (e.g. Gouda/ Norvegia) .........
- brown cheese ...............................







  Coarse 
brown  
   Crisp 
  bread 
Skimmed milk (ordinary or curdled) (glasses)
Tick a box for all foodstuffs listed. 
slices   
 Less 
 than 1 
 More 
than 6 
  Never 
 Less 
 than 1 
  almost  
daily 










What kind of bread (bought or hom -made) do you usually eat?         
      ALCOHOL
How often do you usually drink   
Never, or just a few times a year .......
1-2 times a month ..............................
About once a week ............................
2-3 times a week ...............................
More or less daily ..............................
Approximately how often during the last year have you consumed 
alcohol corresponding to at least 5 small bottles of beer, a bottle 
of wine, or 1/4 bottle of spirits?            
Not at all the last year ...............................................
A few times ...............................................................
1-2 times a month .....................................................
1-2 times a week ......................................................
3 or more times a week ............................................
For approximately how many years has your alcohol       
consumption been as you described above? ..................
- before age 20 ..................................................
years
   spirits?   wine?beer?
 TO BE ANSWERED BY WOMEN ONLY 
      MENSTRUATION   
      PREGNANCY     
      WEIGHT REDUCTION   
      URINARY INCONTINENCE       
      CONTRACEPTION AND ESTROGEN  
- later .................................................................
If you have lost weight deliberately, about how many                 
kilos have you ever lost at the most? 
- before age 20 ..............................................................
- later .............................................................................
What weight would you be satisfied with 
(your "ideal weight")? ....................................................
How often do you suffer from urinary incontinence?
Never ...................................................................
Not more than once a month ...................................
Two or more times a month .....................................
Once a week or more ..............................................
Your comments:            
Do you use, or have you ever used: 
Oral contraceptive pills (incl. minipill) ...
Hormonal intrauterine device ....................
Estrogen (tablets or patches) ..............
Estrogen (cream or suppositories) ............
If you use oral contraceptive pills, hormonal intrauterine device,                 
or estrogen, what brand do you currently use? 
If you use or have ever used oral contraceptive pills: 
How many years in total have you taken the pill? .....
If you have given birth, how many years did you 
take the pill before your first delivery? .......................
If you have stopped taking the pill: 
       Age when you stopped? .....................................
Thank you for the help! Remember to mail the form today! 
The Tromsø Health Survey 
How old were you when you started                       
menstruating? ................................................................
If you no longer menstruate, how old were
you when you stopped menstruating? ...........................
you ever stopped having menstruation for      
6 months or more? ...................................................
If "Yes", how many times? ..................................
If you still menstruate or are pregnant:                         
What date did your last menstruation period begin?
Do you usually use painkillers to                       
relieve period pains? ............................................
How many children have you given birth to? .............
Are you pregnant at the moment? ....................
Have you during pregnancy had 
high blood pressure and/or proteinuria? ...........
If "Yes", during which pregnancy? 
High blood pressure ....................................
Proteinuria ...................................................
If you have given birth, fill in for each child the year of birth 
and approximately how many months you breastfed the child. 
Child Year of birth:  
About how many times have you deliberately tried to 
lose weight? Write 0 if you never have. 
Apart from pregnancy and after giving birth, have        
Yes  No 
day/month/year
 times  
  No Yes 
years
years
Number of months 
breastfed:
Yes  No 
Yes  No 
 children  
 Don't know  
 Pregnancy
First         Later  
Age when you started to take the pill? ......................
  times  





  times  
 The main aim of the Tromsø Study is to improve our 
knowledge about cardiovascular diseases in order to aid 
prevention. The survey is also intended to improve our 
knowledge of cancer and other general conditions, such as 
allergies, muscle pains and mental conditions. Finally, the 
survey should give knowledge about the older part of the 
population. We would therefore like you to answer the 
questions below. 
    This form is a part of the Health Survey, which has been 
approved by the Norwegian Data Inspectorate and the 
Regional Board of Research Ethics. The answers will only 
be used for research purposes and will be treated in strict 
confidence. The information you give us may later be stored 
along with information from other public health registers in 
accordance with the rules laid down by the Data 
Inspectorate and the Regional Board of Research Ethics. 
     If you are in doubt about what to answer, tick the box that 
you feel fits best. 
     The completed form should be sent to us in the enclosed 
pre-paid envelope. 
Thank you in advance for helping us. 
Yours sincerely, 
Faculty of Medicine National Health 
University of Tromsø Screening Service 
 If you do not wish to answer the questionnaire, tick the box below 
and return the form. Then you will not receive reminders. 
I do not wish to answer the questionnaire ..................................
 Date for filling in this form: ..............................
Day   Month   Year
 Who do you live with?      
 Tick once for each item and give the number.        Yes    No   Number
Spouse/partner ..............................................
Other people over 18 years ...........................
People under 18 years ...................................
 What type of house do you live in? 
Villa/ detached house ....................................
Farm ...................................................................
Flat/apartment ...................................................
Terraced /semi-detached house ......................
Other ...................................................................
How long have you lived in your present home? .............
 Is your home adapted to your needs? .............
 If "No", do you have problems with: 
Living space ...................................................
Variable temperature, 





Other (please specify) ...................................
Spouse/partner Would y  like to move into a retirement home? ..
How will you describe the type of work you had for the last 5-10   
years before you retired? 
Mostly sedentary work? ..........................................
(e.g. office work, mounting)     
Work that requires a lot of walking? .........................
(e.g. shop assistant, housewife, teaching) 
Work that requires a lot of walking and lifting? .......
(e.g. postman, nurse, construction) 
     
Did you do any of the following jobs    
(full-time or part-time)? 




How old were you when you retired? ............................
What kind of pension do you have? 
Basic state pension ..............................................
An additional pension ...........................................





Yes   No 
Years 
years  









How was your family's financial situation during your              
childhood? 
If you did not live in Norway, give country instead of municipality
 
In which Norwegian municipality did you live at the age of 1year?  
CHILDHOOD/YOUTH  
PREVIOUS WORK AND FINANCIAL SITUATION 
   HOME    
Tromsø Health Survey 
for the over 70s 
Heavy manual work .....................................................
(e.g. forestry, heavy farm-work, heavy construction)
Yes   No 
Yes   No 
Yes   No 
Yes   No 
Yes   No 
 No A little 
   ILLNESS IN THE FAMILY       HEALTH AND ILLNESS    
   YOUR OWN ILLNESSES    
    SYMPTOMS      
Tick for the relatives who have or have ever had 
any of the following diseases: 
Has your state of health changed in the last year?
 Yes, it has got worse ..............................................
No, unchanged ...........................................................
Yes, it has got better ..................................................
How do you feel your health is now compared to       
others of your age? 
Much worse .............................................................
A little worse ...............................................................
About the same ..........................................................
A little better ...............................................................
Much better .................................................................
Have you ever had:                
Hip fracture ....................................................
Have you ever had:      Wrist /f rearm fr cture ..................................
Whiplash  .......................................................
Injury requiring  hospital admission ...........
Gastric ulcer  .................................................
Duodenal ulcer  .............................................
Gastric/duodenal ulcer surgery ...................
Have you ever had, or do you have: 
Tick one box only for each item. Give your age at the time. 
If you have had the condition several times, how old were 
you last time? 
Neck surgery ..................................................
Tick one box only for each item. 
Cancer  ......................................................................






Fibromyalgia/fibrositis/chronic pain syndrome ......
Psychological problems for which you have sought help 
Thyroid disease ..........................................................
Liver disease ............................................................







Allergy and hypersensitivity 
Atopic eczema (e.g. childhood eczema) .............
Hand eczema .........................................................
diarrhoea/vomiting or similar in the last 6 months?
Food allergy ...........................................................
Other hypersensitivity (not allergy) ....................
How many times have you had a common cold, influenza (flu), 
times    
Hey fever ............................................................
Have you had this in the last 14 days? .................
Tick "None" if none of your relatives have had the disease.                  
Mother Father Brother Sister Child  None 
Cerebral stroke or brain haemorrhage  









- age when they got
diabetes ..........................................
Do you cough about daily for some periods 
of the year? ..................................................................
If “Yes”:     
Is your cough productive? ................................
Have you had this kind of cough for as long 
as 3 months in each of the last two years? ......
Have you had episodes with wheezing in your chest?
If "Yes", has this occurred:        
Tick one box only for each item. 
At night ....................................................................
In connection with respiratory infections ................
In connection with physical exertion .......................
In connection with very cold weather ...................
Have you noticed sudden changes in your pulse 
or heart rhythm in the last year? ................................
Have you lost weight in the last year? ......................
If “Yes”:   
How many kilograms? ............................................
How often do you suffer from sleeplessness? 
Never, or just a few times a year ...........................
1-2 times a month .......................................................
Approximately once a week .......................................
More than once a week ...............................................
If you suffer from sleeplessness, what time of 
the year does it affect you most? 
No particular time of year ......................................
Especially during the polar night ..............................
Especially during the midnight sun season ............
Especially in spring and autumn ..............................
Do you usually take a nap during the day? ....
Do you feel that you usually get enough sleep? 
Do you suffer from: 
Dizziness .......................................................
Poor memory ....................................................
Lack of energy ..................................................
Constipation .................................................
 Age  
  A lot 
     BODILY FUNCTIONS       
MEDICATION AND DIETARY SUPPLEMENTS
   FAMILY AND FRIENDS   
 USE OF HEALTH SERVICES  
Does the thought of getting a serious illness ever 
worry you?             
Not at all ..................................................................
Only a little ..................................................................
Some ............................................................................
Very much ...................................................................
Can you manage the following everyday 
activities on your own without help from 
others? 
Walking indoors on one level ......................
Walking up/down stairs ....................................
Walking outdoors ..............................................
Walking approx. 500 metres ............................
Going to the toilet .............................................
Washing yourself ..........................................
Taking a bath/shower .......................................
Dressing and undressing .................................
Getting in and out of bed .................................
Eating .................................................................
Cooking ..........................................................
Doing light housework (e.g. washing up) ..........
Doing heavier housework (e.g. cleaning floor) 
Go shopping ......................................................
Take the bus ......................................................
Can you hear normal speech 
(if necessary with hearing aid)? .......................
Can you read (if necessary with glasses)? .....
Are you dependent on any of the following aids? 
Walking stick ................................................
Crutches ...........................................................




How many visits have you made during the past year   
due to your own health or illness: 
Put 0 if you have not had such contact 
To a general practitioner (GP)/emergency GP ........
To a psychologist or psychiatrist .................................
To an other medical specialist (not at a hospital) .......
To a hospital out-patient clinic .................................
Admitted to a hospital ....................................................
To a physiotherapist ......................................................
To a chiropractor .......................................................
To a acupuncturist .........................................................
To a dentist .....................................................................
To a chiropodist .........................................................
To an alternative practitioner (homoeopath, foot zone therapist, etc.)
To a healer, faith healer, clairvoyant ............................
Do you have home aid? 
Private ...........................................................
Municipal ..........................................................
Do you receive home nursing care? ...................
Are you pleased with the health care and home
assistance services in the municipality? 
Assigned family GP .................................
Home nursing care ......................................
Home assistance services ..........................
Do you feel confident that you will receive health 





Have you for any length of time in the last year used any of the 
following medicines or dietary supplements daily or almost daily? 
Indicate how many months you have used them. 








Heart medicines (not blood pressure) ...............
Insulin .......................................................................
Diabetes tablets  ......................................................
Drugs for hypothyroidism (Thyroxine) .............
Cortisone tablets .....................................................
Remedies for constipation .....................................
Dietary supplements: 
Iron tablets ...........................................................
Vitamin D supplements ...........................................
Other vitamin supplements ....................................
Calcium tablets or bone meal ............................
Cod liver oil or fish oil capsules ............................
Do you have close relatives who can give 
you help and support when you need it? .......




How many good friends do you have whom you  
can talk confidentially with and who give you 
help when you need it? ...............................................
Do not count people you live with, but do include 
other relatives! 
Do you feel you have enough good friends?
Do you feel that you belong to a community (group of people) 
who can depend on each other and who feel committed to each 
other (e.g. a political party, religious group, relatives, neighbours, 
work place, or organisation)? 
Strong sense of belonging ...................................
Some sense of belonging .........................................
Not sure ......................................................................






 No  
Yes With difficulty  No 
 No  Yes 
Number of times




 No  Yes 


















        FOOD HABITS           
     WELL BEING       
     MENSTRUATION       
       PREGNANCY        
        ESTROGEN           
How often do you normally take part in organised gatherings, 
e.g. sewing circles, sports clubs, political meetings, religious 
or other associations? 
Never, or just a few times a year ..........................
1-2 times a month ......................................................
Approximately once a week .....................................
More than once a week .............................................
How many meals a day do you normally eat      
(dinner and bread meals)? ...............................................
How many times a week do you eat warm dinner? ........
What kind of bread (bought or home-made) do you              
usually eat? 
Tick one or two boxes. 
The bread type is most similar to:
What kind of fat is normally used in cooking 






How much (in number of glasses, cups, potatoes or slices) do you   
usually eat/drink daily the following foodstuffs? 
Tick one box for each foodstuff. 
Milk of all types (glasses) ..................
Orange juice (glasses) ...........................
Potatoes ..................................................
Slices of bread in total (incl. crispbread)
Slices of bread with 
fish (e.g. mackerel in tomato sauce) 
cheese (e.g. Gouda/Norvegia) ...................
smoked cod caviare .......................
How many times per week do you normally 
eat the following foodstuffs? 
Tick for all foodstuffs listed. 
Yoghurt .........................................
Boiled or fried egg ...........................
Breakfast cereal/oatmeal, etc. .........
Dinner with   
unprocessed meat ........................
fatty fish (e.g. salmon/red-fish)
lean fish (e.g. cod) ....................
vegetables (fresh or cooked) .......
Carrots (fresh or cooked) ................
Cauliflower/cabbage/broccoli .........
Apples/pears ....................................
Oranges, mandarins, etc. ............
Your comments:       
How content do you generally feel with growing old? 
Good ........................................................................
Quite good ..................................................................
Up and down ..............................................................
Bad ...............................................................................
What is your view of the future?        
Bright ......................................................................
Not too bad .................................................................
Quite worried ..............................................................
Dark ..............................................................................
How old were you when you started  
menstruating? ................................................................
TO BE ANSWERED BY WOMEN ONLY  
How old were you when you stopped menstruating? 
How many children have you given birth to? ........
If you have given birth, fill in for each child the year of birth 
and approximately how many months you breastfed the child. 
If you have given birth to more than 6 children, note their birth 
year and number of months you breastfed at the space provided 
below for comments.   
Child  Year of birth: Number of months    
breastfed:  
Children
Have you during pregnancy    
had high blood pressure and/or             
proteinuria? .......................................................
If "Yes", during which pregnancy? 
High blood pressure ..................................
Proteinuria ..................................................
  First    Later   
Pregnancy      
 No  Yes 
Do you use, or have you ever used estrogen:              
Tablets or patches ...........................................
Cream or suppositories ...................................
If you use estrogen, what brand do you currently use?     
Now  Previously  Never
years 
years 
 Never   
 Less  
   than 1     




 Less    
 than 1  
None  
 White





  Coarse   
brown  
   Crisp   
  bread  
 Number  
Thank you for the help! Remember to mail the form today! 




                                                        
 
    Appendix IV 






5.3 (Municipality) (County) (Country)
9.3 (Business) 9.4 (Occupation) 14.7 (Mark)






Fibromyalgia/chronic pain syndrome ......
Psychological problems for which you  
have sought help  ............................................
A heart attack .........................................
Angina pectoris (heart cramp) ................
Cerebral stroke/brain haemorrhage .........
2.1 Have you suffered from pain and/or stiffness in 
muscles and joints during the last 4 weeks?
(Give duration only if you have had problems)
5.1 How long altogether have you lived in the county?
(Put 0 if less than half a year)
5.2 How long altogether have you lived in the municipality?
(Put 0 if less than half a year)
5.3 Where did you live most of the time before the age of 16?
(Tick one option and specify)
Same municipality ....
Another municipality
in the county .............. Which one:
Another county in Norway Which one:
Outside Norway ........ Country::
5.4 Have you moved within the last five years?
No Yes, one time Yes, more than once
1           2       3
NoYes
1.1 What is your current state of health? (Tick one only)
Poor Not so good Good Very good
1                  2               3           4
1.4 Do you get pain or discomfort in the chest when:
Walking up hills, stairs or walking fast on level ground?
1.6 If you stop, does the pain disappear within
10 minutes? ...........................................................
1.7 Can such pain occur even if you are at rest?........
1.5 If you get such pain, do you usually:
Stop? Slow down? Carry on at the same pace?









Upper part of your back... 
Lumbar region .................
Hips, legs, feet ................
Other places ....................











2.2 Have you ever had:
Fracture in the wrist/forearm  ...................
Hip fracture?..............................................
1. YOUR OWN HEALTH 3. OTHER COMPLAINTS
4. USE OF HEALTH SERVICES
5. CHILDHOOD/YOUTH AND AFFILIATION
6. BODY WEIGHT
2. MUSCULAR AND SKELETAL COMPLAINTS
3.1 Below is a list of various problems. Have you experienced 
any of this during the last week (including today)?
(Tick once for each complaint)
Sudden fear without reason ....................
Felt afraid or anxious ..............................
Faintness or dizziness ............................
Felt tense or upset ..................................
Tend to blame yourself ...........................
Sleeping problems ..................................
Depressed, sad ......................................
Feeling of being useless, worthless ........
Feeling that everything is a struggle ......










1             2            3           4
4.1 How many times in the last 12 months have you been to/used:
(Tick once for each line)
General practitioner (GP) .......................
Medical officer at work ...........................
Psychologist or psychiatrist ....................
(private or out-patient clinic)
Other specialist (private or out-patient clinic)
Emergency GP (private or public) ..............
Hospital admission .................................











6.1 Estimate your body weight when you
were 25 years old: kg
1.3 Have you noticed attacks of sudden changes in  









7. FOOD AND BEVERAGES 8. SMOKING
9. EDUCATION AND WORK
7.1 How often do you usually eat these foods?
(Tick once per line)
7.2 What type of fat do you usually use? (Tick once per line)
7.3 Do you use the following dietary 
supplements:
8.1 How many hours a day do you normally spend
in smoke-filled rooms? Number of total hours
8.2 Did any of the adults smoke at home 
while you were growing up? .................................
8.3 Do you currently, or did you previously live
together with a daily smoker after your
20th birthday? 
8.4 Do you/did you smoke daily? ..................
If NEVER: Go to question 9 : (EDUCATION AND WORK)
8.5 If you smoke daily now, do you smoke:
8.6 If you previously smoked daily, how
long is it since you quit? Number of years











Cod liver oil, fish oil capsules ..............
Vitamins and/or mineral supplements?
7.4 How much of  the following do you usually drink?
(Tick once per line)
7.5 Do you usually drink soft drink: with sugar 1 without sugar      2
7.6 How many cups of coffee and tea do you drink daily?
(Put 0 for the types you don't drink daily)
7.7 Approximately how often have you during the last year 
consumed alcohol? (Do not count low-alcohol and alcohol-free beer)
7.8 When you drink alcohol, how many
glasses or drinks do you normally drink? number
7.9 Approximately how many times during the last
year have you consumed alcohol equivalent to




















Yes, daily Sometimes No
1               2             3              4              5             6
Full milk, full-fat curdled milk, 
yoghurt ..................................
Semi-skimmed milk, semi-skimmed 
curdled milk,low-fat yoghurt ......
Skimmed milk, skimmed 
curdled milk ..............................
Extra semi-skimmed milk ......
Juice .....................................
Water ....................................
Mineral water (e.g. Farris, 
Ramløsa etc)
Cola-containing soft drink .....














1 2            3            4            5
Filtered coffee ..........................................................
Boiled coffee/coarsely ground coffee for brewing .....



















1              2        3 4
5               6        7 8
7.10 When you drink, do you normally drink:(Tick one or more)
Beer Wine Spirits 
9.1 How many years of education
have you completed? Number of years
(Include all the years you have attended school or studied)
9.2 Do you currently have paid work?
9.3 Describe the activity at the workplace  where 
you had paid work for the longest period in the
last 12 months. (e.g. Accountancy firm, school, paediatric  
department, carpentry workshop, garage, bank, 
grocery store, etc.)
Business:
If retired, enter the former business and occupation.
Also applies to 9.4
9.4 Which occupation/title have or had you at this workplace?
(e.g. Secretary, teacher, industrial worker, nurse,
carpenter, manager, salesman, driver, etc.)
Occupation:
9.5 In your main occupation, do you work as self-employed, 
as an employee or family member without regular salary?
9.6 Do you believe that you are in danger of losing 
your current work or income within the next 
two years? ...........................................................
9.7 Do you receive any of the following benefits?
Yes No





Sickness benefit (are on sick leave) .......................
Old age pension, early retirement (AFP) or
survivor pension ..................................................... 
Rehabilitation/reintegration benefit .........................
Disability pension (full or partial) .............................
Unemployment benefits during unemployment .......
Social welfare benefits ............................................
Transition benefit for single parents ........................
How many cigarettes do you or did you
normally smoke per day? Number of cigarettes
How old were you when you began
daily smoking? Age in years
How many years in all have you
smoked daily? Number of years
Yes       No
Yes No
Yes, full-time Yes, part-time No1                    2                  3




(not sweating/out of breath)...
Hard physical activity
(sweating/out of breath).........
Blood pressure lowering drugs ...................
Cholesterol-lowering drugs .........................
Reading, watching TV or 
other sedentary activity? ......................................... .........
Walking, cycling or other forms of  
exercise at least 4 hours a week? .....................................
(Include walking or cycling
to work, Sunday walk/stroll,etc.)
Participation in recreational sports, heavy gardening, etc.?
(Note: duration of activity at least 4 hours a week)
Participation in hard training or sports competitions, 
regularly several times a week? ........................................
None Less than 1 1-2 3 or more
10.1 How has your physical activity in leisure time been 
during this last year?
Think of a weekly average for the year.
Time spent going to work is count as leisure time. Answer both questions.
11.3 How much interest do people show for what you do?
(Tick only once)
11.4 How many associations, sport clubs,groups, religious
        communities or similar do you take part in?  Number
(Write 0 if none)
11.5 Do you feel that you can influence what happening
in your local community where you live? (Tick only once)
12.1 Have one or more of your parents or siblings
had a heart attack (heart wound) or
angina pectoris (heart cramp)? ..........................
12.2 Tick for the relatives who have or have
had any of the illnesses: (Tick for each line)
Cerebral stroke or 
brain haemorrhage .......
Heart attack




12.3 If any relatives have diabetes, at what age did they get
diabetes (if for e.g. many siblings, consider the one who 
got it earliest in life):
11.2 How many good friends do you have? Number of friends
Count the ones you can talk confidentially with
and who can give you help when you need it.
Do not count people you live with, but do include
other relatives.
10.2 Describe exercise and physical exertion in your leisure time.
If your activity varies much e.g. between summer and winter, 
then give an average. The question refers only to the last year.
(Tick the most appropriate box)
1 2 3                 4
10. EXERCISE AND PHYSICAL ACTIVITY
11. FAMILY AND FRIENDS
12. ILLNESS IN THE FAMILY
13. USE OF MEDICINES
14. THE REST OF THE FORM IS TO
BE ANSWERED BY WOMEN ONLY
13.1 Do you use:
14.1 How old were you when you  
started menstruating? Age in years
14.2 If you no longer menstruating, how old were
you when you stopped menstruating? Age in years
14.3 Are you pregnant at the moment?
14.4 How many children have you 
        given birth to? Number of children
14.5 Do you use, or have you ever used?
(Tick once for each line)
13.2 How often have you during the last 4 weeks used
the following medicines?
(Tick once for each line)
13.3 For those medicines you have checked in points 13.1 and 























Mother's age Father's age Brother's age Sister's age Child's age
Father Brother Sister Child
None
of these
Yes, some Yes, a little No
Never 
tried




With medicines, we mean drugs purchased at pharmacies.
Supplements and vitamins are not considered here.
Painkillers non-prescription ....




Other prescription medicines ...
Oral contraceptive pills/mini pill/
contraceptive injection ................
Hormonal intrauterine device (IUD)
(not ordinary IUD)..
Estrogen (tablets or patches) .....
Estrogen (cream or suppositories)
State the name and the reason that you are taking/have taken
these (disease or symptom):











Name of the medicine: Reason for use of Up to 1 year
(one name per line) the medicine 1 year or more
If there is not enough space here, you may continue on a separate sheet that you attach
How long have you
used the medicine
Yes No Uncertain Above fertileage 






























but not now Never
14.6 If you use/have used prescription estrogen:
How long have you used it? Number of years
14.7 If you use contraceptive pills, mini pill, contraceptive 
injection, hormonal IUD or estrogen, what brand do you use?
1 2 3 4
1          2                    3        4                 5




Do not write here:









Fibromyalgia/chronic pain syndrome .....
Psychological problems for which you 
have sought help ....................................
A heart attack .........................................
Angina pectoris (heart cramp) ................
Cerebral stroke/brain haemorrhage ........
Have one or more of your parents or siblings had:
NoYes
What is your current state of health? (Tick only once)
Poor Not so good Good Very good
1                  2               3           4
Do you get pain or discomfort in the chest when:
Walking up hills, stairs, or walking fast on level ground?
If you stop, does the pain disappear 
within 10 minutes? .............................................
Can such pain occur even if you are at rest?....
If you get such pain, do you usually:
Stop? Slow down? Carry on at the same pace?






A heart attack (heart wounds) or




E1. YOUR OWN HEALTH E3. COMPLAINTS
E4. TEETH, MUSCLE AND SKELETON
E5. EXERCISE AND PHYSICAL ACTIVITY
E6. BODY WEIGHT
E2. ILLNESS IN THE FAMILY
Below is a list of various problems.
Have you experienced any of this during the last week
(including today)?
(Tick once for each line)
Sudden fear without reason ..........
Felt afraid or anxious ....................
Faintness or dizziness ..................
Felt tense or upset ........................
Tend to blame yourself ..................
Sleeping problems.........................
Depressed, sad .............................
Feeling of being useless, worthless ..
Feeling that everything is a struggle










  1 2 3 4
How many teeth have you lost/extracted? Number of teeth
(disregard milk-teeth and wisdom teeth)
Estimate your body weight when you 
were 25 years old: kg.
Have you been bothered by pain and/or stiffness in 
muscles and joints during the last 4 weeks?
Neck / shoulders ....................
Arms, hands..........................
Upper part of the back ..........
Lumbar regions ....................








Have you ever had:
Fracture in wrist/forearm? ........................
Hip fracture?............................................
Have you fallen down during the last year? (Tick once only)
NoYes




(not sweating/out of breath).....
Hard physical activity
(sweating/out of breath)............
Less than 1None 1-2 3 or more
How has your physical activity been during this last year?
Think of a weekly average for the year.
Answer both questions.
1                   2 3                 4
Hours per week
1              2                 3
Tick for the relatives who have or have
had any of the illnesses: (Tick for each line)
Cerebral stroke or 
brain haemorrhage ...
Heart attack




If any relatives have diabetes, at what age did they get 
diabetes (if for e.g. many siblings, consider the one who 

















Fat fish (e.g. salmon, 
trout, mackerel, herring)
E7. EDUCATION
E8. FOOD AND BEVERAGES
E9. SMOKING
E10. BODILY FUNCTIONS AND SAFETY
How often do you usually eat these foods?
(Tick once for each line)
Do you use dietary supplements:
How many hours a day do you normally spend
in smoke-filled rooms? Number of total hours
Did any of the adults smoke at home
while you were growing up? ........................... 
Do you currently, or did you previously live
together with a daily smoker after your 20th 
birthday?
Do you/did you smoke daily? .................
If you have NEVER smoked daily;
Go to question E11  (BODILY FUNCTIONS AND SAFETY)
If you smoke daily now, do you smoke:
If you previously smoked daily, how
long is it since you quit? Number of years
If you currently smoke, or have smoked 
previously:
Cod liver oil, fish oil capsules ................
Vitamins and/or mineral supplements ...
How much of the following do you usually drink?













1               2                 3                 4                 5                 6
Yes, daily Sometimes No
Full milk, full-fat curdled 
milk, yoghurt ...........................
Semi-skimmed milk, semi-skimmed 
curdled milk, low-fat yoghurt .......
Skimmed milk, skimmed 
curdled milk .........................
Extra semi-skimmed milk ....
Juice ...................................
Water ..................................














1 2 3                4                 5
123
1                   2      3      4
How many years of education have 
you completed? Number of years
(include all the years you have attended school or studied)
Would you feel safe by walking alone in the evening
in the area where you live?
When it comes to mobility, sight and hearing, can you:
(Tick once for each line)
Do you because of chronic health problems have
difficulties with: (Tick once for each line)
Take a 5 minute walk
in fairly high pace? ................
Read ordinary text in newspaper,
if necessary with glasses? .........
Hear what is said in a
normal conversation? ............
Move around in your home? .................
Get out of your home by yourself? .......
Participate in organization or other 
leisure time activities? ..........................
Use public transport? ............................












How many cigarettes do you or did you 
normally smoke per day? Number of cigarettes
How old were you when you began 
daily smoking? Age in years
How many years in all have 
you smoked daily? Number of years














Approximately, how often have you during the last year  
consumed alcohol? (Do not count low-alcohol and alcohol-free beer)
When you drink alcohol, how many 
glasses or drinks do you normally drink? Number
Approximately how many times during the last 
year have you consumed alcohol equivalent to
5 glasses or drinks within 24 hours? Number of times
Filtered coffee ...........................................................
Boiled coffee/coarsely ground coffee for brewing .....



















1              2        3 4
5               6         7 8
Number of cups
How many cups of coffee and tea do you drink daily?
(Put 0 for the types you do not drink daily)
Name of the medicine: Reason for use of Up to One year
(one name per line): the medicine: 1 year or more
Blood pressure lowering drugs .............
Cholesterol-lowering drugs ...................
Drugs for osteoporosis ..........................
Insulin.....................................................
Tablets for diabetes ................................
How much interest do people show for what you do?
(Tick only once)
How many associations, sport clubs, 
groups, religious communities, 
or similar do you take part in? Number 
(write 0 if none)
Do you live: At home? In an institution/shared apartment?
Do you live with:
Spouse/ partner?.......................
Other people? ...........................
How many good friends do you have?
Count the ones you can talk confidentially with
and who can give you help when you need it.
Do not count people you live with, but do include
your children and other relatives........................
How many times in the last 12 months
have you been to/used:
(Tick once for each line)
Are you confident that you 
will receive health care and 
home assistance if you need it?
E11. USE OF HEALTH SERVICES
E12. FAMILY AND FRIENDS
E13. CHILDHOOD/YOUTH AND AFFILIATION
E14. USE OF MEDICINES
E15. THE REST OF THE FORM IS TO
BE ANSWERED BY WOMEN ONLY
Do you use?
(Tick once for each line)
How old were you when you  
started menstruating? Age in years
How old were you when you 
stopped menstruating? Age in years




Do you use, or have you ever used estrogen?
How often have you during the last 4 weeks used the 
following medicines?














1      2          3               4                   5
With medicines, we mean drugs purchased at pharmacies. 
Supplements and vitamins are not considered here
Painkillers non-prescription........ 




Other prescription medicines ....
Tablets or patches .....................
Cream or suppositories .............










If there is not enough space here, you may continue on a separate sheet that you attach.
How long have you
used the medicine
Never Previously Now
If you use estrogen, which brand you use now?
Have you ever used contraceptives pills? ......
1 2 3 4
A general practitioner (GP) ..............
Specialist (private or out-patient clinic)
Emergency GP (private or public).....
Hospital admission ...........................
Home nursing care ..........................
Physiotherapist ................................
Chiropractor .....................................







How long altogether have you lived  in the county?
How long altogether have you lived in 
the municipality?
Where did you live most of the time before the age of 16?
(Tick one option and specify)
Same municipality.........
Another municipality
in the county.................. Which one:
Another county in Norway Which one:
Outside Norway ........... Country:
Have you moved during the last five years?
No Yes, once Yes, more than once










































State the name of the medicines you are using now and the 




1.1 In which municipality did you live at the age of 1 year?
(If you have not lived in Norway, state country of residence
instead of the municipality)







T1. NEIGHBORHOOD AND HOME
Additional questions to the health survey
in Troms and Finnmark 2001-2002
The main aim of the Tromsø Study is to improve our 
knowledge about cardiovascular diseases in order to aid 
prevention. The study is also intended to improve our 
knowledge of cancer and other general conditions, such 
as allergies, muscle pains and mental conditions. We 
would therefore like you to answer some questions about 
factors that may be relevant for your risk of getting these 
and other illnesses. This form is part of the Health Survey, 
which has been approved by the Norwegian Data 
Inspectorate and the Regional Board of Research Ethics. 
The answers will only be used for research purposes and 
will be treated strictly confidential. 
The information you give us may later be linked with
information from other public health registers in accordance
with the rules laid down by the Data Inspectorate and the
Regional Board of Research Ethics.
If you are unsure about what to answer, tick the box that 
you feel fits best.
The completed form should be sent to us in the enclosed 
prepaid envelope. Thank you in advance for helping us.
Yours sincerely
National Health 
Screening ServiceUniversity of Tromsø
If you do not wish to answer the questionnaire, tick the box 
below and return the form. Then you will not receive reminders.
I do not wish to answer the questionnaire
T1. NEIGHBORHOOD AND HOME (cont.)







1.8 How often do you normally take part in organised
gatherings, e.g. sewing circles, sports clubs,  
political meetings or other associations?
(Tick only once)
Never, or just a few times a year .....................
1-3 times a month ............................................
Approximately once a week .............................
More than once a week ....................................
Mostly sedentary work?
(e.g. office work, mounting) ..............................
Work that requires a lot of walking?
(e.g. shop assistant, light industrial work, teaching)
Work that requires a lot of walking and lifting?
(e.g. Postman, nursing, construction) ...............
Heavy manual labour?










1.3 How big is your house? m2 (gross)
Yes
1.4 Are you bothered by: (Tick once for each line)
Moisture, drought or coldness in your home 
Other forms of bad indoor climate  ..........
Traffic noise (cars or aircraft) ...................
Other noise (industrial, construction, etc.) .....
Neighbour noise .......................................
Drinking water quality ...............................
Air pollution from traffic ............................








Yes   No
1.6 What do you consider yourself as?
(Tick for one or more alternatives)
2.1 If you have paid or unpaid work, how would you
describe your work? (Tick only once)
No, not at all ....................................................
To a small extent .............................................
Yes, to a large extent .......................................





2.2 Can you decide yourself how your work (paid
or unpaid) should be organised? (Tick only once)
2.3 Are you on call, do you work 
shifts or nights?









1.5 What home language did your grandparents have?
(Tick for one or more alternatives)







T5. FOOD AND DIETARY SUPPLEMENTS
T6. BODY WEIGHT
T7. ILLNESSES AND INJURIES
3.1 Do you smoke?
If “Yes, sometimes”,
What do you smoke?
If YES:
How many years altogether have you
used snuff?
4.5 Have you, in one or more periods in the last 
5 years consumed so much alcohol that it has
inhibited your work or social life?
5.4 Do you use the following dietary supplements?
7.1 Have you ever had:
Tick once for each question. Also give the age 
at the time. If you have had the condition 
several times, how old were you the last time
Iron tablets .....................................
Calcium tablets or bonemeal .........
Vitamin D supplements ..................



















Atopic eczema (e.g. childhood eczema)
Hand eczema........................................
Food allergy .........................................





Peptic ulcer surgery ......................
Neck surgery .................................
Prostate surgery ............................










1          2    3                  4
6.1 Do you currently try to change your
body weight?
No
Yes, I try to
gain weight
Yes, I try to 
lose weight
1            2    3
No 1-2 times More than 2 times
1          2   3
1                 2         3














7.2 Do you have, or have you ever had:
(Tick once for each question)
Yes, daily
Cigarettes Pipe Cigar/cigarillos
Yes, sometimes No, never
5.3 How important is it for you to have a healthy diet?
1   2                  3          4
Very Somewhat Little Not
3.2 Have you used or do you use snuff daily?
Yes, now Yes, previously Never
Yes   No
4.1 Are you a teetotaller?..................................
Yes   No
5.1 Do you usually eat breakfast every day?...
7.3 Have you had common cold, influenza,
gastroenteritis, etc. during the last 14 days?
7.4 Have you during the last 3 weeks had
common cold, influenza, bronchitis, 
pneumonia, sinusitis, or other respiratory
infection?......................................................
7.5 Have you ever had bronchitis or 
pneumonia?..................................................
7.6 Have you during the last 2 years had 
bronchitis or pneumonia? (Tick only once)
4.2 How many times a month do you
normally drink alcohol?..................
(Do not count low-alcohol beer.
Put 0 if less than once a month)
4.3 How many glasses of beer, wine or spirits
do you normally drink in a fortnight?
(Do not count low-alcohol beer.
Put 0 if you do not drink alcohol)
Number of times
years
4.4 For approximately how many years
has your alcohol consumption been at 
the same level you described above? years
5.2 How many times a week do you
eat a warm dinner?.......................................
6.2 What weight would you be satisfied .....




T8. SYMPTOMS T8. SYMPTOMS (continue)
T9. MEDICINES
8.2 Do you cough about daily for periods of the year?
If YES:
8.11 Do you usually sleep during the day?...........
8.12 How often do you suffer from urinary incontinence?
Never ................................................................
Not more than once a month ............................
Two or more times a month ..............................
Once a week or more .......................................
8.1 Have you in the last two weeks felt:
(Tick once for each question)
8.5 Do you get short-winded in the following situations?
(Tick once for each question)
While walking fast on level ground
or slight up hills .....................................................
While walking calmly on 
level ground ..........................................................
While washing or dressing yourself ......................
While resting .........................................................
8.6 Do you have to stop because of short-windedness
while walking in your own pace on level ground?...
Is your cough productive? ................................
Have you had this kind of cough for as long 
as 3 months in each of the last two years?......





Yes   No
8.4 Do you get pain in the calf while walking ..........
If YES:
How long can you go
before you notice the pain?...............
8.13 Are you able to walk down 10 steps without 
holding on to something (e.g. a handrail) ....
8.14 Do you use glasses?.......................................
8.15 Do you use a hearing aid?..............................
8.16 How is your memory?
(Tick once for each question)
Do you forget what you just have
heard or read?.....................................................
Do you forget where you have placed things?.....
Is it more difficult to remember now than earlier?..
Do you more often write memos now than earlier?
If “YES” on one of these questions;
Is this a problem in your daily life?................
Drugs for
osteoporosis....................
Tablets for diabetes ........
Drugs for hypothyroidism
(thyroxine) ......................
Yes   No
Yes   No
Yes   No
8.7 Have you during the last year suffered from
pain and/or stiffness in muscles and joints
that have lasted continuously for 
at least 3 months?...............................................
If YES:
Has the complaint reduced your leisure 
time activity? .......................................................
For how long has the complaint endured in total?
Yes   No
Yes   No
Yes   No




Has the complaint reduced your ability to work during 
the last year? (Also applies to domestic workers and 
pensioners (Tick once)
Have you been on sick leave due to these
complaints during the last year?................
No/insignificantly To some extend Significantly reduced Do not know
1               2        3  4
Yes   No
Do not
work
9.1 Do you use, or have you used any of
the following medicines:
9.2 Do you use any medicines which you take 
as injections? ...................................................
If YES:
Give the name of the medicines (for injection):





used 1st time Never
used
meter
8.8 How often do you suffer from sleeplessness?
(Tick only once)
Never, or just a few times a year .......................
1-3 times a month ..............................................
Approximately once a week ..............................









8.9 If you suffer from sleeplessness monthly or more
frequently, what time of the year does it affect you most?
No particular time of the year ............................
Especially during the polar night ........................
Especially during the midnight sun season ........
Especially in spring and autumn .........................
8.10 Have you in the last year suffered from 
sleeplessness to the extend that it has 
affected your ability to work ? ........................
Yes   No
Yes   No
Yes   No
Yes   No




Nervous or worried .....................
Bothered by anxiety.....................
Confident and calm ....................
Irritable.........................................
Happy and optimistic ..................
Down/depressed ........................
Lonely..........................................
8.3 Have you had episodes with wheezing in the chest?
If YES:
Has this occurred: (Tick once for each question)
At night ..................................................................
In connection with respiratory infections ...............
In connection with physical exertion ......................
In connection with very cold weather .....................
T10. ILLNESS IN THE FAMILY
T11. MOBILE TELEPHONE



























12.2 If you still have mensturate or are pregnant:
What date did your last menstruation start?
12.5 Do you use or have you used oral 
        contraceptive pills?..............................
If YES:
How old were you when 
you started taking the pill?..................
How many years in total
have you taken the pills?.... Number of years
If you have given birth:
How many years did you take the pill 
before your first delivery?...  Number of years
If you stopped taking the pill:
How old were you when you stopped?....
12.6 Apart from pregnancy and after giving
birth, have you ever stopped having
menstruation for 6 months or more?.
If YES:
How many times?........................
12.7 How is your current menstruation status?
I have not had menstruation in the last year
I have regular menstruation ........................
I have irregular menstruation ......................
12.8 When you were 25-29 years old, how many days
usually passed between the start of two periods?
The periods were of approximately
equal length every time?...............
How many days did a typical
menstrual bleeding period last?...
Thank you for the help!
Remember to mail the form today!
(If more children, use additional sheet)
12.4 Do you use or have you used prescribed
estrogen (tablets or patches)?..................
If YES:
How old were you when 
you started taking estrogen ? .............
If you stopped using estrogen,
How old were you when 






10.1 Tick for the relatives who have or have ever had
any of the diseases: (Tick for each line)
10.2 How many siblings and children do you have?
10.3 Do you usually do extra caring work because
of illness etc. in your close family?
Heart attack (heart wound)
Angina pectoris (heart cramp)
High blood pressure ........
Aneurysm.........................













Yes, daily/almost daily Yes, sometimes No
1                2        3
11.1 Do you have (own, rent, etc.) a mobile telephone?
If Yes:
What do you use your mobile telephone for, and how 
often do you use it?(Tick once for each line)
T12. THE REST IS TO BE ANSWERED BY WOMEN ONLY
12.1 If you have given birth, fill in each child's birth year and 
how many months you breastfed after delivery.
(If you did not breastfeed, write 0)
Number of months







Yes, always Yes, sometimes
30 or
more
10-29 2-9 1 or
less
Never
Number of times per day
No
1                2         3
12345
Yes   No10.4 Do you/your family receive home aid 
or home nursing care?.................................
10.5 Is your mother alive? .......






12.3 If you no longer menstruate; why did
your periods stop? (Tick once)
It stopped by itself ............................................
Uterus surgery .................................................
Surgically removed both ovaries ......................





















                                                        
 
    Appendix V 






- part of The Tromsø Survey
 
- part of The Tromsø Study   
FILL OUT THE FORM IN THIS WAY:
The form would be read by machine, it is therefore important that you tick appropriately:
 Correct 
 √ Wrong 
 rWrong 
If you tick the wrong box, correct by filling the box like this
Write the numbers clearly  1 2 3 4 5 6 7 8 9 0
Correct 
Wrong 
Use only black or blue pen, do not use pencil or felt tip pen
7 4
r
7   4
3
1.6 To allow you to show us how good or bad 
your state of health is we have made a 
scale (almost like a thermometer) where 
the best state of health you can imagine is 
marked 100 and the worst 0. We ask you to 
show your state of health by drawing a line 
from the box below to the point on the 
scale that best fits your state of health.   















   1. DESCRIPTION OF YOUR HEALTH STATUS
By placing a tick in one  box in each 
group below, please indicate which 
statements best describe your own 
health state today:
1.03 Usual activities (e.g. work, study, housework,
family or leisure activities)
I have no problems with performing my
usual activities 
I have some problems with performing my
usual activities 
I am unable to perform my usual 
activities 
1.04 Pain and discomfort
I have no pain or discomfort
I have moderate pain or discomfort
I have extreme pain or discomfort
1.01 Mobility 
I have no problems in walking 
about 
I have some problems in walking about
I am confined to bed
1.02 Self-care 
I have no problems with self-care
I have some problems washing or 
dressing myself 
I am unable to wash or dress myself
1.05 Anxiety and depression
I am not anxious or depressed
I am moderately anxious or depressed




2.01 Where did you live at the age of 1 year?
In Tromsø (with present municipal borders)
In Troms, but not Tromsø
In Finnmark 
In Nordland 
Another place in Norway
Abroad 
2. CHILDHOOD/YOUTH AND AFFILIATION
2.05 How many siblings and children do 
you have/have you had? 
Number of siblings ......................................
Number of children .....................................
2.02 How was your family's financial





2.07 What was/is the highest completed education for your parents and your spouse/partner?




7-10 years primary/secondary school, modern secondary school
Technical school, vocational school, 1-2 years senior high school
High school diploma .........................................................................................
College or university (less than 4 years) .............................................
College or university (4 years or more) ................................................
2.06 Is your mother alive?
Yes No
If NO: her age when she died .............
Is your father alive?
Yes No
If NO: his age when he died ................
2.04 What do you consider yourself as? (Tick 





2.03 What is the importance of religion 





3.03 I consider my occupation to have the following social status in the society







3.01 Below are three statements about satisfaction with life as a whole. Then there are two 
statements about views on your own health. Show how you agree or disagree with 
each of the statements by ticking in the box for the number you think fits best for you.
(tick once for each statement)
Completely
disagree  1     2     3     4     5     6     7
In most ways my life is close to my ideal .................
My life conditions are excellent ....................................
I am satisfied with my life .................................................
I have a positive view of my future health .............
By living healthy, I can prevent serious diseases
3.02 Below are four statements concerning your current job conditions, or if you are not
working now, the last job you had. (Tick once for each statement)
 
My work is tiring, physically or mentally ................
1 2 3 4 5 6 7
I have sufficient influence on when and how 
my work should be done ...................................................
I am being bullied or harassed at work ...................
I am being treated fairly at work ................................
3. WELL BEING AND LIVING CONDITIONS









Been tormented, or threatened with violence ................
Been beaten, kicked at or victim of other types of violence
Someone in your close family have used alcohol or
drugs in such a way that it has caused you worry ..........
If you have experienced anything of the above, how much are you affected by that now?








4.01 Have you during the last month
experienced any illness or injury?
Yes No
4. ILLNESS AND WORRIES
4.03Do you become breathless in the following 
situations? (tick once for each question)
Yes  NoWhen you walk rapidly on level 
ground or up a moderate slope .............
When you walk calmly on level 
ground ...................................................................
While you are washing or dressing ......
At rest ....................................................................
4.04 Do you cough about daily for some 
periods of the year?
Yes No
If YES: Is the cough usually productive?
Yes No
Have you had this kind of cough for as long 
as 3 months in each of the last two years? 
Yes No
4.02Have you noticed sudden changes in your 
pulse or heart rythm in the last year? 
Yes No
4.09 Below, please answer a few questions
about your memory: (tick once for each
question) 
Yes  No
Do you think that your memory
has declined? ....................................................
Do you often forget where you 
have placed your things? ..........................
Do you have difficulties finding 
common words in a conversation? ......
Have you problems performing 
daily tasks you used to master? ............
Have you been examined for 
memory problems? ........................................
If YES: have you during the same period?
(Tick once for each line)
Yes  No
Been to a general practitioner ..............
Been to a medical specialist ...................
Been to emergency department ...........
Been admitted to a hospital ....................
Been to an alternative  practitioner
(chiropractor, homeopath or similar) .............
If YES to at least one of the first four questions
above: Is this a problem in your daily life?
Yes No
4.05How often do you suffer from sleeplessness?
(tick once) 
Never, or just a few times a year
1-3 times a month
Approximately once a week
More than once a week
If you suffer from sleeplessness monthly or 
more often, what time of the year does it 





4.06 Have you had difficulty sleeping during 
the past couple of weeks? 
Not at all
No more than usual
Rather more than usual
Much more than usual
4.07 Have you during the last two weeks felt 
unhappy and depressed?
Not at all
No more than usual
Rather more than usual
Much more than usual
4.08 Have you during the last two weeks felt
unable to cope with your difficulties?
Not at all
No more than usual
Rather more than usual
Much more than usual
7
4.17 If you have had abdominal pain or 
discomfort during the last year:
Yes  No
Was it located in your upper stomach?.
Were you bothered as often as once a
week or more during the last 3 months?... 
Do you feel symptoms relief after 
bowel movement?........................................................
Are the symptoms related to more 
frequent or rare bowel movements
than normally? ...........................................................
Are the symptoms related to more
loose or hard stool than normally?............. 
Do the symptoms appear after a meal? ....
4.15 Have you ever experienced infertility 
for more than 1 year?
Yes No
If Yes: was it due to: Do not 
knowYes No
A condition concerning you?......
A condition concerning your 
partner?.........................................................
4.14 Do you have or have you ever had some 
of the following:




4.19 For women: Have you ever had a 
miscarriage?
Yes No Do not know
If Yes: number of times .........................
4.16 To which degree have you had the following 
complaints during the last 12 months?









4.20For men: Have your partner ever had 
a miscarriage?
Yes No Do not know
If Yes: number of times .........................
4.22Have you been diagnosed with 
Dermatitis Herpetiformis (DH)? 
Yes No Do not know
4.21 Is your diet gluten-free?
Yes No Do not know
4.11 Have you suffered from pain and/or 
stiffness in muscles or joints during 
the last 4 weeks? (tick once for each line)
Neck, shoulders ...................
Arms, hands ...........................
Upper part of the back ...
The lumbar region .............
Hips, leg, feet ......................
Other places ..........................
4.10 Have you during the last last year suffered 
from pain and/or stiffness in muscles or 
joints in your neck/shoulders lasting for 
at least 3 consecutive months?
(tick once for each line)
Neck, shoulders .................
Arms, hands............................




4.12 Have you ever had: Age 




4.18 Have you ever had: Age
last timeYes  No
Gastric ulcer .........................
Duodenal ulcer ....................
Ulcer surgery ........................4.13 Have you been diagnosed with arthrosis 
by a physician?
Yes No













4.27 What kind of headache are you 
suffering from?
Migraine Other headache
4.28 How many days per month do you 
suffer from headache? 
Less than one day
1-6 days 
7-14 days
More than 14 days
4.26 Have you been suffering from 
headache the last year?
Yes No
If No: go to section 5, food habits
4.30 What is the normal intensity of your 
headache attacks? 
Mild (do not hinder normal activity) 
Moderate (decrease normal activity) 
Strong (block normal activity) 
4.31 What is the normal duration of the 
headache attacks? 
Less than 4 hours
4 hours – 1 day
1-3 days
More than 3 days
4.29 Is the headache attacks usually:
(tick once for each line)
Yes   No
Pounding/pulsatory pain ..............
Pressing/tightening pain ............. 
Unilateral pain (right or left) ........ 
4.33 Before or during the headache, do you 
have a temporary: Yes  No
Visual disturbances? (flickering,
blurred vision, flashes of light)....................
 
Unilateral numbness in your face 
or hand? ...........................................................
Aggravated pain by moderate 
physical activity? .......................................
 
Nausea and/or vomiting? ......................
4.34 Describe how many days you have been 
away from work or school during the 
last month due to headache?
Number of days........................................
4.32 If you suffer from headache, when during






4.23 Have you been diagnosed with coeliac 
disease, based on a biopsy from your 
intestine taken in a gastroscopy 
examination?
Yes No Do not know
4.24 Do you have your natural teeth?
Yes No
4.25 How many amalgam tooth fillings do 
you have/have you had?
0 1-5 6-10 10+
9
5. FOOD HABITS









Fresh water fish (not farmed) ........................................................
Salt water fish (not farmed) ............................................................
Farmed fish (salmon, trout, char) .................................................. 
Tuna fish (fresh or canned) ................................................................
Fish bread spread ...............................................................................
Mussels, shells ......................................................................................
The brown content in crabs ........................................................
Whale or seal meat ...........................................................................
Pluck (liver/kidney/heart) from reindeer or elk/moose..
Pluck (liver/kidney/heart) from ptarmigan/grouse .............
5.02 How many times during the year do/did you usually eat the following? (number of times)
In adulthood In childhood
Mølje (cod or pollack meat, liver, and roe)(Number of times per year) 
Sea gull's egg (Number of eggs per year) ....................................................................
Reindeer meat (Number of times per year) ..............................................................
Local mushroom and wild berries (blueberries/lingonberries/cloudberries)
(Number of times per year)
5.03 How many times per month do you eat 
canned (tinned) foods (from metal boxes)? 
Number ...............................................................
5.04 Do you take vitamins and/or mineral 
supplements?
Yes, daily Sometimes Never 










3 times per day 
or more
Dark chocolate .......................................
Light chocolate/milk chocolate ....
Chocolate cake ......................................
Other sweets ........................................... 










3 times per  
day or more
5.06 If you eat chocolate, how much do you usually eat each time?
Compared with the size of a Kvikk-Lunsj sjokolade (a chocolate brand in the market) and describe how 
much do you eat in relation to it.






8.01 How many hours per week, do you do the 
following leisure- or professional activities: 
Automobile repair/paint, ceramic work, 
painting/varnishing/solvents, hair dressing, 
glazier, electrician. (Put 0 if you do not 
engage in such leisure or professional activities)  
Number of hours per week on average .........
8.02 Do you use hair color preparations
Yes No
If Yes: How many times per year? ..
7.01 Have you involuntary lost weight during 
the last 6 months?
Yes No
If Yes: how many kilograms? ..............
7.03 Are you satisfied with your present body 
weight?
Yes No
7.02 Estimate your body weight when you were 
25 years old: 
Number of kilograms ..........................
7.04 What weight would you be satisfied with 
(your "ideal" weight)? 
Number of kilograms ...........................
Never




6.02 Have you or someone else been injured because of your 
drinking? .........................................................................................................................
Has a relative, friend, physician, or other health care workers 







6.01 How often have you in the last year:
Never Monthly Weekly
Not been able to stop drinking alcohol 
when you have started? ....................................... 
Failed to do what was normally expected
of you because of drinking? ................................
Needed a drink in the morning to get 
yourself going after a heavy drinking session?
Had feeling of guilt or remorse after 
drinking? ..........................................................................
Not been unable to remember what happened 
the night before because of your drinking? ..... .............
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9.09 Altogether, how much of a problem, 







9. USE OF HEALTH SERVICES
9.01 Have you ever experienced that diseases
have been insufficiently examined or 
treated, and this had a serious consequence?  
Yes, this has happened to me
Yes, this has happened to a close relative
(child, parents, spouse)
No
If Yes, was it caused by?







more than one person due to deficient
routines and interaction
9.03Have you ever complained about a treatment
you have received?
Have never had a reason for complaining
Have considered complaining, but 
did not do 
Have complained verbally
Have complained in writing
9.04 How long have you had your current
general practitioner/other physician?
Less than 6 months
6 to 12 months
12 to 24 months
More than 2 years
9.02Have you ever felt persuaded to accept
an examination or treatment that you did
not want?
Yes No
If Yes, do you think this has had unfortunate
consequences for your health?
Yes No
9.05 At the last visit to your GP, did you have
a hard time to understand what the 
doctor(s) told you? Answer on a scale
from 0 to 10, where 0 = they were difficult
to understand and 10 = they were always
easy to understand
0   1    2   3    4   5   6    7   8   9  10
9.06 How would you rate the treatment
or counselling, you got at your last visit to 
your GP? Answer on a scale from 0 to 10,
where 0 = worst treatment or counselling, 
and 10 = best treatment or counselling
9.07 During the last 12 months, how much of  
a problem, if any, was it to get a
referral to special examinations (as x-ray,
etc.) or to a specialist health care (private





9.08 During the last 12 months, how much of  
a problem, if any, was it to get a referral


















Have you, during the last 12 months, used
herbal or natural medicine?
During the last 12 months, have you 
been examined or treated by the
specialist health care?
Have you, during the last 12 months, used
meditation, yoga, qi gong or thai chi as
self-treatment?
Have you ever, previous to the year 2002,
had an operation at a hospital or a 
specialist clinic?
How would you rate the treatment or
counselling you got at your last visit to
a specialist? Answer on a scale from 0 to 10,
where 0 = worst treatment or counselling, 
and 10 = best treatment or counselling
If Yes, did you have a difficult time to 
understand what the doctor(s) told you? 
Answer on a scale from 0 to 10, where 0 = 
they were difficult to understand and 10 = 
they were always easy to understand
Yes
0   1    2   3    4   5   6    7   8   9  10











10. USE OF ANTIBIOTICS
10.01 Have you used antibiotics during the last 12 months? (all penicillin-like medicine in the 
form of tablets, syrups or injections)
Yes No Do not remember
If YES: What did you get the treatment for? 
Have you taken many antibiotic treatments, 
tick for each treatment.
Treatment
 1
● Urinary tract infection (bladder infection, cystitis) .....
● Respiratory tract infection (ear, sinus, throat or 
lung infection, bronchitis) ............................................................
● Other ..........................................................................................
Treatment duration: number of days ............................
How did you acquire the antibiotics for treatment?
Have you acquired many treatments, tick for each one.
With prescription from a physician/dentist ...............
Without contacting a physician/without prescription:
· Purchase from a pharmacy abroad .........................
· Purchase over the internet  .........................................
· Remnants from earlier treatment at home ......
· From family/friends .........................................................
· Other ways ..............................................................................
10.02 Do you presently have antibiotics at home?
Yes No
10.03 Would you consider using antibiotics 
without consulting your physician? 
Yes No
If YES:is this after an agreement with your 
physician for treatment of chronic or frequently 
recurring disease? 
Yes No
If No: how did you acquire this antibiotic?
(Multiple ticks are possible)
Purchased from a pharmacy abroad ....
Purchased over the internet .....................
Remnants from earlier treatment .........
From family/friends .......................................
Other ways ...........................................................
If YES: which conditions would you treat in 










Urinary tract infection ...............................
Other infections ..............................................
Treatment








   6
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11. YOUR CIRCADIAN RHYTHM
Then I go to bed at ....................................................................................................................................
I get ready to fall asleep at .................................................................................................................
Number of minutes I need to fall asleep ....................................................................................................
I wake up at ....................................................................................................................................................
With help of: Alarm clock External stimulus (noise, family members etc.) By myself
Number of minutes I need to get up .............................................................................................................
Then I go to bed at ....................................................................................................................................
I get ready to fall asleep at .................................................................................................................
Number of minutes I need to fall asleep ....................................................................................................
I wake up at ....................................................................................................................................................
With help of: Alarm clock External stimulus (noise, family members etc.) By myself
Number of minutes I need to get up .............................................................................................................
11.02 Number of days per week which you cannot freely choose when you sleep (e.g. work days)?
0    1     2    3    4    5    6    7
We will ask you some questions about your sleeping habits
11.03 Number of days per week which you can freely choose when you sleep (e.g. free days or holidays)
11.01 Have you worked in a shift work schedule during the last 3 months? 
Yes No
0    1     2   3     4    5    6    7
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12.07 Have you recurring large acne/abscesses
that are tender/painful and often form 
scars in the following places? 
(tick once for each line) 
Yes  No
Armpits ...............................................................
Under the breasts .......................................
Stomach groove/the navel ....................
Around the genitalia ..................................
Around the anus ...........................................
The groin ..........................................................
If Yes: How many times in average per year did
you take antibiotics during the period you were
most affected (tick once) 
1-2 3-4 More than 4 times
12.05 Have you often or always any of the 
following complaints? (tick once for each line)
Yes  NoSwelling in the ankles or legs, 
particularly in the evenings ...................
Varicose veins .................................................
Eczema (red, itchy rash) on
your legs .............................................................
Leg pain that is getting worse when you
are walking and is relieved when you
are standing still ......................................................
12.04 Have you or have you ever had the following
skin disorders? (tick once for each line)
Yes  No
Psoriasis ................................................................
Atopic eczema (children's eczema)....
Recurrent hand eczema .............................
Recurrent pimples/spots for 
several months ..................................................
Leg or foot ulcer that did not heal
for 3-4 weeks ....................................................
12. SKIN AND DERMATOLOGY
If YES on the question concerning leg and/or
foot ulcer, do you have any leg ulcer today?
Yes No
12.03 Have you ever taken any antibiotics 
(penicillin and penicillin-like medicines)
because of a skin disease, for example
infected eczema, acne, non-healing leg
ulcers, recurrent  abscess?
Yes No
12.01 How often do you usually take a shower 
or a bath? (tick once)
2 or more times daily
1 time daily
4-6 times per week
2-3 times per week
Once a week
Less than once a week
12.02 How often do you usually wash your





More than 20 times
12.06 Have you ever had the following diagnoses





If Yes, did you get any of the following 





A larger surgical intervention 
including skin removal ...............................
Surgical laser treatment ..........................





The following pages with questions should not be answered by everybody. If you have answered
yes to one or more of questions below, we ask you to move on to the follow-up questions on the 
topic or topics you have answered yes to. The first four topics are from the first questionnaire 
and the last question  is from this form.
We have for the sake of simplicity highlighted topics with different colours so that you will find 
the questions that applies to you.
If you answered YES to that you have: long-term or recurrent pain that has lasted for 3 months 
or more, please answer the questions on page 19 and 20. The margin is marked with green.
If you answered YES to that you have undergone any surgery during the last 3 years, 
please answer the questions on page 21 and 22. The margin is marked with purple.
If you answered YES to that you're working outdoors at least 25% of the time, or in facilities 
with low temperature, such as warehouse/industrial halls, please answer the questions on page 23.
The margin is marked with red.
If you answered YES to that you have used non-prescription pain relievers, please answer 
questions on page 24. The margin is marked with orange.
If you answered YES to that you have or have ever had skin problems (such as psoriasis, atopic 
eczema, non-healing leg or foot ulcers, recurrent hand eczema, acne or abscesses), please 
answer the questions on page 25. The margin is marked with yellow.
If you have answered NO to these five questions, you are finished with your answers. The 
questionnaire is to be returned in the reply envelope you were given at the survey site. The 
postage is already paid.
Should you wish to give us written feedback on either the questionnaire or The Tromsø Study 
in general, you are welcome to that on page 26.
Do you have any questions, please contact us by phone or by e-mail. You can find the contact 
information on the back of the form. THANK YOU for taking the time to the survey and to
answer our questions.
INFORMATION TO FOLLOW-UP QUESTIONS
19
13.01 How long have you had this pain?
Number of years months










13.02 How often do you have this pain?
Every day Once a month or more
Once a week or more Less than once a month
13.05 Which kind of treatment have you received for the pain? (Tick for all types of pain 
treatments you have received) 
No treatment Psycho-educative/relaxation training/
psychotherapy
Analgesic medications/painkillers Acupuncture 
Physiotherapy/chiropractic treatment Complimentary and alternative medicine 
(homeopathy, healing, aromatherapy, etc. Treatment at a pain clinic
Surgery Other treatment
You answered in the first questionnaire that you have protracted or constantly recurrent 
pain that has lasted for 3 months or more. Here, we ask you to describe the pain a little closer.
13. FOLLOW-UP QUESTIONS ON PAIN
13.04 What do you believe is the cause of the pain? (Tick for all known causes) 
Accident /acute injury Fibromyalgia  
Long-term stress Angina pectoris 
Surgical intervention/operation Poor blood circulation 
Herniated disk (prolapse) /lumbago Cancer 
Whiplash Nerve damage/neuropathy 
Migraine/headache Infection 
Osteoarthritis Herpes zoster 
Rheumatoid arthritis Another cause (describe below)
Bechterews syndrome Don't know
Describe the other cause:
..........................................................................................................................................................................................................
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13.06 On a scale of 0 to 10, where 0 corresponds to no pain and 10 corresponds to the worst 




to sleepTo what degree does the pain 
interfere with your sleep?  ............................ 
0 1 2 3 4 5 6 7 8 9 10
Can not do
anything
To what degree does the pain 
interfere with performing common
activities at home and at work?  ..........
0 1 2 3 4 5 6 7 8 9 10
How strong is the pain when it is in 
its strongest Intense?  ...........................................





painHow strong would you say that the 
pain usually is?  .............................................................









14. FOLLOW-UP QUESTIONS ON SURGERY
In the first questionnaire you answered that you have undergone an operation during 
the last 3 years.
Below, please describe the operation. If you have undergone several operations during the  
last 3 years, these questions concern the last surgery you underwent.
14.02 Where in your body did you have surgery?
(If you were operated simultaneously in several
places in the body, tick more than once)








· Another surgery in
  the chest region .............................
Surgery in the stomach/pelvis
· Stomach/intestines .....................
· Inguinal hernia ...............................
· Urinary tract/reproductive organs
· Gall bladder/biliary tract .......
· Another surgery in the
  stomach/pelvis ...............................










14.03 Reason for the surgery:
Acute illness/trauma ...................................
Planned non-cosmetic operation .........
Planned cosmetic operation ...................
14.04 Where did you have the surgery?
The hospital in Tromsø  .............................
The hospital in Harstad .............................
Other public hospital ..................................
Private clinic ....................................................
14.01 How many times have you undergone surgery during the last 3 years? 
Number  ......................................................................................................................................................................................
14.05 How long time is it since you had surgery?
Number 
of years ..... Months ......
14.06 Do you have reduced sensitivity in an area 
near the surgical scar?
Yes No
14.07 Are you hypersensitive to touch, heat or 
cold in an area near the surgical scar? 
Yes No
14.08 Does slight touch from clothes, showering 
or similar cause discomfort/pain?
Yes No
14.09 If you had pain at the site of surgery before 
you had surgery, do you have the same  
type of pain now? 
Yes No
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14.10 The pain at the site of surgery: Answer on a scale from 0 to 10, where 0=no pain and 





painHow strong pain did you have at the 
site of surgery before you had surgery
0 1 2 3 4 5 6 7 8 9 10
How strong pain do you normally  
have at the site of surgery now ...........
0 1 2 3 4 5 6 7 8 9 10
How strong pain do you normally 
have at the site of surgery when it
is most intense ...............................................












15.06Have you during the last 12 months had
an accident where cold has been involved, 
and which required medical treatment?
Yes  No
At work ...........................................................
In leisure time ............................................
15.02 For how long have you been exposed to 
cold air below 0ºC during the last winter?
Leisure/hobbies (hours/week) ................
Work (hours/week) .........................................
Outdoors, with suitable clothing
(hours/week) ......................................................
Outdoors, without suitable clothing
(hours/week) ......................................................
Indoors, with no heating (hours/week)
In cold, with wet clothing
(hours/week) ......................................................
Contact with cold objects/tools
(hours/week) ......................................................
15. FOLLOW-UP QUESTIONS ABOUT WORK IN COLD ENVIRONMENT
In the first questionnaire you answered yes to that you work in cold environments. Here are  
some follow-up questions that we hope you will answer.




15.05Have you had itching and/or rash in relation
to cold exposure?
Yes No
15.07 Do you experience any of the following 
symptoms while you are in a cold environment?
If so, at what temperature do the symptoms
occur?
Yes No  Under °C
Breathing problems ............
Wheezy breathing ...............
Mucus secretion from lungs
Chest pain ................................











15.08 How does cold environments and cold-related symptoms influence your performance?
Decrease No effect Improve 
Concentration ......................................................................................................
Memory .....................................................................................................................
Finger sensitivity (feeling) ..............................................................................
Finger dexterity (motor) .................................................................................. 
Control of movement (for example tremor) ............................................
Heavy physical work ........................................................................................
Long-lasting physical work ...........................................................................





Performing other activities 
outdoors ..................................................... ...
15.04 Have you during the last 12 months had a 
frostbite with blisters, sores or skin injury?
Yes No
If Yes, how many times? ...........................
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16. USE OF NON-PRESCRIPTION PAINKILLERS 
Paracetamol: (Pamol, Panodil, Paracet, 
Paracetamol, Pinex)
Not used
Less than every week
Every week, but not daily
daily
How much do you usually take daily
when you use these medicines?
(number of tablets, suppositories) ..............
16.01 What types of non-prescription 
painkillers have you used?
Ibuprofen: (Ibumetin, Ibuprofen, Ibuprox, Ibux)
Not used
Less than every week
Every week, but not daily
Daily
How much do you usually take daily
when you use these medicines?
(number of tablets, suppositories) ..............
Acetylsalicylates: (Aspirin,Dispril, Globoid)
Not used
Less than every week
Every week, but not daily
Daily 
How much do you usually take daily
when you use these medicines?
(number of tablets) .........................................
Naproxen: (Ledox, Naproxen)
Not used
Less than every week
Every week, but not daily
Daily
How much do you usually take daily
when you use these medicines?
(number of tablets) .........................................






16.02 For which complaints do you use non-









Phenazone with caffeine: (Antineuralgica, 
Fanalgin, Fenazon-koffein, Fenazon-koffein sterke) 
Not used
Less than every week
Every week, but not daily
daily
How much do you usually take daily
when you use these medicines?
(number of tablets) .........................................
16.05 Do you combine the treatment with the 
use of painkillers on prescription?
Yes No
16.03 Do you think you have experienced side 
effects of some of the medicines? (tick 





Phenazone with caffeine ......................
In the first questionnaire you answered that you had used non-prescription painkillers 
(analgesics) in the last 4 weeks. Here are some follow-up questions we hope you will answer.
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17. FOLLOW-UP QUESTIONS ABOUT SKIN DISEASES
On page 15 in this questionnaire you answered that you have or have had a skin disease. 
Here are some follow-up questions we hope you will answer.
17.08 How old were you when you got 
abscesses for the first time?
0-12 years 26-35 years
13-19 years 36-50 years  
20-25 years Older than 50 years
17.07 How many episodes of abscesses
do you usually have per year? (tick once)
0-1 4-6
2-3 More than 6
17.09 If you no longer have abscesses, how
old were you when it disappeared?
0-12 years 26-35 years
13-19 years 36-50 years  
20-25 years Older than 50 years
17.06 Here is a list of factors that might 
trigger or exacerbate abscesses, tick for 







Answer on a scale from 0 to 10, where 0 corresponds to no symptoms and 10 correspond 







· How much are you affected 
 by your psoriasis today? ...............................
0 1 2 3 4 5 6 7 8 9 10
· How much are you affected by
 your psoriasis when it is most severe?  .............
17.02 Atopic eczema
· How much are you affected by
 your atopic eczema today? .......................
· How much are you affected by your
 atopic eczema when it is most severe?
 
17.03 Hand eczema
· How much are you affected by
 your hand eczema today? ..........................
· How much are you affected by your
 hand eczema when it is most severe? ......
17.04 Acne 
· How much are you affected by
 your acne today? ............................................
· How much are you affected by
 your acne when it is most severe? ....
17.05 Abscesses
· How much are you affected by
 your abscesses today? ..............................
· How much are you affected by your
 abscesses when it is  most severe? ..
Should you wish to give us a written feedback on either the questionnaire or The Tromsø 
Study in general, you are welcome to do it here:
FEEDBACK







Institute of community medicine, University of Tromsø
9037 TROMSØ
Telephone:  77 64 48 16
Telefax: 77 64 48 31
email: tromsous@ism.uit.no
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